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ABSTRACT 
 
 
Bacterial keratitis and bacterial endophthalmitis are two of the most devastating sight 
threatening eye infections. It is currently unclear whether the organisms isolated from 
these infections represent specialised members of these species or whether all strains 
are equally likely to cause infection. One method of differentiating strains 
genotypically is by a typing technique known as multilocus sequence typing (MLST). 
Using this technique, a better understanding of the molecular epidemiology of eye 
infections can be achieved.    
 
Propionibacterium acnes (P. acnes) is an important anaerobic organism causing 
several types of eye infections. Although it is now beginning to be recognised as a 
serious opportunistic pathogen, few studies have been done to investigate the 
population biology of P. acnes at the molecular level. Our continuing inability to 
distinguish between strains of P. acnes means that we still do not fully understand 
how antibiotic-resistant strains spread, nor whether certain strains, or clonal 
complexes, of P. acnes are associated with certain infections. These are key issues that 
can now be understood with our development of an MLST system for P. acnes. A 
diverse culture collection of 125 P. acnes isolates have been analysed using the MLST 
scheme developed. Sequence analysis shows that there are phylogenetically distinct 
groups within P. acnes and identified a novel cluster not previously described. 
Analysis of recombination using several methods suggests that frequent 
recombination occurs within these subgroups. There appears to be no association 
between these subgroups and clinical manifestation of P. acnes infection or 
geographical location. The P. acnes MLST scheme was validated against 16S rRNA 
gene and complete recA gene typing as well as immunofluorescence microscopy 
(IFM) and random amplification of polymorphic DNA (RAPD) analysis.   
 
P. acnes is a slow growing organism and is difficult to culture from ocular samples. A 
real-time PCR assay was developed in order to overcome the low culture positive rate 
and delay associated with conventional culture methods. Primers targeting one of the 
seven housekeeping genes used in the MLST scheme (gmk), specific for P. acnes 
were selected. The real-time PCR assay was both specific to P. acnes and highly 
sensitive.  
 
Pseudomonas aeruginosa (P. aeruginosa) is another important organism in the 
development of serious eye infections, and is the commonest cause of contact lens 
related microbial keratitis. Infections with this organism can lead to rapid deterioration 
of vision and possible blindness. A previously developed MLST scheme has been 
applied to 117 eye isolates from around the UK and China. This typing data was 
compared to 166 P. aeruginosa isolates from other clinical and environmental 
sources. Overall, MLST data supports previous findings that P. aeruginosa has a non-
clonal population with epidemic clones. Sequence analysis showed that eye isolates do 
not cluster away from isolates from other clinical infection sites.   
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Chapter 1  Introduction 
 
CHAPTER 1 INTRODUCTION 
 
1.1 Infections of the eye 
 
1.1.1 Anatomy of the eye 
The eyeball is made up of two main segments; the anterior segment and the 
posterior segment. The cornea is a transparent structure at the front of the eye 
(Figure 1.1). Its transparency allows light to enter the eye and it acts as the main 
refractive structure, focusing light onto the retina (Snell & Lemp, 1998). The 
cornea also serves as a protective physical barrier against the environment, with 
the aid of the tear film. Tears contain lysozyme, immunoglobulin A (IgA) and 
beta-lysin (bactericidal protein), which contribute to protection against infection 
(Doane, 1981; Ffooks, 1962).  
 
The anterior and posterior chambers of the eye are filled with a clear fluid called 
aqueous humour (Snell & Lemp, 1998). This fluid contains glucose, amino acids, 
ascorbic acid and dissolved gases, which help to provide the metabolic needs of 
the avascular lens and cornea (Snell & Lemp, 1998).  
  
The vitreous body fills the space between the lens and the retina, occupying about 
four-fifths of the eyeball (Bron et al., 2001). The vitreous fluid is a colourless, 
transparent, gelatinous substance consisting of 98% water. It also contains 
hyaluronic acid, amino acids, soluble proteins, salts and ascorbic acid (Snell & 
Lemp, 1998). Importantly, the vitreous body allows light to be transmitted to the 
retina. It supports the back of the lens and assists in supporting the neural part of 
the retina against the pigmented part of the retina (Snell & Lemp, 1998).  
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Figure 1.1 Anatomy of the eyeball.  
Taken from www.matossianeye.com/anatomy.htm 
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1.1.2 Microbial keratitis 
 
1.1.2.1 Epidemiology  
It is estimated that around 38 million people globally are bilaterally blind and 
about 110 million have severely impaired vision in both eyes (WHO, 1997). 
Corneal disease is one of the major causes of blindness in the world, second only 
to cataracts, and includes a wide range of infectious and inflammatory eye 
diseases (Whitcher et al., 2001). The prevalence of corneal blindness differs in 
each country and even varies from one population to another (Smith & Taylor, 
1991). In parts of Africa and Asia, the incidence of cornea-related visual loss in 
children is 20-times higher than in developed countries (Whitcher et al., 2001). 
The epidemiology of corneal blindness is diverse and those of worldwide 
importance include trachoma, onchocerciasis, leprosy, ophthalmia nenatorum and 
xerophthalmia (Whitcher et al., 2001). Recent public health programmes to 
control these causes have resulted in a decrease in cases but has highlighted the 
significance of ocular trauma and corneal ulceration in corneal blindness 
(Whitcher et al., 2001). 
 
The incidence of ulcerative keratitis due to infection varies greatly between 
different countries. In Olmsted County, Minnesota, USA, the incidence was 11 
per 100,000 per year (Erie et al., 1993). Applying this incidence rate to the 1990 
US population yields an estimate of 27,000 corneal ulcers annually. In contrast, 
the annual incidence of corneal ulceration in Madurai District, South India was 
113 per 100,000 (Gonzales et al., 1996). By applying this rate to all of India, 
around 840,000 people per year develop an ulcer (Whitcher et al., 2001). 
Extrapolating the data to the rest of Africa and Asia, the number of corneal ulcers 
occurring annually in the developing world is estimated to be 1.5-2 million 
(Whitcher et al., 2001). This is likely to be an underestimate as in Bhaktapur 
District, Nepal, the annual incidence of corneal ulceration was found to be 799 per 
100,000 people (Upadhyay et al., 2001), 70 times the rate in the United States.      
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1.1.2.2 Clinical findings 
Patients with corneal ulceration often complain of pain, photophobia, watering of 
the eyes, foreign body sensation, redness and decreased vision (Agrawal et al., 
1994). The anterior segment of the eye is usually inflamed and congested. The 
eyelids may be oedematous and the palpebral conjunctivae inflamed. Diffuse 
conjunctival vessel injection and chemosis are commonly observed. Discharge 
from the eye may be thick and is often mucoid to purulent in consistency. The 
infected area of the cornea usually has a focal area of stromal infiltrate with an 
overlying epithelial defect (Figure 1.2 and 1.3). The cornea may become 
oedematous and visual acuity is reduced. The severity and degree of visual loss 
depends on the extent and location of the lesion. Severe cases can lead to 
profound anterior chamber reaction and hypopyon (accumulation of white blood 
cells in the anterior chamber). Ciliary body inflammation can cause hypotony 
(low intraocular pressure). However, the presence of inflammatory cells in the 
aqueous may also block the trabecular meshwork, leading to an increase in the 
intraocular pressure (Suwan-Apichon et al., 2007).    
 
Microbial keratitis is relatively rare in the absence of any predisposing factors and 
only 8% to 15% of patients with microbial keratitis do not have an identifiable 
risk factor (Bourcier et al., 2003; Keay et al., 2006; Seal et al., 1999; Wong et al., 
2003). Contact lens wear is now the most common risk factor for developing a 
corneal infection in developed nations (Bourcier et al., 2003; Schaefer et al., 
2001). This is followed by ocular surface disease, such as herpetic infection, 
Sjögren’s syndrome, severe blepharitis, bullous keratopathy and basement 
membrane dystrophy (Seal et al., 1999). Ocular trauma and ocular surgery, 
including corneal grafts, are also predisposing factors to microbial keratitis (Bates 
et al., 1990; Harris et al., 1988; Keay et al., 2006; Wong et al., 2003).  
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Figure 1.2 Pseudomonas corneal ulcer. 
Image from http://mcrcr4.med.nyu.edu/Ophth/dosc/cornea.htm
 
 
 
 
Figure 1.3 Bacterial corneal ulcer with hypopyon. 
Image from http://bestpractice.bmj.com/best-
practice/monograph/561/resources/images.html 
 
 
 
HypopyonCorneal ulcer 
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Any laser refractive surgical procedure which breaches the epithelial barrier poses 
a small risk of infection of the cornea, with an estimated 0.02% to 0.1% 
occurrence in laser in situ keratomileusis (LASIK) (Alio et al., 2000; Aras et al., 
1998; Levartovsky et al., 2001; Lin & Maloney, 1999; Quiros et al., 1999; 
Reviglio et al., 1998; Watanabe et al., 1997). Bacterial keratitis has also been 
reported after laser-assisted subepithelial keratectomy (LASEK), another surgical 
technique used to correct refractive error (Laplace et al., 2004). 
 
1.1.2.3 Causative organisms  
The spectrum of microbial organisms is partly dependant on the climatic 
conditions. Gram-positive bacteria and Acanthamoeba, associated with contact 
lens wear are commonly found in temperate climates such as in the UK (Tuft & 
Matheson, 2000). In contrast, P. aeruginosa and filamentous fungi tend to 
predominate in tropical and semitropical areas such as South Florida (Liesegang 
& Forster, 1980), Ghana (Hagan et al., 1995), Bangladesh (Dunlop et al., 1994; 
Williams et al., 1991) and South India (Bharathi et al., 2007; Srinivasan et al., 
1997).  
 
At Moorfields Eye Hospital in London, a study of bacterial keratitis cases 
demonstrated that of the 1,312 organisms isolated, Gram-positive organisms 
accounted for 54.7%, and the most common organisms were Staphylococcus spp. 
(33.4%), Pseudomonas spp. (24.8%), Streptococcus spp. (19.0%), Moraxella spp. 
(5.9%) and Serratia spp. (3.0%) (Tuft & Matheson, 2000).  
 
A study in Florida demonstrated that of the 1,338 organisms isolated, the overall 
numbers of Gram-positive and Gram-negative isolates were similar (48% and 
50% respectively) (Alexandrakis et al., 2000a). P. aeruginosa and S. aureus were 
the most common isolated organisms (25.7% and 19.4%, respectively). Over the 
9-year study period, 108 (8%) P. acnes isolates were also recovered. 
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A recent study in Taiwan showed that of the 272 bacterial pathogens isolated, 
32.4% were Gram-positive and 61% were Gram-negative (Fong et al., 2007). The 
remainder were non-tuberculous Mycobacterium. Pseudomonas spp. were again 
demonstrated to be the most commonly isolated organism (46.7%), followed by 
Staphylococcus spp. (11%), Propionibacterium spp. (8.1%), Streptococcus spp. 
(7.6%), and non-tuberculous Mycobacterium (6.6%). 
 
A study in Aukland, New Zealand looking at 103 cases of presumed infective 
keratitis found a high proportion of Gram-positive organisms (72%) (Wong et al., 
2003). The most common organisms identified were coagulase-negative 
Staphylococcus (16.4%), P. acnes (13.9%), S. epidermidis (11.5%), S. 
pneumoniae (9%), S. aureus (5.7%) and P. aeruginosa (5.7%).  
 
Bourcier et al. investigated 300 cases of bacterial keratitis in Paris and also 
observed a high percentage of Gram-positive bacteria (83%) (Bourcier et al., 
2003). The most common organisms identified were coagulase-negative 
Staphylococcus (48.5%), P. acnes (15%), P. aeruginosa (10.2%) and S. aureus 
(7.8%). In the contact lens wear group, P. aeruginosa was the most common 
organism identified. 
 
1.1.2.4 Conventional diagnosis  
Microbial keratitis is a sight threatening condition, and if delay in the diagnosis 
and initiation of appropriate antibiotics occur, then only 50% of eyes are 
estimated to heal with a good visual prognosis (Jones, 1981). Definitive diagnosis 
of microbial keratitis requires culture of the causative organism from a corneal 
scrape sample. This can be obtained using a Kimura spatula or the tip of a sterile 
disposable needle (Tuft & Matheson, 2000). Smears are routinely examined by 
Gram staining and also inoculated onto solid and liquid media (e.g. blood agar, 
Robertson’s cooked meat, thioglycolate broth, and brain heart infusion broth) 
(Tuft & Matheson, 2000).  
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Culture positive rates from corneal scrapes vary considerably from centre to 
centre. Studies from around the world have demonstrated culture positive rates 
ranging from 50% to 86% (Alexandrakis et al., 2000a; Bennett et al., 1998; 
Bourcier et al., 2003; Fong et al., 2007; Neumann & Sjostrand, 1993; Schaefer et 
al., 2001; Wong et al., 2003). In cases where corneal scrape cultures are negative 
and the clinical course worsens despite intensive topical antimicrobial treatment, a 
cornea biopsy may help in providing material for culture and histopathologic 
examination (Allan & Dart, 1995). Alexandrakis et al. observed a positive culture 
result in 27 (82%) of 33 corneal biopsies taken for microbial keratitis 
unresponsive to intense topical treatment (Alexandrakis et al., 2000b).   
 
Confocal microscopy is a non-invasive, high-contrast imaging technique which 
allows direct visualisation of the organisms in vivo and can be helpful in 
diagnosing fungal and Acanthamoeba keratitis (Brasnu et al., 2007; Matsumoto et 
al., 2007).   
 
1.1.2.5 Treatment 
Treatment for microbial keratitis is commenced once cultures have been obtained 
from the lesion to enable identification of the organism and test its sensitivity to 
antibiotics. Gram stain result has been used to determine initial therapy (Jones, 
1979; Sharma et al., 2007) but this is not always available and may not be reliable 
enough to select a specific antibiotic. The mainstay of treatment for microbial 
keratitis has been a combination treatment (dual therapy) of two fortified 
antibiotic preparations to cover the whole range of Gram-positive and Gram-
negative pathogens (Tuft & Matheson, 2000). Despite its effectiveness, problems 
with toxicity of the aminoglycosides and the poor stability at room temperature of 
fortified preparations, has led to the use of alternative antibiotic treatments (Bowe 
et al., 1991; Davison et al., 1991; Petroutsos et al., 1984). Monotherapy with 
fluoroquinolones (e.g ofloxacin and ciprofloxacin) became a popular alternative to 
combination therapy due to their broad spectrum coverage, low toxicity, good 
corneal penetration and their efficacy at a commercially available strength (Chin 
& Neu, 1984; Diamond et al., 1995; McDermott et al., 1993; Neu, 1991; Price et 
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al., 1995). Unfortunately, the systemic use of fluoroquinolones resulted in rapid 
emergence of resistance, especially in Staphylococcus spp. and Pseudomonas spp. 
(Ball, 1990; George et al., 1990; Humphreys & Mulvihill, 1985; Raviglione et al., 
1990). Fluoroquinolone resistant bacterial keratitis isolates were then reported 
(Bower et al., 1996; Knauf et al., 1996; Maffett & O'Day, 1993; Snyder & Katz, 
1992), with high rates of resistance at some centres (Garg et al., 1999; Goldstein 
et al., 1999; Kunimoto et al., 1999b). 
 
A study done in London looking at bacterial keratitis cases between 1984 and 
1999 did not find an increase in resistance against the combination therapy of 
cefuroxime and gentamicin or monotherapy with ofloxacin (Tuft & Matheson, 
2000). However, it did identify a significant increase in the proportion of Gram-
negative organisms resistant to chloramphenicol, the routine prophylactic 
treatment of corneal epithelial defects at the centre (Tuft & Matheson, 2000).  
 
In Florida, S. aureus resistance to fluoroquinolones amongst eye isolates increased 
from 11% in 1990 to 28% in 1998. S. aureus resistance to aminoglycosides (e.g. 
tobramycin and gentamicin) was 11% over the whole study period, with little 
fluctuation between the years. In contrast to S. aureus, P. aeruginosa only showed 
1% resistance to fluoroquinolones and 0.6% to aminoglycosides (Alexandrakis et 
al., 2000a). From their findings, the authors recommended initial empiric 
intensive treatment using either a fluoroquinolone or fortified cefazolin with a 
fortified aminoglycoside (Alexandrakis et al., 2000a). 
 
Newer topical fluoroquinolones, including third-generation levofloxacin and 
fourth-generation gatifloxacin and moxifloxacin, have been introduced. These 
provide better corneal penetration, greater potency for Gram-positive organisms 
and reduced likelihood of resistance compared to ciprofloxacin and ofloxacin 
(Alfonso & Crider, 2005; Blondeau, 2004; Hwang, 2004).   
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The role of corticosteroids as adjunctive therapy to topical antimicrobials remains 
controversial. Many practitioners are cautious about using corticosteroids as their 
immunosuppressive effect may potentiate bacterial replication and delay healing 
of the corneal ulcer. However, if adequate sterilisation has been achieved, 
corticosteroids can be beneficial in reducing the inflammatory response and 
limiting neovascularisation and scarring (Suwan-Apichon et al., 2007). In severe 
cases of corneal ulceration when antibiotic treatment has failed, penetrating 
keratoplasty (corneal graft transplant) has been necessary for therapy or visual 
rehabilitation (Chen et al., 2004; Miedziak et al., 1999).  
 
1.1.3 Endophthalmitis 
 
1.1.3.1 Background 
Endophthalmitis is an inflammatory reaction of intraocular fluids or tissues of the 
eye following introduction of an infectious organism into the posterior segment of 
the eye. Organisms enter the eye through one of the following routes: (a) as a 
consequence of intraocular surgery (postoperative), (b) following penetrating 
injury of the globe (posttraumatic), or (c) from haematogenous spread of infection 
to the eye from a distant anatomical site (endogenous) (Callegan et al., 2002). 
90% of postoperative endophthalmitis occurs after cataract surgery (Verbraeken, 
1995), as this is the most frequently performed surgical procedure in the UK and 
US (http://www.dh.gov.uk). Other procedures that can lead to postoperative 
endophthalmitis include pars plana vitrectomy (Eifrig et al., 2004), penetrating 
keratoplasty (Taban et al., 2005a), glaucoma filtering procedures (Busbee et al., 
2004), strabismus surgery (Recchia et al., 2000), pterygium excision (Farrell & 
Smith, 1989) and suture removal (Culbert & Devenyi, 1999). 
 
Over 300,000 cataract operations are carried out in England and Wales each year 
(http://www.dh.gov.uk) and the incidence of endophthalmitis following cataract 
surgery has been estimated to range from 0.06% to 0.30% (Aaberg et al., 1998; 
Kamalarajah et al., 2004; Norregaard et al., 1997; Powe et al., 1994; Somani et 
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al., 1997; Taban et al., 2005b; Wejde et al., 2005; West et al., 2005). This gives 
an estimated 180 to 900 cases of postoperative endophthalmitis after cataract 
surgery per year. Alarmingly, endophthalmitis rates have increased over the past 
decade (Taban et al., 2005a), possibly related to more frequent use of clear 
corneal incisions (Cooper et al., 2003; Nagaki et al., 2003). 
 
1.1.3.2 Clinical findings 
 
Acute postoperative endophthalmitis 
Acute postoperative endophthalmitis is classified as endophthalmitis occurring 
within six weeks of surgery (Kresloff et al., 1998). Ciliary injection, chemosis and 
lid oedema may be present. If infection spreads to the orbit, restriction of 
extraocular movement and proptosis may occur. Signs and symptoms of 
intraocular inflammation include decreased visual acuity, afferent pupillary 
defect, pain, hypopyon, corneal oedema, corneal infiltrate, fibrin in the anterior 
chamber, vitreous inflammation, retinitis, and retinal periphlebitis (Figure 1.4 and 
1.5) (Kresloff et al., 1998).   
 
Chronic postoperative endophthalmitis 
Postoperative endophthalmitis occurring more than six weeks after surgery is 
classified as chronic (Kresloff et al., 1998). Patients typically present with a 
persistent low-grade uveitis that may respond to corticosteroids. However, they 
may also present with the same signs and symptoms as acute postoperative 
endophthalmitis. A small hypopyon may be visible. The uveitis is commonly 
granulomatous, usually with vitritis. Fibrin strands may be present in the anterior 
chamber and keratic precipitates may be seen on the intraocular lens as well as on 
the corneal endothelium. A white plaque on the posterior capsule, intraocular lens 
or retained lens particles suggests the diagnosis (Carlson et al., 1998). This plaque 
contains a mixture of lens material and adherent organisms and may be observed 
in both bacterial and fungal infections (Chien et al., 1992).  
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Figure 1.4 Postoperative endophthalmitis. 
Image from www.revophth.com/index.asp?page=1_13822.htm 
 
 
 
 
 
 
Figure 1.5 Serratia marcescens endophthalmitis with scleral injection, corneal 
oedema and hypopyon (Williams et al., 2006). 
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1.1.3.3 Causative organisms  
The ocular surface and adnexa (e.g. eye lids, lacrimal sac and conjunctiva) are 
thought to be the main sources of organisms for postoperative endophthalmitis 
(Bannerman et al., 1997; Kresloff et al., 1998; Speaker et al., 1991). Molecular 
techniques showed that the external bacterial flora matched the bacteria isolated 
from vitrectomy specimens in 14 of 17 (82%) cases of postoperative 
endophthalmitis (Speaker et al., 1991). Outbreaks or clusters of endophthalmitis 
cases may have originated from external sources, such as contaminated surgical 
instruments, irrigation solutions, donor corneas, tubing, intraocular lenses, 
airborne contaminants, and viscoelastics (Arsan et al., 1996; Roy et al., 1997).    
 
Acute postoperative endophthalmitis 
The Endophthalmitis Vitrectomy Study (EVS) demonstrated that of the 69% of 
patients with culture-positive endophthalmitis, 70% were infected with coagulase-
negative staphylococci (mostly S. epidermidis), 10% with S. aureus, 9% with 
Streptococcus spp., 2% with Enterococcus spp., 3% with other Gram-positive spp. 
and 6% with Gram-negative spp. (Doft, 1991; Han et al., 1996). P. acnes and 
fungi, commonly associated with delayed-onset infections, may also cause acute 
postoperative endophthalmitis (Stern et al., 1989; Winward et al., 1993). 
 
Chronic postoperative endophthalmitis 
P. acnes is the most common cause of chronic postoperative endophthalmitis, 
followed by S. epidermidis (and other coagulase-negative Staphylococcus spp.), 
fungi (mainly Candida spp.), anaerobic Streptococcus spp., Actinomyces spp., and 
Nocardia asteroids (Fox et al., 1991; Menikoff et al., 1991; Rao et al., 1991; 
Roussel et al., 1991; Zimmerman et al., 1993).   
 
1.1.3.4 Risk factors 
Preoperative risk factors include blepharitis, conjunctivitis, canaliculitis, 
dacryocyctitis, lacrimal duct obstruction, contact lens wear, ocular prosthesis in 
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the fellow orbit (Morris et al., 1993), immunosuppression, diabetes mellitus 
(Johnson et al., 1997; Phillips & Tasman, 1994), upper respiratory tract infections 
(Wilson, 1987), atopic dermatitis and keratoconjunctivitis sicca (Sunaric-
Megevand & Pournaras, 1997). Intraoperative risk factors include suboptimal lid 
and conjunctival disinfection, prolonged length of surgery of more than sixty 
minutes, vitreous loss, use of prolene haptic intraocular lenses, and ocular 
penetration during ocular surface surgery (Menikoff et al., 1991). Postoperative 
risk factors include wound leak/dehiscence, inadequately buried sutures, suture 
removal, vitreous incarceration in the surgical wound, and the presence of a 
filtering bleb (Katz et al., 1985; Wolner et al., 1991).   
 
1.1.3.5 Prophylaxis 
If risk factors for developing postoperative endophthalmitis are identified prior to 
surgery then it is important to control or treat these beforehand. Some 
ophthalmologists routinely perform conjunctival cultures preoperatively on 
patients with risk factors for developing endophthalmitis, although their value is 
debatable (Hara & Hoshi, 1996; Starr, 1983).  
 
It has been shown that preoperative administration of topical 5% povidone-iodine 
solution into the conjunctival sac significantly reduced the incidence of 
endophthalmitis as compared to silver protein solution (Speaker & Menikoff, 
1991). Povidone-iodine has been shown to be effective against bacteria, fungi, 
viruses, protozoa and spores (Boes et al., 1992). Prophylactic preoperative topical 
antibiotics are commonly used even in the absence of risk factors. This is based 
on the fact that a reduction in the number of organisms after a 1- or 2-day 
preoperative antibiotic course have been observed (Burns & Oden, 1972; Shapiro, 
1982). More recently, it has been shown that topical moxifloxacin may provide 
protection against S. aureus endophthalmitis in a rabbit model (Kowalski et al., 
2004). However, prophylactic use of topical antibiotics is expensive, may lead to 
antibiotic resistance and can induce allergic reactions. 
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Subconjunctival antibiotics administered postoperatively may bypass the corneal 
epithelial barrier, allowing diffusion of high concentrations of the drug into the 
corneal stroma and aqueous humour. However, vitreous concentrations remain 
low. Current clinical data remain inconclusive, despite experimental evidence that 
subconjunctival injections of ceftazidine, gentamicin, and ciprofloxacin prevent 
endophthalmitis after cataract extraction (Ng et al., 1996).  
 
1.1.3.6 Conventional diagnosis 
Once infectious endophthalmitis is suspected, urgent diagnosis and prompt 
therapeutic management is essential in preventing severe visual loss. 
Conventional diagnosis relies on obtaining intraocular fluid (aqueous humour and 
vitreous humour) for culture and Gram stain. Vitreous samples yield positive 
cultures more often than aqueous samples (Barza et al., 1997; Forster, 1978; 
Forster et al., 1980). Nonetheless, aqueous samples have been found to be the sole 
source of positive culture in a minority of cases (Barza et al., 1997; Mollan et al., 
2007). Therefore, combination of aqueous and vitreous sample is required to 
provide the optimal diagnostic yield (Mollan et al., 2007). In chronic 
postoperative endophthalmitis, intraocular plaques should also be cultured.  
 
Aqueous material can be obtained with a 30-gauge needle attached to a tuberlin 
syringe through a limbal stab incision into the anterior chamber, and 0.1-0.2ml of 
fluid aspirated. Vitreous specimen may be obtained by vitreous needle tap using a 
27-22 gauge needle attached to a tuberlin syringe or by vitreous biopsy with a 
vitrectomy probe attached to a tuberlin syringe. 0.1-0.3ml of vitreous is then 
removed from the anterior vitreous cavity (Kresloff et al., 1998; Lemley & Han, 
2007).  
 
Intraocular fluids should be directly inoculated on blood agar, chocolate agar, and 
thioglycolate broth, and incubated at 37ºC (Speaker & Menikoff, 1993). Samples 
should also be inoculated on Sabouraud’s agar and incubated at 25ºC to isolate 
fungi. Aerobic and anaerobic blood culture bottles may also be inoculated with 
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vitreous samples, as they provide results comparable to those with direct solid 
media inoculation or membrane filtering systems (Joondeph et al., 1989). Chronic 
endophthalmitis cases should be maintained for a minimum of two weeks to grow 
anaerobes and fungi. Samples should also be placed on glass slides for Gram and 
Giemsa stain. Although smears should be used to guide initial therapy, specific 
treatment should be dictated by culture results, as only approximately two thirds 
of smears in culture-positive cases are consistent with the organism cultured 
(Durfee & Smith, 1982; Forster et al., 1980). Results of antibiotic susceptibility 
testing of any cultured organism is essential for appropriate antimicrobial 
treatment (Kresloff et al., 1998). 
 
A positive culture is determined by growth of the same organism on two different 
media, confluent growth on a solid medium, or any growth in an anaerobic 
medium (Forster et al., 1980; Hibberd et al., 1991; Speaker et al., 1991). Current 
culture techniques may yield a positive result in approximately 22% to 30% of 
aqueous humour (Auclin et al., 2001; EVSG, 1995; Fisch et al., 1991; Ng et al., 
2005) and 40% to 69% of vitreous humour (Donahue et al., 1993; EVSG, 1996; 
Han et al., 1999; Kunimoto et al., 1999a; Ng et al., 2005; Sharma et al., 1996). 
This low detection rate may reflect low microbial count, sterilisation of infection 
by host defenses (Meredith et al., 1990), sequestration of organisms in phagocytes 
or retained lens material, infection by fastidious organisms, or sterile 
inflammation (Speaker & Menikoff, 1993).  
 
Electron microscopy may be used to visualise microorganisms within phagocytes 
and to identify organisms (Sawusch et al., 1989). Ultrasound visualisation of the 
globe should be carried out if significant opacification of media prevents adequate 
view of the fundus. Vitreous opacities secondary to vitritis and chorioretinal 
thickening are consistent with a diagnosis of endophthalmitis. The presence of 
retinal or choroidal detachment, dislocated lens material, or retained foreign 
bodies should be excluded on ultrasound examination (Lemley & Han, 2007).  
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1.1.3.7 Treatment 
 
Acute postoperative endophthalmitis 
Injection of intravitreal antibiotics is the mainstay of treatment for acute 
postoperative endophthalmitis. The intraocular concentration of antibiotics after 
intravitreal injection is greater than that achieved by any other modality, such as 
topical and subconjunctival (Baum et al., 1982; EVSG, 1995). Because rapid 
initiation of therapy is essential for the successful treatment, antibiotics must be 
initiated before culture results are available. Vancomycin is considered the drug of 
choice for the Gram-positive organisms, including methicillin-resistant 
Staphylococcus spp. and Bacillus cereus (EVSG, 1995). Aminoglycosides 
(gentamicin and amikacin) have traditionally been recommended for Gram-
negative coverage. However, several clinical and laboratory reports have shown 
that aminoglycosides are toxic to the retina and retinal pigment epithelium (RPE) 
at doses close to therapeutic (Bennett & Peyman, 1974; Campochiaro & Conway, 
1991; Campochiaro & Lim, 1994; D'Amico et al., 1985; McDonald et al., 1986). 
In view of this, ceftazidime has now been recommended as an alternative 
antibiotic to cover Gram-negative organisms because of its broad therapeutic 
index, lower risk of retinal toxicity, and in vitro antimicrobial activity, which is as 
effective as the aminoglycosides against Gram-negative bacteria (Lemley & Han, 
2007; Mochizuki et al., 1992; Roth & Flynn, 1997). Sensitivities of Gram-positive 
bacteria to vancomycin and Gram-negative bacteria to ceftazidime have been 
shown to be 99% and 100% respectively in the US (Recchia et al., 2005). In 
India, however, susceptibilities of Gram-negative bacteria to amikacin and 
ceftazidime have been observed to be only 68% and 63% respectively (Anand et 
al., 2000) In suspected cases of vancomycin-resistant enterococcus 
endophthalmitis, ampicillin or linezolid have been suggested as alternatives 
(Lemley & Han, 2007; Roth & Flynn, 1997). If no clinical improvement occurs or 
if worsening is noted within 48 to 72 hours, repeat vitreous tap and injection of 
antibiotics (plus pars plana vitrectomy) should be considered, as a single 
intravitreal injection is not always adequate.   
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In addition to intravitreal antibiotics, subconjunctival and topical antibiotics are 
often used in the treatment of postoperative endophthalmitis. The aim is to 
increase the number of routes of antibiotic delivery to increase the likelihood of 
achieving high concentrations of antibiotics within the eye and also to achieve 
higher anterior segment concentrations than are obtainable with intravitreal 
injections alone (Barza, 1989). However, several studies have shown no 
additional benefit with subconjunctival antibiotics when given in combination 
with intravitreal antibiotics (Iyer et al., 2004; Smiddy et al., 1989). Topical 
antibiotics are able to penetrate the anterior chamber much more efficiently than 
the vitreous (Costello et al., 2006; Solomon et al., 2005).  
 
Intravenous and oral antibiotics have been advocated in the past as adjunct 
treatments of postoperative infectious endophthalmitis, although controversy 
exists as to their benefit (Davis, 1996; Engelbert et al., 2004; Hariprasad et al., 
2002; Hariprasad et al., 2003; Hariprasad et al., 2006). Despite the fact that the 
blood-ocular barrier may not be intact in an inflamed eye, it is unclear whether 
intravitreal antibiotic levels are adequate after intravenous administration 
(Pflugfelder & Flynn, 1992). If intravenous therapy is considered necessary, 
vancomycin or cefazolin may be appropriate choice for Gram-positive coverage, 
and ceftazidime for Gram-negative coverage (Kresloff et al., 1998).  
 
To reduce the destructive effect of the host inflammatory response to the infection 
in endophthalmitis, many ophthalmologists use systemic, topical, subconjunctival, 
and intravitreal corticosteroids in combination with antibiotics (Maxwell et al., 
1991; Yoshizumi et al., 1998). However, as the evidence for corticosteroid benefit 
is limited, its use should be carefully considered, especially in patients with 
contraindications (Das et al., 1999; Shah et al., 2000). Vitrectomy (surgical 
cutting and aspiration of vitreous contents and replacement with balanced salt 
solution) has several potential advantages including reduction of infecting 
organisms and their toxins, removing vitreous membranes that could lead to 
retinal detachment and improving intraocular antibiotic distribution. However, the 
absence of vitreous might also predispose to higher levels of drug toxicity as well 
as drug clearance. Controversy still exists as to whether therapeutic vitrectomy is 
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necessary in all cases of endophthalmitis and most ophthalmologists tend to 
reserve therapeutic vitrectomy for severe cases (Kresloff et al., 1998). 
 
Chronic postoperative endophthalmitis 
Treatment of chronic postoperative endophthalmitis involves administration of 
intravitreal antibiotics. If inflammation is not severe, antibiotic therapy can be 
delayed until smear, culture, and sensitivity data are available from aqueous and 
vitreous specimens (Kresloff et al., 1998). However, if inflammation is severe, 
then management is the same as for acute postoperative endophthalmitis. Surgical 
removal of vitreous infiltrate and partial capsulectomy, including areas of white 
capsular plaque, is sometimes required (Aldave et al., 1999). Removal of the 
intraocular lens and total capsulectomy may be necessary to completely eliminate 
the infection and prevent recurrent inflammation (Aldave et al., 1999; Kresloff et 
al., 1998; Winward et al., 1993; Zambrano et al., 1989). 
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1.2 Propionibacterium acnes 
 
1.2.1 Background 
Propionibacterium acnes (P. acnes), Propionibacterium avidum (P. avidum), 
Propionibacterium granulosum (P. granulosum) and Propionibacterium 
propionicus (P. propionicus) belong to the human cutaneous propionibacteria 
(Perry & Lambert, 2006). In the past, P. acnes has been designated as Bacillus 
acnes, Corynebacterium acnes (Marples & McGinley, 1974) and 
Corynebacterium parvum (Eady & Ingham, 1994).  
 
P. acnes is a Gram-positive, non-sporulating pleomorphic rod that forms part of 
the normal skin microbiota, but also inhabits the conjunctiva, oral cavity, external 
ear canal, respiratory tract, genitourinary tract and large intestine (Brook & 
Frazier, 1991; Funke et al., 1997; Ingham, 1999). P. acnes is capable of growing 
under aerobic conditions but it is treated as an anaerobe in the clinical setting as 
anaerobic conditions are necessary for optimal isolation from specimens (Cove et 
al., 1983). P. acnes is still frequently dismissed as a contaminant when isolated 
from clinical samples due to the perception that it has a very low pathogenic 
potential and, therefore, low capacity to cause infection (Jakab et al., 1996). This 
view now appears incorrect as increasing numbers of reports are linking the 
organism to a range of serious conditions including postoperative endophthalmitis 
(Aldave et al., 1999), keratitis (Jones & Robinson, 1977; Perry et al., 1982; Wong 
et al., 2003; Zaidman, 1992), endocarditis (Brook, 2002; Pan et al., 2005; 
Vandenbos et al., 2001), osteomyelitis (Sulkowski et al., 1994), central nervous 
system infections (Beeler et al., 1976; Ramos et al., 1995; Richards et al., 1989), 
fatal bacterial granuloma after trauma (FBGT) (Gao et al., 2002), septic arthritis 
(Yocum et al., 1982), prosthetic hip infections (Tunney et al., 1999), SAPHO 
syndrome (synovitis, acne, pustulosis, hyperostosis and osteitis) (Kirchhoff et al., 
2003), sarcoidosis (Eishi et al., 2002; Moller & Chen, 2002; Yasuhara et al., 
2005), prostate cancer (Cohen et al., 2005) and periodontal and dental infections 
(Goldberg, 1971; Le Goff et al., 1997). P. acnes also plays an important role in 
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the pathogenesis of the common skin condition acne vulgaris (Leyden et al., 
1998).  
 
The genome of P. acnes strain KPA171202 (GenBank accession no. AE017283, 
Gottingen Genomics Laboratory, www.g21.bio.uni-goettingen.de) is currently the 
only completely sequenced species of the genus Propionibacterium (Bruggemann 
et al., 2004). Based on recent recA and tly phylogenetic analyses, this strain was 
identified as a type IB strain (see Section 1.2.2) (McDowell et al., 2005). The 
genome consists of a single circular chromosome of 2,560,265 basepairs, which 
encodes approximately 2,333 genes (Figure 4.1) (Bruggemann et al., 2004). 1,587 
of these genes have been given a predicted function based on significant identity 
to database entries. Publication of the P. acnes genome sequence, as well as more 
recent studies, have further highlighted the pathogenic potential of the organism 
by identifying enzymes involved in tissue degradation, putative toxins, 
immunogenic proteins and phase variable cell surface proteins (Bruggemann et 
al., 2004; Lodes et al., 2006; Valanne et al., 2005).  
 
1.2.2 Population biology of P. acnes 
Johnson and Cummins first identified two distinct phenotypes of P. acnes, known 
as types I and II, based on serological agglutination tests and cell wall sugar 
analysis (Johnson & Cummins, 1972). They demonstrated that the cell walls of 
the type I strains contained galactose, glucose, and mannose whereas those of type 
II strains only contained glucose and mannose (Johnson & Cummins, 1972). No 
difference in the GC content between types I and II, which ranged from 57% to 
60% were observed (Johnson & Cummins, 1972). Fermentation typing (Higaki et 
al., 2000; Kishishita et al., 1979; Pulverer & Ko, 1973), bacteriophage typing 
(Webster & Cummins, 1978), and immunofluorescence with polyclonal antisera 
(Holmberg & Forsum, 1973) have all been used to discriminate between P. acnes 
types I and II. 
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Random amplification of polymorphic DNA (RAPD) carried out on 46 P. acnes 
isolates revealed two distinct genomic profiles (Perry et al., 2003). Although the 
type status of these isolates was not identified, RAPD profiles from the type I 
(NCTC 737) and type II (NCTC 10390) reference strains, did match the two 
RAPD lineages. Amplified-fragment length polymorphism (AFLP) analysis has 
been used to study the molecular relationship of Propionibacterium spp. 
responsible for contamination of platelet concentrates (PCs) and red blood cell 
concentrates (RBCs) (Mohammadi et al., 2005). Based on the AFLP profiles, 
isolates of PCs and the corresponding RBCs were grouped into three main 
clusters, designated groups 1, 2 and 3 (Mohammadi et al., 2005). It was not 
determined whether these groups correlated with the different P. acnes types. 
 
Analysis of the P. acnes recA gene and a more variable haemolysin/cytotoxin (tly) 
gene sequence has demonstrated that types I and II represent distinct phylogenetic 
lineages, although the 16S rRNA gene sequences of these groups share 99.8-
99.9% identity (McDowell et al., 2005). Furthermore, type I strains have been 
subdivided into groups IA and IB based on recA and tly sequences, monoclonal 
antibody (MAb) typing and pulsed-field gel electrophoresis (PFGE) profiles 
(Cohen et al., 2005). PFGE has also been used to investigate the phylogenetic 
relationship between P. acnes isolates with different antibiotic resistance profiles 
(Oprica et al., 2004; Oprica et al., 2005; Oprica & Nord, 2005). Recently, a novel 
lineage of strains, known as type III, has been described (McDowell et al., 2008). 
Type III isolates display an atypical cellular morphology for P. acnes, with long 
slender filaments more characteristic of P. propionicus and Actinomyces spp. The 
16S rRNA gene sequence of type III organisms was found to have 99.8-99.9% 
identity with those of types I and II (McDowell et al., 2008).  
 
Using RAPD analysis, P. acnes isolates from different clinical sources were 
distributed amongst the RAPD profile types (Perry et al., 2003). However, 
McDowell et al. showed that using recA sequencing, P. acnes isolates from bone, 
tissue samples, acne, dental infections and surgical incision sites, were 
predominantly of type I and those cultured from prosthetic hip implants revealed 
similar numbers of types I and II strains (McDowell et al., 2005).  
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1.2.3 Pathogenesis of P. acnes infection 
P. acnes has a ubiquitous presence on human skin, where it usually resides within 
sebaceous follicles as a harmless commensal (Bruggemann, 2005). However, 
there is evidence to show that P. acnes has some features of an opportunistic 
pathogen (Bojar & Holland, 2004; Brook & Frazier, 1991; Csukas et al., 2004; 
Holland et al., 1998; Huynh et al., 1995; Ingham, 1999; Jakab et al., 1996; Jappe 
et al., 2002; Koreck et al., 2003; Merlin et al., 2002). In vitro, P. acnes is slow 
growing and is capable of surviving for up to eight months under anaerobic 
conditions, suggesting that it could also survive in human tissues at low oxidation 
potentials (Csukas et al., 2004). The organism’s complex cell wall structure and 
its surface fibrillar layer render it resistant to phagocytosis by macrophages, where 
it persists intracellularly (Montes & Wilborn, 1970; Webster et al., 1985). 
 
In addition, P. acnes produces several exocellular enzymes (Hoeffler et al., 1977; 
Ingham et al., 1981; Kabongo Muamba, 1982) and metabolites that can directly 
damage host tissue (Allaker et al., 1987). Individuals with acne have been found 
to have elevated levels of P. acnes antibodies (Ashbee et al., 1997; Holland et al., 
1986; Ingham et al., 1987). P. acnes-derived components possess chemoattractant 
properties (Webster & Leyden, 1980) and the organism itself can activate 
complement, leading to the release of C5-dependant chemotactic factors (Webster 
et al., 1978). P. acnes has also been reported to induce the pro-inflammatory 
cytokines, interleukin (IL)-1α. IL-1β, IL-6, IL-8, IL-12 and tumour necrosis factor 
(TNF) - α (Smith et al., 1993b; Tsuji et al., 1999; Vowels et al., 1995).  
 
Extensive research on the modulation of the immune system by bacteria or their 
products has shown that P. acnes is one of the most potent adjuvants (Ingham, 
1999; Jung et al., 2007; Roszkowski et al., 1990). Pre-treatment with heat-killed 
cells of P. acnes provide protection against infection and anti-tumour activity in a 
variety of animal models (Eady & Ingham, 1994). For this reason, P. acnes has 
been used in therapeutic trials designed to combat malignant tumours (Bardana, 
1985; Davies, 1982; DiSaia et al., 1987). 
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 P. acnes Biofilm 
Some microorganisms are capable of producing a biofilm after adherence to a 
surface. A biofilm consists of an aggregation of bacteria that encase themselves 
within an extracellular polysaccharide lining (Burkhart & Burkhart, 2007). 
Multiple microenvironments exist within a biofilm, allowing for the same species 
of bacteria to live in diverse niches with varying rates of metabolism, replication, 
and responsiveness to antibiotics (Burkhart & Burkhart, 2007). Microorganisms 
within biofilms, compared to free-floating (planktonic) bacteria, are 50 to 500 
times more resistant to antimicrobial therapies (Burkhart & Burkhart, 2007). Once 
a biofilm is established, the bacteria undergoes a phenotypic shift in behaviour in 
which genes are up- and down-regulated (Horswill et al., 2007). The existence of 
bacterial biofilm is a common cause of persistent infections (Costerton et al., 
1999), and increased tolerance to antibiotics is a major problem for the 
management of infectious diseases (Donlan, 2001). 
 
The recently published genome sequence of P. acnes (Bruggemann et al., 2004) 
shows that the organism possesses three clusters of genes that encode enzymes 
involved in extracellular polysaccharide biosynthesis, suggesting that it is capable 
of forming extracellular biofilm matrix. Several proteins potentially involved in 
adhesion were also identified (Bruggemann et al., 2004; Burkhart & Burkhart, 
2006). The existence of the P. acnes biofilm has been hypothesized (Burkhart & 
Burkhart, 2003a; Burkhart & Burkhart, 2003b; Burkhart & Burkhart, 2006), but 
conflicting data on the biofilm-forming ability of P. acnes exists. Several studies 
have shown that P. acnes strains can form highly resistant biofilms on various 
orthopaedic biomaterials in vitro (Bayston et al., 2007; Ramage et al., 2003), and 
the failure of hip replacement surgery is often attributed to P. acnes biofilm on the 
implanted material (Tunney et al., 1998). P. acnes recovered from cases of FBGT 
were also shown to be capable of biofilm production and the investigators 
suggested that this led to the failure of antibiotic treatment in these patients (Qi et 
al., 2008). In contrast, Takemura et al. showed the inability of P. acnes to form 
biofilms on dental root filling gutta-percha points (Takemura et al., 2004).  
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1.2.4 P. acnes in postoperative endophthalmitis 
 
Clinical features and pathophysiology 
Delayed-onset endophthalmitis secondary to the P. acnes organism is a well-
recognised complication of cataract surgery (Meisler et al., 1986; Roussel et al., 
1987; Sawusch et al., 1989). Features of P. acnes infection include the presence 
of a white plaque on the posterior capsule or intraocular lens (IOL), hypopyon and 
beaded fibrin strands in the anterior chamber, granulomatous-appearing keratic 
precipitates and vitritis (Aldave et al., 1999; Clark et al., 1999; Meisler & 
Mandelbaum, 1989; Zambrano et al., 1989).  
 
P. acnes endophthalmitis is thought to be caused by sequestration of the organism 
between the IOL optic and the posterior capsule and colonies of the organism may 
be visualised as a white capsular plaque (Meisler et al., 1987; Sawusch et al., 
1989; Winward et al., 1993). In this encapsulated state, the organism is shielded 
from antimicrobial agents and host defence mechanisms. Despite preference for 
the lens capsule, infection following intracapsular cataract extraction with anterior 
chamber IOL placement has also been reported (Chien et al., 1992), and white 
plaques can be seen on the posterior corneal surface (Abrahams, 1989; Chien et 
al., 1992). In addition, the IOL itself can support the bacteria (Busin et al., 1995; 
Elder et al., 1995); thus the capsular bag is not the only reservoir for P. acnes.   
 
P. acnes has the ability to cause persistent inflammation within the eye due to 
several unique characteristics. Meisler et al. noted a lack of inflammatory cells in 
the capsule on histopathology, despite the presence of a large number of 
organisms (Meisler et al., 1987). P. acnes is able to inhibit suppressor T-cell 
lymphocytes (Whitcup et al., 1991) and its cell wall structure protects against 
degradation by neutrophils and macrophages (Webster et al., 1985). Additionally, 
P. acnes is thought to exert an adjuvant effect in provoking immune response with 
residual soft lens material (Meisler et al., 1986; Piest et al., 1987; Semel et al., 
1992; Smith, 1986).  
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Diagnostic techniques 
Diagnosis of P. acnes endophthalmitis can be challenging for several reasons. The 
intraocular inflammation may be indistinguishable from sterile postoperative 
inflammation. The organism can be difficult to culture, as it usually resides within 
the capsular bag, and also because it has a very slow growth rate. Its generation 
time for doubling is 5.1 hours (Hall et al., 1994) and as a result, it may take up to 
10 days to obtain a positive culture (Aldave et al., 1999; Clark et al., 1999). 
Aqueous and vitreous specimens should undergo Gram staining and cultures 
should include anaerobic and fungal media (Carlson et al., 1998). Laboratories 
should be specifically instructed to incubate samples for at least 14 days before 
discarding them as negative (Carlson et al., 1998; Meisler & Mandelbaum, 1989). 
To overcome the low culture positive rate, molecular diagnostic tests have been 
developed to aid the diagnosis of chronic endophthalmitis. These are discussed in 
more detail in Section 1.4.3.   
 
Treatment  
Unlike the conventional management of endophthalmitis, intraocular antibiotics 
alone are not sufficient to treat P. acnes endophthalmitis (Meisler et al., 1986; 
Zambrano et al., 1989). Clark et al. (Clark et al., 1999) and Aldave et al. (Aldave 
et al., 1999) reported on relatively large numbers of patients in retrospective 
reviews of culture-positive cases. Treatment strategies included injection of 
intraocular antibiotics (usually vancomycin), pars plana vitrectomy, vitrectomy 
with partial capsulectomy, and vitrectomy with total capsulectomy and IOL 
removal or exchange. Both groups demonstrated that injection of intravitreal 
antibiotics alone was associated with a very high rate of recurrence. Pars plana 
vitrectomy with partial capsulectomy was more efficacious than vitrectomy alone. 
Vitrectomy with total capsulectomy and IOL removal or exchange appeared to be 
curative (Meisler et al., 1987; Winward et al., 1993). 
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1.2.5 P. acnes in other clinical diseases 
As well as being a cause of eye infections, P. acnes has the potential to cause a 
range of other diseases. Some of these are discussed below.  
 
P. acnes in acne vulgaris 
Acne vulgaris is the commonest skin disorder amongst the adolescent population 
and affects around 80% of individuals at some stage in their lives (Dreno & Poli, 
2003). It is a multifactorial disorder of the pilosebaceous follicles, and disease 
mechanisms include sebaceous hyperplasia, follicular hyperkeratinisation, 
hormone imbalance, bacterial infection and immune hypersensitivity (Gollnick, 
2003; Jappe, 2003; Thiboutot, 2000; Webster, 2002). P. acnes is considered to 
play a vital role in the pathogenesis of acne vulgaris where it is thought to 
contribute to the inflammatory phase of the condition  (Leyden, 2001). The 
organism is able to metabolise sebaceous triglycerides, releasing free fatty acids 
that irritate the follicular wall and surrounding dermis (Coenye et al., 2007). In 
addition, P. acnes can also produce exoenzymes and neutrophils chemoattractants 
(Kabongo Muamba, 1982; Thiboutot, 2000; Webster, 2002).  
 
Treatment of acne includes keratinolytic and sebosuppressive agents like retinoids 
(Thiboutot et al., 2008) as well as antibacterial agents. Topical antimicrobial 
agents include benzoyl peroxide, clindamycin, erythromycin, tetracycline, azelaic 
acid and triclosan (Bojar et al., 1994; Dreno, 2004; Krautheim & Gollnick, 2004; 
Tan, 2004; Taylor & Shalita, 2004; Webster, 2000). Systemic antibiotics such as 
tetracycline, doxycycline, minocycline and erythromycin may be indicated in 
cases where topical treatment is not successful or in patients at risk of scarring and 
pigmentary changes (Ross et al., 2003).  
 
Shortly after the introduction of topical erythromycin and clindamycin in acne 
treatment over 40 years ago, resistant strains were detected in the US (Leyden et 
al., 1983). Since then, reports of resistant P. acnes strains from acne patients have 
been described around the world (Kurokawa et al., 1988; Oakley et al., 1995; 
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Ross et al., 2003; Tan et al., 2001). It has been demonstrated that the proportion 
of patients carrying resistant bacteria in the UK doubled between 1991 and 1997. 
Consequently 60% of acne patients were found to carry resistant strains (Eady, 
1998). A study carried out in Europe showed that 50% of acne patients were 
colonised by clindamycin and erythromycin resistant P. acnes and 20% of patients 
by tetracycline resistant P. acnes (Ross et al., 2003). 
 
SAPHO and sarcoidosis 
In patients suffering from SAPHO syndrome, P. acnes has been recovered from 
bone biopsy, synovial fluid and tissue samples (Schaeverbeke et al., 1998). P. 
acnes has also been isolated from lymph nodes of patients with sarcoidosis, a 
systemic granulomatous disease of unknown aetiology (Eishi et al., 2002; Ishige 
et al., 1999; Yamada et al., 2002). This is not conclusive evidence as recent 
findings have shown that P. acnes can normally reside in peripheral lung tissue 
and mediastinal lymph nodes. Therefore their presence is not exclusive to 
sarcoidosis (Ishige et al., 1999).  
 
Prostate disease 
P. acnes was isolated from the prostate gland in a substantial portion (35%) of 
patients with prostate cancer and an association was demonstrated between 
positive culture and prostatic inflammation (Cohen et al., 2005). In addition to 
this, another study reported P. acnes 16S rRNA gene sequences as the most 
common bacterial DNA extracted from prostatic tissue of patients with benign 
prostatic hyperplasia (BPH) (Alexeyev et al., 2006). Direct visualisation using 
multi-colour fluorescence in situ hybridisation (FISH) assay of P. acnes in 
prostate tissue has revealed that the organism demonstrated intracellular 
localisation and stromal biofilm-like aggregates (Alexeyev et al., 2007). It has 
therefore been proposed that infection of the prostate gland by P. acnes might be a 
contributory factor in developing prostatic inflammation, which in turn might 
contribute to the development of BPH and prostate cancer through cellular injury 
and proliferation (Shannon et al., 2006b; Shannon et al., 2008).  
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Prosthetic joint infections 
Prosthetic hip, knee and shoulder-associated infections are common indications 
for revision arthroplasties (Berthelot et al., 2006; Zeller et al., 2007). P. acnes has 
been implicated in up to 22% of revision operations (Tunney et al., 1998). As P. 
acnes grow predominantly within a biofilm on the surface of the prosthesis, which 
renders them more resistant to antibiotics, treatment with systemic antibiotics 
usually fail. Therefore, removal and replacement of the infected implant is often 
necessary to eliminate infection (Ramage et al., 2003; Tunney et al., 2007). 
 
Spinal surgery and sciatica 
P. acnes is described as a cause of wound contamination during spinal surgery 
and immunofluorescence microscopy (IFM) carried out on surgical specimens 
suggest that P. acnes detected in wounds originates from patient skin (McLorinan 
et al., 2005). It has also been isolated in cases of spinal osteomyelitis and discitis 
(Chia & Nakata, 1996; Esteban et al., 1998; Harris et al., 2005; Kowalski et al., 
2007; Noble & Overman, 1987). Culture of P. acnes from microdiscectomy 
material removed for the treatment of sciatica has lead to an association between 
the organism and sciatica (Stirling et al., 2001). However, others have failed to 
culture P. acnes from microdiscectomy material and suggest that these organisms 
were contaminants from the skin during the surgical procedure (McLorinan et al., 
2005).  
 
Central nervous system infections  
P. acnes is increasingly recognised as a cause of infection after neurosurgical 
procedures (Brook, 1988; Brook & Frazier, 1991; Nisbet et al., 2007; Ramos et 
al., 1995; Skinner et al., 1978). Although it is most frequently isolated from 
infected neurosurgical shunts, it has also been described as a pathogen in a wide 
range of central nervous system (CNS) infections including brain abscess (Barazi 
et al., 2003; Berenson & Bia, 1989; Cohle et al., 1981; Maniatis & Vassilouthis, 
1980), subdural and epidural empyema (Critchley & Strachan, 1996; Yoshikawa 
et al., 1975), and meningitis (Beeler et al., 1976; Everett et al., 1976; Schlesinger 
& Ross, 1977). 
 - 29 -
Chapter 1  Introduction 
 
Fatal bacterial granuloma after trauma (FBGT) 
P. acnes has recently been identified as the causative agent in FBGT (Gao et al., 
2002). The major clinical presentations of FBGT patients were the development 
of skin lesions after slight trauma to the face, followed by spreading of dark-red 
plaques on the skin and frequently death from encephalitis within 5 years.  
 
Endocarditis 
P. acnes has been shown to cause infection of prosthetic heart valves (Gunthard et 
al., 1994; Hinestrosa et al., 2007; Horner et al., 1992; Pan et al., 2005), native 
valves (Mohsen et al., 2001) and annuloplasty rings (Vanagt et al., 2004), leading 
to endocarditis. Prompt diagnosis and treatment of P. acnes endocarditis are 
essential, since the infection tends to follow a very aggressive clinical course 
resulting in extensive valvular destruction, congestive heart failure, abscess 
formation, and systemic embolisation (Delahaye et al., 2005; Horner et al., 1992; 
Huynh et al., 1995; Lazar & Schulman, 1992; Lewis & Abramson, 1980; Mohsen 
et al., 2001). Many antibiotics, including penicillin, vancomycin, teicoplanin, and 
gentamicin, are considered active in vitro for the treatment of P. acnes infections 
and have been reported to be effective in eliminating infection in endocarditis 
(Horner et al., 1992; Huynh et al., 1995).  
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1.3 Pseudomonas aeruginosa 
 
1.3.1 Background 
Pseudomonas aeruginosa (P. aeruginosa) is considered to be the quintessential 
opportunistic pathogen, because it can infect a broad range of hosts, from amoeba 
to humans (Lavenir et al., 2007; Pukatzki et al., 2002; Rahme et al., 2000). It is 
responsible for infection in cystic fibrosis (CF) patients (Saiman & Siegel, 2004), 
in burned, mechanically ventilated and immunocompromised individuals 
(McManus et al., 1985; Richard et al., 1994). It can lead to serious infections 
including septicaemia, pneumonia, endocarditis, otitis, keratitis and 
endophthalmitis (Eifrig et al., 2003; Jackson et al., 2003; Kashkouli et al., 2007; 
Kielhofner et al., 1992). This Gram-negative rod displays a wide range of 
virulence, from weakly virulent isolates, to highly virulent broad spectrum isolates 
(Lau et al., 2003; Rahme et al., 1995; Rahme et al., 2000) and is capable of 
producing numerous virulence factors (Lyczak et al., 2000).  
 
P. aeruginosa is also able to grow in a diverse range of environmental niches 
including rivers (Pellett et al., 1983), sea water (Kimata et al., 2004), bottled and 
tap waters (Aoi et al., 2000; Ganguli & Tripathi, 1999; Hunter, 1993; Pellett et al., 
1983; Romling et al., 1994), wastewaters (Filali et al., 2000) and soil (Cavalca et 
al., 2000). It can also colonise plants (Green et al., 1974; Morales et al., 1996) and 
animals (Lashev & Lasarova, 2001; Marlier et al., 2000; Martin Barrasa et al., 
2000). Its ability to survive in different environments allow it to colonise several 
hospital niches, including taps, drains, water pipes and clinical devices. 
Genotyping studies have demonstrated the close relatedness of clinical and 
environmental isolates, and infer an environmental origin of the isolates 
encountered in several infections (Romling et al., 2005). Therefore, hospital and 
environmental populations of P. aeruginosa represent a serious public health 
concern.  
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1.3.2 Population biology of P. aeruginosa 
P. aeruginosa has been considered to have a panmictic population structure 
(Denamur et al., 1993; Picard et al., 1994). A panmictic-epidemic population 
structure with frequent recombination events leading to the evolution of highly 
successful epidemic clones has been favoured by others (Dinesh et al., 2003; 
Lomholt et al., 2001; Morales et al., 2004; Pirnay et al., 2002; Romling et al., 
1994). Lombolt et al. analysed the diversity of 11 metabolic enzymes by 
multilocus enzyme electrophoresis (MLEE) of 145 P. aeruginosa isolates from 
different origins, and obtained an index of association (IA) (Smith et al., 1993a) 
value not significantly different from zero, indicating that P. aeruginosa has a 
non-clonal population structure (Lomholt et al., 2001). From the MLEE data of 
Martin et al. on isolates from cystic fibrosis patients in France, an IA value of -
0.07 was calculated, also suggesting a non-clonal population structure (Martin et 
al., 1999). The same conclusion was reached by Ruimy et al. when they analysed 
74 clinical and environmental isolates using RAPD (Ruimy et al., 2001). Pirnay et 
al. compared the sequencing results of three outer membrane genes with the 
results of one DNA-based and two phenotypic typing methods (Pirnay et al., 
2002). They observed no congruence between the results obtained by each 
method, but showed the existence of clonal complex, further supporting the view 
that the population structure of P. aeruginosa is panmictic-epidemic.  
 
Using multilocus sequence typing (MLST) (Section 1.5.2), Kiewitz et al. analysed 
six sequences of 19 isolates from environmental and disease origins and 
demonstrated that the frequency of recombination among different P. aeruginosa 
genotypes was high (Kiewitz & Tummler, 2000). Curran et al. recently developed 
an MLST scheme to characterise a large collection of clinical and environmental 
isolates of P. aeruginosa, including epidemic clones from the UK and Europe 
(Curran et al., 2004). The 143 isolates investigated were assigned to 139 different 
STs. The IA value for the 139 individual STs was found to be 0.17, indicating that 
P. aeruginosa has a non-clonal population structure. Both Kiewitz and Curran 
demonstrated no correlations between habitat and particular clones, in line with 
previous studies (Pirnay et al., 2002; Romling et al., 1994).  
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These results are in contrast to a more recent P. aeruginosa MLST scheme, where 
different housekeeping genes to previous MLST schemes were sequenced 
(Vernez et al., 2005). Of the 34 clinical isolates analysed, 26 different sequence 
types were identified and the IA was calculated to be 1.95 (standard error 0.24), 
indicating linkage disequilibrium in the study population and therefore, a clonal 
population structure. In support of this, Wiehlmann et al. (Wiehlmann et al., 
2007) recently developed a microarray method for genotyping of P. aeruginosa in 
both the conserved core and flexible accessory genome of P. aeruginosa. They 
analysed 240 isolates from diverse habitats and geographic origin and showed that 
the majority of P. aeruginosa belonged to a few dominant clones widespread in 
disease and environmental habitats (Wiehlmann et al., 2007). Majority of the loci 
were freely recombining with each other, but some loci exist in fixed 
combinations of genotypes, suggesting that the free flow of genes in the P. 
aeruginosa population occurs at most, but not all, loci of the genome. 
 
1.3.3 P. aeruginosa in the eye  
P. aeruginosa is an important Gram-negative pathogen in the eye and is capable 
of inducing keratitis and postoperative endophthalmitis (Eifrig et al., 2003; Irvine 
et al., 1992; Jackson et al., 2003; Kashkouli et al., 2007). P. aeruginosa keratitis 
is a rapidly developing, devastating disease that may lead to corneal perforation, 
with a higher incidence in extended wear contact lens users (Mondino et al., 1986; 
Rattanatam et al., 2001; Wilhelmus, 1996), tropical climates, and in patients that 
are either debilitated or hospitalised (Laibson, 1990). Studies to identify the 
source of the infection in contact-lens induced keratitis have shown that P. 
aeruginosa cultured from the cornea, conjunctiva, contact lens case and cleaning 
solution all had identical PFGE banding patterns (de Melo et al., 2007). 
Pseudomonal infections often present as a rapidly progressing, suppurative 
stromal infiltrate with mucopurulent exudates. Yellowish coagulative necrosis 
surrounded by inflammatory epithelial oedema can be seen and stromal ulceration 
can lead to significant stromal tissue destruction and loss. A hypopyon is usually 
present and a ring infiltrate may be seen in the surrounding paracentral cornea. 
Descemetocele formation or corneal perforation may also result from P. 
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aeruginosa infection (Wilhelmus, 1996). Other sight-threatening complications 
include development of secondary glaucoma and cataract (Lotti & Dart, 1992). 
These consequences are due to the hosts’ inflammatory response, the influence of 
bacterial toxins, exoproducts and toxicity from antibiotic treatment, as well as the 
effects the of corticosteroids (Chusid & Davis, 1979; Hazlett et al., 1977; 
Hyndiuk, 1981; Kernacki et al., 1995; Moon et al., 1988; Ohman et al., 1980; 
Steuhl et al., 1987; Thiel et al., 1987). The incidence of antibiotic resistant strains 
has also started to increase (Chaudhry et al., 1999; Landman et al., 2002).  
 
1.3.4 Pathogenesis of P. aeruginosa infection 
P. aeruginosa has the ability to adapt to hostile environments and survive on 
limited nutrients. Because of this, it has a wide environmental and ecological 
distribution (Lomholt et al., 2001). This versatility is probably due to a substantial 
collection of enzymes combined with a fit gene regulation (Kiewitz & Tummler, 
2000; Stover et al., 2000).  
 
P. aeruginosa has only limited binding affinity to healthy corneal epithelial cells. 
Binding to and colonisation of the cornea occur predominantly after tissue 
damage, when exposed stroma uncover receptors for bacterial adhesion (Hazlett et 
al., 1986; O'Brien, 2003; Stern et al., 1982). Initial adhesion to contact lenses or 
the cornea may be brought about by lipoplolysaccharide (LPS, endotoxin) and pili 
(Fletcher et al., 1993; Gupta et al., 1994; Gupta et al., 1997; Zaidi et al., 1996). 
Type IV pili-mediated twitching motility and flagella-associated motility are 
important and allow bacteria to move in liquids or along surfaces (Hahn, 1997; 
Semmler et al., 1999; Zolfaghar et al., 2003). Bacterial flagella also appear to be 
involved in the invasion of cells by this microorganism (Fleiszig et al., 2001).  
 
The proteases elastase, alkaline protease, and protease IV are associated with 
virulence, extensive tissue damage, invasiveness, dissemination, and colonisation, 
and are able to enhance the destruction of corneal tissue (Engel et al., 1998a; 
Engel et al., 1998b; Hobden, 2002; O'Callaghan et al., 1996; Pillar & Hobden, 
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2002; Zhu et al., 2001). Protease IV destroys certain host proteins (Engel et al., 
1998a) while elastase and alkaline protease mediate penetration through the 
corneal epithelium (Bejarano et al., 1989; Burns et al., 1990; Heck et al., 1986; 
Hobden, 2002; Howe & Iglewski, 1984; Twining et al., 1986).  
 
Another determinant of virulence is the type III secretion system (TTSS), present 
in several Gram-negative bacilli (Galan & Collmer, 1999). Using the TTSS, P. 
aeruginosa is able to produce and secrete virulence factors directly into the 
cytoplasm of host cells (Ajayi et al., 2003). The system consists of three different 
protein complexes: the secretion apparatus, the translocation or targeting 
apparatus, and the secreted toxins (effector proteins) and their cognate chaperones 
(Hueck, 1998). The effector proteins comprise two ADP-ribosylating enzymes, 
ExoS and ExoT (Frank, 1997; Frithz-Lindsten et al., 1997; Yahr et al., 1996), an 
acute cytolytic factor, ExoU (Finck-Barbancon et al., 1997; Hauser et al., 1998), 
and an adenylate cyclase, ExoY (Yahr et al., 1998).  
 
The genes that encode these effector proteins, which are distributed throughout 
the P. aeruginosa genome, are characterised by variable traits (Stover et al., 
2000). The TTSS has been identified in nearly all clinical and environmental 
isolates but individual isolates and populations of isolates from distinct disease 
sites appear to differ in their effector genotype (Feltman et al., 2001). Although 
exoY and exoT are present in nearly all clinical P. aeruginosa isolates, the 
majority possess only exoS or exoU, not both (Feltman et al., 2001; Finck-
Barbancon et al., 1997; Hauser et al., 1998). P. aeruginosa strains have been 
classified based on the genotypic expression of these toxins. Invasive strains tend 
to express ExoS (Fleiszig et al., 1997), whereas non-invasive or cytotoxic strains 
express ExoU (Finck-Barbancon et al., 1997; Hauser et al., 1998).  
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1.4 Molecular Diagnostics 
 
1.4.1 Background 
The inability of conventional diagnostic protocols to provide rapid and accurate 
data for identifying pathogens causing microbial keratitis and endophthalmitis 
leads most ophthalmologists to adopt a conservative management approach by 
using empiric antibiotic therapy. However, this may potentially lead to added 
costs, increased rates of antimicrobial resistance and iatrogenic complications 
associated with unnecessary treatment. A rapid and accurate diagnostic assay is 
therefore essential to provide early and effective management of infected patients.  
 
Polymerase chain reaction (PCR) technology is perhaps the most important 
advancement in bacterial molecular diagnostics in recent years. PCR has the 
ability to amplify a specific target region of DNA exponentialy using 
oligonucleotide primers, leading to detectable amounts of DNA from one or a few 
original sequences. Due to their high sensitivity, specificity, and speed of 
application, PCR-based diagnostic methods can be applied to clinical specimens 
for identifying organisms that cannot be grown in vitro or where existing culture 
techniques are insensitive or need prolonged incubation times. It also has the 
advantage of being unaffected by prior treatment with antibiotics unlike culture 
methods. In these instances, empiric antibiotic therapy that may not be effective 
can be altered based on PCR results (Song, 2005).  
 
One of the most common approaches to using PCR in rapid diagnostics is the use 
of broad-range PCR, which is based on the observation that certain genes are 
universal to many different organisms. Studies have mainly focused on the 16S 
rRNA genes (Wilson et al., 1990), which are found in all bacteria. These genes 
have highly variable portions that are considered unique for each bacterium as 
well as conserved regions that are found in all bacteria. Multiplex PCR 
(Chamberlain et al., 1988) simultaneously amplifies more than one locus in the 
same reaction by using multiple sets of primers. Nested PCR (Erlich et al., 1991) 
uses a second round of PCR with a different primer set internal to the first round, 
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leading to increased amplification of a specific region within the first PCR-
amplified target locus. This is much more specific and sensitive than conventional 
PCR, allowing the detection of the target DNA at a substantially lower 
concentration. Reverse transcriptase PCR (RT-PCR) convert RNA to cDNA using 
the enzyme reverse transcriptase before PCR and has the advantage of 
determining gene activity (Erlich et al., 1991). Quantitative real-time PCR  is a 
major advancement in PCR diagnostic technology as it eliminates the need for 
post-amplification processing (i.e. gel electrophoresis) conventionally required for 
amplicon detection, and allows real-time measurement of DNA synthesis (Heid et 
al., 1996; Higuchi et al., 1992; Higuchi et al., 1993).  
 
The high sensitivity of PCR-based protocols and their ability to amplify millions 
of copies of the target sequence come with disadvantages. The principal problems 
include false-positive results from DNA contamination, the potential for false-
negative results, detection sensitivity exceeding clinical significance, and limited 
ability to detect multiple targets simultaneously (Song, 2005).  
 
1.4.2 Molecular diagnostics in microbial keratitis 
Although there have been numerous studies looking at using the PCR technique to 
detect fungal- (Bagyalakshmi et al., 2008; Ghosh et al., 2007; Kumar & Shukla, 
2005) and Acanthamoeba- (Goldschmidt et al., 2008; Lehmann et al., 1998; 
Mathers et al., 2000) associated keratitis, few exist which look at bacterial 
keratitis. Available publications have suggested that PCR of 16S rDNA may be a 
useful diagnostic tool for severe cases of bacterial keratitis (Knox et al., 1998; 
Lohmann et al., 2000b; Rudolph et al., 2004). Knox et al. showed that PCR 
matched culture results in a series of eleven patients with bacterial keratitis (Knox 
et al., 1998). However, sensitivity proved to be low as two cases with culture 
positive results were negative for PCR. Lohman et al. reported a series of 16 
patients with keratitis that included 10 patients with negative culture results 
(Lohmann et al., 2000b). PCR was found to be positive for nine of these 10 
patients. Rudolph et al. investigated a small series of four patients diagnosed with 
severe infectious keratitis (Rudolph et al., 2004). They used primers to amplify 
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the 16S rRNA gene, followed by sequencing of the amplified product. Culture 
results for all cases were negative but PCR detected a causative organism in all 
four cases.   
 
1.4.3 Molecular diagnostics in endophthalmitis 
Several investigators have looked at using PCR to detect the causative organism 
in endophthalmitis. Therese et al. designed primers to target the 16S rRNA gene 
from aqueous and vitreous samples in culture-negative endophthalmitis cases 
(Therese et al., 1998). They were able to determine a bacterial cause in 100% of 
culture-positive and 44% of culture-negative cases. Of the remaining culture-
negative cases, one third was found to be fungal. They did not, however, 
determine the specific organism detected by the PCR. The primary drawback of 
using PCR directed at the 16S rRNA gene has been the labour and time involved 
in determining the bacterium responsible for a positive PCR product. To 
overcome this, the amplicon has been subjected to DNA sequencing (Knox et al., 
1999; Lohmann et al., 1998). Although this technique yields a definitive 
identification of the causative organisms, sequencing of PCR products requires 
specialised equipment and can be costly.  
 
Carroll et al. used nested PCR primers to distinguish between Gram-positive and 
Gram-negative 16S rRNA gene (Carroll et al., 2000). The test was highly 
sensitive and could be completed in 3.5 hours. Okhravi et al. investigated 
restriction endonuclease digest fingerprinting of the 16S rRNA gene (Okhravi et 
al., 2000b). They were able to distinguish the major bacterial causes of 
postoperative endophthalmitis, but were unable to distinguish between 
Escherichia coli (E. coli) and Serratia marcescens (S. marcescens). DNA 
sequencing was required to identify these two bacteria. The sensitivity of the 
assay was a single organism as determined by nested PCR detection of serial 
tenfold dilutions of genomic DNA and viable organisms (Okhravi et al., 2000b). 
Application of this protocol to nine eyes with a clinical diagnosis of bacterial 
endophthalmitis was carried out (Okhravi et al., 2000a). A PCR product was 
amplified from all 18 intraocular samples, whereas only 55.6% of the vitreous 
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(n=9) and 11.1% of the aqueous (n=9) samples were culture-positive. Chiquet et 
al. recently carried out a large prospectively study on one hundred patients with 
clinical diagnosis of acute postoperative endophthalmitis (Chiquet et al., 2008). 
16S rDNA amplification and DNA sequencing of aqueous humour and/or vitreous 
humour from tap or vitrectomy was carried out. The detection rate was not 
significantly different between cultures and PCR on aqueous and vitreous tap 
samples (38.2% for cultures versus 34.6% for PCR in aqueous humour samples; 
54% versus 57% in vitreous tap samples). However, from vitrectomy samples, 
after intravitreous injection of antibiotics, PCR detected an organism in 70% of 
the cases, and only 9% of cases had positive culture results.  
 
Delayed-onset postoperative endophthalmitis is commonly caused by P. acnes, S. 
epidermidis, Actinomyces israelli (A. israeli), and fungi. It presents even further 
diagnostic challenges as these organisms are frequently present in low numbers 
and can be difficult to culture. Hykin et al. used a nested PCR approach to 
amplify the 16S rDNA from vitreous samples of patients with clinical delayed-
onset postoperative endophthalmitis (Hykin et al., 1994). Seventeen (74%) of 23 
cases gave positive results with universal eubacterial primers and eight of 23 
samples gave positive results with P. acnes primers.  However, four (14%) of 29 
non-infected cases also gave positive results with the universal eubacterial 
primers, giving an acceptably high false-positive rate. Lohmann et al. used 16S 
ribosomal primers and fungal PCR primers, in parallel with culture and stain for 
25 eyes with delayed-onset endophthalmitis (Lohmann et al., 2000a). They were 
unable to culture any organisms from aqueous samples and 24% of vitreous 
samples were positive by culture. In contrast, PCR identified a causative organism 
in 84% of the aqueous samples and 92% of the vitreous tap samples.  
 
1.4.4 P. acnes molecular diagnostics 
Dasen et al. first published a PCR and sequencing method to identify cutaneous 
and dairy propionibacteria (Dasen et al., 1998). PCR amplification of P. acnes 
16S rRNA gene has also been used to identify P. acnes in the vitreous humour of 
sarcoidosis patients (Yasuhara et al., 2005), from an abscess caused by a vascular 
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prosthesis (Le Page et al., 2003) and from prosthetic hip infections (Tunney et al., 
1999). Nakamura et al. used primers to target the 16S rRNA and lipase genes to 
discriminate between P. acnes, P. avidum and other Propionibacterium spp. 
(Nakamura et al., 2003). Buggage et al. used a nested PCR approach to detect P. 
acnes in the vitreous sample of a patient with chronic postoperative 
endophthalmitis (Buggage et al., 2003). Recently, Lai et al. published a case of 
chronic postoperative endophthalmitis, in which PCR amplification of the 16S 
rRNA gene fragment of P. acnes was used to detect P. acnes from the aqueous 
humour sample and the explanted intraocular lens (Lai et al., 2006). Shannon et 
al. recently developed a PCR-based technique for identifying P. acnes types IA, 
IB and II (Shannon et al., 2006a). Three sets of primer pairs were used to analyse 
bacterial isolates cultured from urine specimens and facial skin, which showed 
high sensitivity and specificity to the three P. acnes subtypes. 
 
1.4.5 P. aeruginosa molecular diagnostics  
Several PCR screening tests have been used to identify P. aeruginosa. Most 
significant examples are those targeting 16S rDNA, toxA, gyrB, and the ribosomal 
operon (Kimata et al., 2004; Kurupati et al., 2005; Song et al., 2000; Tyler et al., 
1997; Widmer et al., 1998). Some of these protocols were shown to be applicable 
directly on human samples like skin DNA (De Vos et al., 1997). These gene 
targets have also been used for FISH detection of P. aeruginosa in sputum 
(Hogardt et al., 2000), in quantitative real-time PCR on blood (Jaffe et al., 2001) 
and wound biopsy samples (Pirnay et al., 2000). Supression subtraction 
hybridisation has been used to detect strain-specific sequences. PCR assays were 
then designed to detect epidemic strains commonly found in CF patients (Panagea 
et al., 2003; Smart et al., 2006).  
 
Lavenir et al. investigated the reliability of the most widely used PCR screenings 
for P. aeruginosa (Lavenir et al., 2007). PCR protocols using the following DNA 
targets were evaluated: (1) the 16S rDNA, (2) the internally transcribed 16S-23S 
rDNA spacer (ITS), (3) gyrB encoding the DNA gyrase subunit B, (4) oprI 
encoding the lipoprotein I, (5) oprL endcoding an outer-membrane peptidoglycan-
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associated lipoprotein, (6) fliC encoding the C-terminus flagellin, and (7) toxA 
encoding the exotoxin A precursor. With the exception of toxA which is P. 
aeruginosa-specific, most of these targets have also been found in other bacterial 
species (Khan & Cerniglia, 1994). Sensitivity of the PCR assays was determined 
on a panel of 59 P. aeruginosa isolates and their specificity was estimated on a 
panel of 15 Pseudomonas spp. closely related to P. aeruginosa. The P. aeruginosa 
oprI, oprL, 16S rDNA and fliC PCR assays were found to be highly sensitive, 
giving the expected PCR products for all P. aeruginosa isolates, which is in line 
with previous findings (De Vos et al., 1997; Qin et al., 2003; Spilker et al., 2004). 
However, they showed specificity as low as 13%. PCR screening making use of 
gyrB and the 16S-23S rDNA ITS gave the expected PCR products for all P. 
aeruginosa strains of their panel (100% sensitivity), and did not yield any 
products for the other Pseudomonas spp. tested (100% specificity). The toxA PCR 
screening did not yield PCR products for all the P. aeruginosa strains tested, a 
characteristic also observed by Khan and Cerniglia (Khan & Cerniglia, 1994). 
Lavenir et al. went on to design a PCR assay targeting the ecfX gene, which 
encodes an ECF (extracytoplasmic function) sigma factor (ecfX) and is restricted 
to P. aeruginosa (Lavenir et al., 2007). The sensitivity and specificity testing on 
59 P. aeruginosa strains and 15 Pseudomonas spp. showed 100% sensitivity and 
specificity. This high sensitivity was further supported by investigating an 
additional set of 241 clinical P. aeruginosa strains of various origins. PCR 
products of the expected size were obtained for all 241 isolates, suggesting that 
the ecfX gene is highly conserved among P. aeruginosa.  
 
DNA microarray for detecting P. aeruginosa, using the species-specific 15mer 
oligonucleotide probes based on the sequences of the 23S rDNA has recently been 
developed (Keum et al., 2006). Two hundred and ten clinical specimens were 
examined and P. aeruginosa was successfully identified from 25 out of 26 clinical 
specimens, and the remaining 184 specimens containing other bacterial species 
were negative, resulting in a sensitivity of 96.2% and a specificity of 100%.  
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1.5 Bacterial population biology 
 
1.5.1 Methods of strain identification  
The characterisation of bacterial pathogens using typing methods allows 
identification of bacterial isolates and provides information about the evolutionary 
biology, population biology, taxonomy, ecology, and genetics of bacteria 
(Wiehlmann et al., 2007). Traditional typing of isolates by serological or other 
methods (antibiotic resistance, phage typing, etc.) are not necessarily suitable for 
bacterial epidemiology because it is based on variable phenotypes that may not be 
related to genetic descent (Achtman, 2002). In addition, phenotypically based 
typing methods are also limited by their typeability and reproducibility. These 
shortcomings have led to the development of typing methods based on the 
microbial genotype or DNA sequences, which try to minimise these problems 
(Olive & Bean, 1999). Examples of these methods are discussed below and Figure 
1.6 compares the laboratory steps involved in some of these techniques.  
 
1.5.1.1 Genotyping methods 
 
Plasmid profile analysis 
This technique involves the extraction of plasmid DNA and then separation of this 
DNA by electrophoresis on agarose gels (Trindade et al., 2003). It is an easy 
technique to carry out and interpret, but it does have limitations. Plasmids are 
mobile extrachromosomal elements that can be lost or acquired with relative ease 
by bacteria. Therefore, epidemiologically related isolates can actually have 
different plasmid profiles. The reproducibility of the plasmid profiles can also be 
variable as plasmids exist in different spatial conformations (supercoiled, nicked, 
and linear), which possess different migration velocities when submitted to gel 
electrophoresis (Hartstein et al., 1995). Both the reproducibility and 
discriminatory power of plasmid profile analysis can be improved by carrying out 
enzymatic restriction of the plasmids, as this procedure identifies the position and 
frequency of restriction sites between two unrelated plasmids, even though they 
might have the same molecular mass (Hartstein et al., 1995).   
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Analysis of chromosomal DNA after restriction endonulease analysis  (REA) 
This technique involves digestion of chromosomal DNA by restriction 
endonucleases and then separation of the resulting fragments by agarose gel 
electrophoresis. Profiles of different isolates can then be compared (Trindade et 
al., 2003). 
 
Restriction fragment length polymorphisms (RFLP) 
In this technique, digestion with REA is followed by separation of chromosomal 
DNA into a series of fragments of different sizes. Southern blot hybridisation is 
then carried out, where fragments are separated by electrophoresis or nylon 
membrane and hybridised using specific nucleic acid probes (Busch & Nitschko, 
1999; Maslow et al., 1993). Alternatively, the specific locus to be examined is 
amplified with gene-specific primers and then subjected to RFLP analysis (PCR-
based locus-specific RFLP) (Olive & Bean, 1999).  
 
Pulsed-field gel electrophoresis (PFGE) 
PFGE involves the digestion of bacterial DNA with restriction endonucleases that 
recognise only a few sites along the chromosome, generating large fragments of 
DNA (Schwartz & Cantor, 1984). During electrophoresis, the orientation of the 
electric field across the gel is periodically changed, allowing these large DNA 
fragments to be effectively separated (Maslow et al., 1993; Olive & Bean, 1999). 
As a result, PFGE allows for the comparison of simpler chromosomal DNA 
profiles than those produced by high-frequency restriction endonucleases (Weller, 
2000).  
 
PFGE has several advantages. It can be used to type most bacterial species and 
generally has excellent discriminatory power (Bannerman et al., 1995; Olive & 
Bean, 1999; Tenover et al., 1994; van Belkum et al., 2001). In addition, PFGE 
results have been correlated with clinical data and standardisation of protocols and 
interpretation of PFGE has allowed extensive databases to be set up (Blanc et al., 
2001; Chung et al., 2000; McDougal et al., 2003; Murchan et al., 2003; Tenover 
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et al., 1995). There are, however, limitations for the use of PFGE, such as the 
lengthy time taken to obtain results and the high cost of reagents and specialised 
equipment required (Ross et al., 2005; Weller, 2000). There are also problems in 
the interpretation of results, especially between laboratories, as even small 
differences in electrophoresis conditions can alter the distance travelled by each 
band (Cookson et al., 1996; van Belkum et al., 1998). 
 
Amplified fragment length polymorphism (AFLP) 
This method involves simultaneous restriction-ligation and selective PCR 
amplification (Savelkoul et al., 1999; Vos et al., 1995). Chromosomal DNA is 
first digested with two restriction enzymes, and then double-stranded 
oligonucleotide adapters are ligated to the DNA fragments. Subsequently, 
adapter-specific primers are used for selective PCR amplification.  
 
Random amplified polymorphic DNA (RAPD) 
RAPD assays make use of short random sequence primers, which hybridise with 
sufficient affinity to chromosomal DNA at low annealing temperatures. If two 
primers anneal within a few kilobases of each other in the correct orientation, a 
PCR product is generated. The frequency and position of these random primer 
sites vary for different strains. Separation of the amplification products by agarose 
gel electrophoresis produces a pattern of bands, characterised by the particular 
bacterial strain (Caetano-Anolles et al., 1991; Meunier & Grimont, 1993; Welsh 
& McClelland, 1990; Williams et al., 1990).  
 
The advantage of RAPD is its relative simplicity and speed. However, the 
discriminatory power is variable and largely depends on the number and 
nucleotide sequence of the primers used (Saulnier et al., 1993; Struelens et al., 
1993). As the primers are not directed against any specific genetic locus, the 
priming events can sometimes be the result of imperfect hybridisation between the 
primer and the target site. Thus, the technique is extremely sensitive to small 
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changes in the annealing temperature, leading to variability in the banding 
patterns (Meunier & Grimont, 1993; Welsh & McClelland, 1990).   
 
Repetitive-sequence-based PCR (Rep-PCR) 
This is a rapid typing method that amplifies the regions between the non-coding 
repetitive sequences in bacterial genomes (Versalovic et al., 1991). The sizes of 
these sequences are unique to each bacterial strain, and therefore the sizes of the 
amplicon may be different among different strains (Healy et al., 2005; Versalovic 
et al., 1991). Rep-PCR was found to be much quicker than PFGE for typing 
MRSA isolates, but it was also less discriminatory than PFGE (Ross et al., 2005).   
 
1.5.2 Multilocus sequence typing 
Multilocus sequence typing (MLST) is a nucleotide sequence-based method 
enabling comparative characterisation of bacterial isolates at the molecular level 
(Maiden et al., 1998). Since its development in 1998 for Neisserria meningitidis, 
it has been applied to many pathogenic and environmental organisms (Maiden, 
2006). MLST is essentially a replacement for MLEE, which identifies variation 
within multiple core metabolic (housekeeping) genes on the basis of differing 
electrophoretic mobilities of the gene products (Selander et al., 1986). The major 
problem with MLEE, and other gel-based methods such as PFGE, is that 
comparison of results between laboratories it is often difficult and unreliable. This 
is not a problem with MLST because variation within housekeeping genes is 
indexed directly by the nucleotide sequencing of internal gene fragments. The 
resolving power of MLST is determined by the number and the type of genes 
analysed, the length of the sequenced gene fragment and the level of diversity 
within the sample being characterised (Cooper & Feil, 2004). 
 
1.5.2.1 The Design of MLST Schemes 
Most MLST schemes employ 400 to 600 bp allele fragments, which was 
originally chosen as the length of nucleotide sequence that could be reliably 
 - 45 -
Chapter 1  Introduction 
 
produced on a single run of the gel-based automated sequencing machines used in 
the mid-1990s. This still has advantages in terms of increased speed and reduced 
costs using current nucleotide sequence determination by the dideoxy chain 
termination method (Maiden, 2006). The number of genes included in an MLST 
scheme is usually limited to between 6 to 10. If more resolution is required, such 
as for outbreak cases which require high-resolution typing, it is more efficient to 
include genes subject to positive selection and therefore exhibiting more diversity, 
than to include more housekeeping gnes (Feavers et al., 1999).  
 
The increasing availability of complete genome sequences of bacterial organisms 
has greatly enhanced the identification of appropriate MLST loci and the design 
of oligonucleotide primers for PCR amplification and sequencing. Housekeeping 
genes are chosen because they encode proteins that are under stabilising selection 
to conserve metabolic function, but at the same time sufficiently diverse to 
identify multiple variants within the target population (Maiden et al., 1998). 
Ideally, separate primers should be used for the PCR amplification and the 
sequencing reaction, the latter nested within the amplified fragment. This 
approach produces better-quality sequences and therefore more reliable data. In 
addition, primers should be designed so that the same annealing temperature can 
be used for all loci for a particular MLST scheme. This emperical step is time-
consuming but benefits in the long run when an MLST scheme is used in large-
scale epidemiological surveillance or population studies (Maiden, 2006).  
 
Once sequencing data is obtained, it is translated into a universal nomenclature 
scheme for storing and interpretation (Maiden & Spratt, 1999; Urwin & Maiden, 
2003). For each locus, the allele fragment is assigned a unique but arbitrary 
number in order of discovery (Figure 1.7). For each isolate, therefore, a code 
made up of numbers for each of the loci is constructed. These codes are referred 
to as an allelic profile and each individual allelic profile is given a sequence type 
(ST) number. 
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1.5.2.2 Databases and analysis tools  
An important component of MLST is the availability of databases accessible to 
public health and research communities (Chan et al., 2001; Jolley et al., 2004). 
The websites available for the storage and access of MLST data include 
http://pubmlst.org/, http://www.mlst.net/ and http://web.mpiib-
berlin.mpg.de/mlst/. Two approaches are generally used to interpret MLST data: 
those that determine relationships on the basis of allelic profiles and STs and 
those that compare nucleotide sequences directly. Both have strengths and 
weaknesses and the most appropriate method required is determined by the 
structure of the bacterial population under investigation (Maiden, 2006).  
   
1.5.2.3 Epidemiological and clinical applications 
In the clinical setting, MLST has been applied directly to clinical specimens 
providing both diagnostic value and epidemiological data (Birtles et al., 2005; 
Diggle et al., 2003; Kriz et al., 2002). It has the advantage of being more rapid 
and accurate than other diagnostic and characterisation methods that require the 
isolation of the organism in culture.  
 
MLST data can also provide useful epidemiological information about bacterial 
organisms. For example, it has been used to confirm that most cases of 
meningococcal disease are caused by a subset of genetic types, the so-called 
hyperinvasive lineages (Caugant, 1998; Maiden et al., 1998; Yazdankhah et al., 
2004). These studies have also shown that the population of meningococci strains 
cultured from the nasopharynx is much more diverse than disease-causing strains.  
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Figure 1.6 Comparison of the steps involved in various molecular typing methods. Adapted from Olive and Bean 1999 (Olive & Bean, 1999).  
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Figure 1.7 Flow diagram of the steps in the multilocus senquence typing (MLST) 
protocol. Adapted from Spratt 1999 (Spratt, 1999) and Urwin and Maiden 2003 
(Urwin & Maiden, 2003).  
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1.6 Aims and Objectives 
 
Microbial keratitis and endophthalmitis are severe sight threatening eye 
infections. Prompt diagnosis of the causative organism and treatment with the 
appropriate topical antimicrobial is essential in providing the best visual outcome. 
Current culture methods are inadequate in both sensitivity and time taken to 
obtain culture results. Therefore, a rapid molecular diagnostic test with high 
sensitivity and specificity is required. In order to tailor the diagnostic assays to 
eye infections, we need to determine whether microorganisms from eye infections 
differ from those of other infection sites using a reliable and robust typing system. 
The main aims of this research project were as follows: 
 
1. To identify the common organisms that cause microbial keratitis in a large 
tertiary eye centre in the West Midlands, UK.  
 
2. To study the population biology of P. acnes and P. aeruginosa cultured from 
eye infections using multilocus sequence typing (MLST). No previous MLST 
scheme had been developed for P. acnes, so a novel scheme had to be set up. 
This was then used to characterise the population structure of P. acnes strain 
using a diverse collection of strains from eye infections, acne infections and 
other invasive diseases. The MLST scheme was validated using 
immunofluorescence microscopy (IFM) and random amplification of 
polymorphic DNA (RAPD). MLST was also used to type P. aeruginosa from 
eye infections from the UK and China using an existing MLST scheme.  
 
3.  To develop rapid polymerase chain reaction (PCR) based diagnostic tests that 
could be incorporated into routine clinical microbiology to identify the 
organisms commonly associated with eye infections. These tests would allow 
faster results and higher pick up rate compared to conventional culture based 
methods.  
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CHAPTER 2 MATERIALS AND METHODS 
 
2.1 Design of P. acnes MLST scheme 
 
2.1.1 Chromosomal mapping and selection of genes 
Potential housekeeping loci were identified within the P. acnes KPA171202 
genome sequence (GenBank accession no. AE017283) (Bruggemann et al., 2004) 
using Artemis genome viewer and annotation software 
(http://www.sanger.ac.uk/Software/Artemis/). In the selection of candidate loci, a 
number of criteria were used. Firstly, only genes encoding putative housekeeping 
products were considered, rather than genes that may come under positive 
selective pressure such as those encoding putative virulence factors, antibiotic 
resistance or cell surface antigens. Secondly, if any candidate genes were located 
near mobile genetic elements they were avoided. Thirdly, genes were at least 500 
bp in length so that universal nested primers could be designed to conserved 
regions that flank a variable central core. The seven housekeeping genes selected, 
along with their gene products, PCR product sizes and location within the 
KPA171202 genome are shown in Table 2.1.  
 
2.1.2 Design of primers for gene amplification and nucleotide sequencing 
Primer 3 v0.3.0 (http://frodo.wi.mit.edu) was used to design the amplification and 
sequencing primers for the MLST scheme. The following parameters were set: 
 
Product size range:  1000-2,000 bp  (for amplification)  
400-600 bp   (for sequencing) 
Primer size:  18 bp 
Primer temp.:  Min. 50ºC Optimal. 58 ºC Max. 65ºC 
Max. temp. difference: 1ºC 
GC content:  Min. 50% Optimal. 55%  Max. 60% 
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 Table 2.1 Primer sequences for the amplification and sequencing of the seven housekeeping genes used in the P. acnes MLST scheme 
 
Housekeeping 
Gene 
 
Putative gene 
product 
 
PPA 
numbera
 
Fragment locationb
 
Amplicon 
size (bp) 
 
                            Primer sequences (5` → 3`)              
 Amplification (For/Rev)                  Sequencing (For/Rev)  
           
           aroE 
 
Shikimate 5-
dehydrogenase 
 
PPA 1181 
 
1288538-1288961 
 
762 
 
 
GTGATTGGCCATCCAGTG/ 
CGCTGTGGACCTCAAAAC 
 
GGGCTATCAGTGACGATG/ 
GATCTTCAGCACGCCTTA 
 atpD ATP synthase beta 
chain 
PPA1239 1346325-1346777 
1261 
 
AATTACCCCCGAGACGAA/ 
CGTGTTCTGGGACAGGAA 
TAAGGGTCACGTCTGGAA/ 
ACATCGCGGAAGTACTCA 
gmk Guanylate kinase PPA1190 1296456-1296855 
444 
 
TAGCCATCCGGAGATCGT/ 
GCGCAACTGCGTGATCTA 
AGATCGTCGTTTCCAGGT/ 
ACAACGGCGTCAAATTC 
guaA GMP synthase PPA1764 1926561-1927040 
1384 
 
TCGCCTTCATGGAACAAC/ 
CCATAAGTACGCCCGTCA 
GCGTTTGAAGACGTTGAG/ 
GCTGGTCAGCATTGAGAC 
lepA GTP-binding 
protein 
PPA0901 982280-982731   
1218 
 
TCGCGCCCAGTACTTAGA/ 
CGGATTTCCACTCGATCA 
GTCAAGGATGTCCGTCAA/ 
GCAGGACTGAGAATGGTG 
recA Recombinase A 
protein 
PPA1012 1095604-1096066 
877 
 
GCTCTATCATGCGCCTTG/ 
GCAACATCCGGGTTACCT 
GGGGTCGATACAGATTCC/ 
TGTCAAACTCTGCCTGCT 
sodA Superoxide 
dismutase 
PPA1818 1983249-1983696 
488 
 
TGGAACTGCACCATGACA/ 
GCTAACGACGTTCCACCA 
ACAAGCACCACAACACCT/ 
TAACGTAGTCGGCCTTGA 
       a Locus tag number for KPA171202 genome 
       b Position in KPA171202 genome (base pair) 
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 Table 2.2 Primer sequences for the amplification and sequencing of the seven housekeeping genes used in the P. aeruginosa MLST scheme 
 
Housekeeping 
Gene 
 
Putative gene product 
 
PPA numbera
 
Fragment 
locationb
 
Amplicon 
size (bp) 
 
                            Primer sequences (5` → 3`)              
    Amplification (For/Rev)                   Sequencing (For/Rev)  
           
acsA 
 
Acetyl coenzyme A 
synthetase 
 
PPA0887 
 
970624-971013 
 
842 
 
 
ACCTGGTGTACGCCTCGCTGAC/ 
GACATAGATGCCCTGCCCCTTGAT 
 
GCCACACCTACATCGTCTAT/ 
AGGTTGCCGAGGTTGTCCAC 
aroE 
Shikimate 
dehydrogenase 
PPA0025  
   
  
26883-27380
825 
 
TGGGGCTATGACTGGAAACC/ 
TAACCCGGTTTTGTGATTCCTACA 
ATGTCACCGTGCCGTTCAAG/ 
TGAAGGCAGTCGGTTCCTTG 
guaA GMP synthase PPA3769 4226547-4226175
940 
 
CGGCCTCGACGTGTGGATGA/ 
GAACGCCTGGCTGGTCTTGTGGTA 
AGGTCGGTTCCTCCAAGGTC/ 
GACGTTGTGGTGCGACTTGA 
mutL 
DNA mismatch repair 
protein 
PPA4946 5551159-5550718
940 
 
CCAGATCGCCGCCGGTGAGGTG/ 
CAGGGTGCCATAGAGGAAGTC 
AGAAGACCGAGTTCGACCAT/ 
GGTGCCATAGAGGAAGTCAT 
nuoD 
NADH dehydrogenase I 
chain C, D 
PPA2639   
  
  
2984590-2984955
1042 
 
ACCGCCACCCGTACTG/ 
TCTCGCCCATCTTGACCA 
ACGGCGAGAACGAGGACTAC/ 
TGGCGGTCGGTGAAGGTGAA 
ppsA 
Phosphoenolpyruvate 
synthase 
PPA1770 1915014-1915383
989 
 
GGTCGCTCGGTCAAGGTAGTGG/ 
GGGTTCTCTTCTTCCGGCTCGTAG 
GGTGACGACGGCAAGCTGTA/ 
GTATCGCCTTCGGCACAGGA 
trpE 
Anthranilate synthetase 
component I 
PPA0609 671831-672273
811 
 
GCGGCCCAGGGTCGTGAG/ 
CCCGGCGCTTGTTGATGGTT 
TTCAACTTCGGCGACTTCCA/ 
GGTGTCCATGTTGCCGTTCC 
       a Locus tag number for PAO1 genome 
       b Position in PAO1 genome (base pair) 
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2.2 Bacterial strains 
 
2.2.1 P. acnes strains 
A total of 125 P. acnes isolates were analysed, including the reference strain 
NCTC 737 (facial acne isolate) which was obtained from the National Collection 
of Type Cultures (NCTC; Colindale, UK), and KPA171202 (DSM 16379; 
contaminated anaerobic culture) which was from the German Collection of 
Microorganisms and Cell Cultures (Braunschweig, Germany). For the remaining 
123 isolates, eight were cultured from brain abscess, bone, lymph node, cadaveric 
skin and blood samples. A total of 31 isolates were recovered from keratitis 
(corneal scrape) and endophthalmitis (aqueous and vitreous humour) infections, 
while 56 isolates were from patients with acne. A further three isolates were 
recovered from fatal head granulomas, seven from microdiscectomy samples 
removed during sciatica surgeries and six from dental infections. Five isolates 
were from surgical skin wounds and seven isolates were recovered from 
prosthetic hip arthroplasties. The availability of data regarding the time of 
isolation for all the isolates was limited, but where dates were known they ranged 
from September 1999 to January 2005.  
 
2.2.2 P. aeruginosa strains 
A total of 117 P. aeruginosa strains from microbial keratitis infections were 
analysed. 18 isolates were from the Birmingham and Midland Eye Centre, five 
from Liverpool, ten from Manchester, 30 from Moorfields eye hospital (London), 
five from Royal Victoria Infirmary (Newcastle), ten from Bristol Royal Infirmary, 
one from Northwick Park and St. Marks (London) and 38 were from Tong Ren 
Hospital, Beijing, China. In addition, MLST data on 164 P. aeruginosa isolates 
from other clinical infections and 2 environmental isolates were already available 
on the P. aeruginosa MLST website (http://pubmlst.org/paeruginosa).  
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2.3 Storage of bacterial strains 
A single colony was inoculated onto an appropriate plate and incubated until a 
patch was produced. The patch was harvested using a sterile swab and 
resuspended in a 1.5ml centrifuge tube containing 1ml of brain heart infusion 
(BHI) supplemented with 12% (v/v) glycerol. The cultures were stored at -80ºC 
until required.  
 
2.4 DNA preparation 
 
2.4.1 P. acnes DNA preparation 
All bacterial strains were maintained at -80ºC in BHI broth containing 12% 
(vol/vol) glycerol. Organisms were cultured on BHI and blood agar at 37ºC in an 
anaerobic cabinet (Mark 3; Don Whitley Scientific, Shipley, United Kingdom) 
under an atmosphere of 10% H2, 10% CO2, 80% N2. Strains were identified as P. 
acnes by using the API 20A multitest identification system (bioMérieux UK Ltd, 
Basingstoke, UK) in accordance with the manufacturer’s instructions. 
 
For the extraction of chromosomal DNA, P. acnes isolates were harvested from 
agar plates into 500µl of 50mM Tris buffer, pH 8.0 containing 10mM EDTA and 
0.8 mg/ml lysozyme (Sigma-Aldrich Company Ltd., Poole, UK) before 
incubation at 37°C for 30 min. Proteinase K (0.6mg/ml; Invitrogen Life 
Technologies, Paisley, UK) was then added to the mixture and incubated at 37°C 
for 30 min before the addition of lauryl sarcosyl (1.6% vol/vol) for 10 min at 
30°C. DNA was then obtained following the standard phenol:chloroform 
extraction and ethanol precipitation protocols previously described and outlined as 
follows (Sambrook et al., 1989). 500µl of 1:1 of phenol/chloroform was added 
and mixture inverted and centrifuged at 13,000×g for 5 min. The top layer was 
removed into a clean microcentrifuge tube. Another 500µl of phenol/chloroform 
was added to the mixture, mixed and centrifuged at 13,000×g for 5 min. 400µl of 
chloroform was then added, mixed well and centrifuged at 13,000×g for 5 min. 
40µl of 3M sodium acetate (pH 5.2) was added and the solution mixed. 1ml of 
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ethanol (-20°C) was added and centrifuged at 13,000×g for 15 min. The 
supernatant was removed and 1ml of ethanol (-20°C) was added. The mixture was 
inverted and then centrifuged at 13,000×g for 5 min. The ethanol was then 
removed with the DNA pellet remaining at the bottom of the 1.5ml tube. The 
pellet was then air-dried and resuspended in 50µl of sterile H2O with 1µl of 
RNase overnight. Extracted DNA was stored at -20°C until needed.  
 
2.4.2 P. aeruginosa DNA preparation 
Bacterial strains were maintained at -80°C in 12% (v/v) glycerol in BHI broth, 
streaked to single colonies, and cultured on BHI agar at 37°C under aerobic 
conditions. Chromosomal DNA was extracted using the Promega Wizard 
Genomic DNA Purification Kit as follows. A single colony of P. aeruginosa was 
added to 10ml BHI broth and incubated in 37ºC shaker for 16 hours. 1-1.5ml of 
overnight culture was added to a 1.5ml microcentrifuge tube. This was 
centrifuged at 16,000×g for 2 min. to pellet the cells and the supernatant was 
removed. 600µl of Nucleic Lysis Solution was added and mixed with a pipette 
until the cells resuspended. The mixture was incubated at 80ºC for 5 min. to lyse 
the cells and then cooled to room temperature. 3µl of RNase Solution was added 
to the cell lysate and inverted 2-5 times to mix. This was incubated at 37ºC for 15-
60 min. and then cooled to room temperature. 200µl of Protein Precipitation 
Solution was added to the RNase-treated cell lysate and vortexed vigorously at 
high speed for 20 seconds. The sample was incubated on ice for 5 min. and then 
centrifuged at 16,000×g for 3 min. The supernatant containing DNA was 
transferred to a clean 1.5ml microcentrifuge tube containing 600µl of room 
temperature isopropanol. The mixture was gently mixed until the thread-like 
strands of DNA formed a visible mass. The tube was centrifuged at 16,000×g for 
2 min. The supernatant was carefully poured off and the tube drained on clean 
absorbent paper. 600µl of room temp 70% ethanol was added and gently inverted 
to wash the DNA pellet. The tube was centrifuged at 16,000×g for 2 min. and the 
ethanol was aspirated. The tube was drained on clean absorbent paper and air 
dried for 10-15 min. 50-100µl of DNA Rehydration Solution was added to the 
tube and incubated overnight at 4ºC. The DNA was stored at -20ºC until required.   
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2.5 Analysis of DNA by agarose gel electrophoresis 
DNA fragments were visualised by gel electrophoresis on agarose gels. The gels 
were prepared by dissolving agarose (Helena Biosciences Europe, Gateshead, 
UK) in 1× Tris-acetate-EDTA (TAE) to a final concentration of 1% (w/v). 
Ethidium bromide (Sigma-Aldrich Ltd, Poole, UK) was added to a final 
concentration of 0.025µg ml-1. Gels were submerged in 1× TAE and samples 
containing 20% (v/v) glycerol loading buffer (Sambrook et al., 1989) were loaded 
alongside 0.5µg of 1 kilobase (Kb) ladder (Fermentas, York, UK). Gels were run 
at 120V and the DNA was visualised and photographed using a UVI-tec 
documentation system. 
 
2.6 Quantification of DNA 
The amount of DNA was determined using the NanoDrop ND-1000 UV-Vis 
Spectrophotometer (NanoDrop Technologies, Wilmington, USA).  
 
2.7 Amplification of DNA by Polymerase chain reaction (PCR) 
 
2.7.1 Optimisation of PCR conditions (P. acnes) 
PCR conditions were optimised by varying the following parameters: 
• MgCl2 concentration in PCR reaction mix 
 
Final Mg2+ concentration in 
reaction (mM): 
1.5 2.0 2.5 3.0 3.5 4.0 4.5 5.0
Required volume of 25mM MgCl2 
per 50µl reaction (µl) 
0 1 2 3 4 5 6 7 
 
• Presence of 10× Q solution (QIAGEN) in PCR reaction mix 
• Annealing temperature (12-step temperature gradient varying from 
54°C - 60°C) 
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2.7.2 PCR reactions (P. acnes) 
Amplification of DNA by PCR using Taq polymerase (QIAGEN, Crawley, UK) 
was used in the amplification of genes for sequencing. Each 50µl amplification 
reaction mixture comprised the following mixture:  
 
Reagents      Volume Final concentration 
DNA (~10ng/µl)     1µl   ~0.2ng/µl 
Forward primer (10pmol/µl)   2µl  0.4pmol/µl 
Reverse primer (10pmol/µl)   2µl  0.4pmol/µl 
10× PCR buffer (containing Tris-HCl, KCl,  
(NH4)2SO4, 15mM MgCl2; pH 8.7)  5µl   1× 
Deoxynucleotide triphosphates (dNTP) mix  
(10mM each dATP, dCTP, dGTP and dTTP) 1µl   0.8mM  
5× Q solution     10µl  1×  
MgCl2 (25mM)     3µl  1.5mM  
Taq polymerase (5U/µl)    0.25µl  0.025U/µl  
H2O      25.75  - 
Total volume     50µl  - 
 
Amplification of DNA by PCR was carried out in 0.2ml centrifuge tubes in an 
automatic thermocycler (DNA Engine TetradTM 2 Peltier Theramal Cycler, Bio-
Rad Laboratories, Hemel Hempstead, UK). A negative control was prepared with 
every set of reactions in which DNA was replaced with H2O.  
 
Amplification primers were designed to have the same melting temperature (Tm) 
and the thermal cycler conditions were as follows: 
 Denaturation  94°C 1 min  1 cycle 
 Denaturation  94°C 1 min    
 Annealing  58°C 1 min  30 cycles 
 Extension  72°C 2 min 
 Final extension 72°C 10 min  1 cycle 
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All PCR products were analysed by electrophoresis on 1.5% (w/v) agarose gels 
(Helena Biosciences Europe, Gateshead, UK) containing 1× TAE buffer and 
ethidium bromide (Sigma-Aldrich Ltd, Poole, UK) to a final concentration of 
0.025µg/ml. 5µl of product containing 20% (v/v) of glycerol loading buffer 
(Sambrook et al., 1989) were electrophoresed alongside 0.5µg of 1Kb ladder 
(Fermentas, York, UK). Gels were run at 120V and the PCR fragments was 
visualised and photographed using a UVI-tec documentation system.  
 
The forward and reverse amplification primers and product lengths for the P. 
acnes MLST scheme are shown in Table 2.1.  
 
2.7.3 PCR reactions (P. aeruginosa) 
The method used was as described previously by Curran et al. (Curran et al., 
2004). Amplification of DNA by PCR using Taq polymerase (QIAGEN) was used 
in the amplification of genes for sequencing. Each 50µl amplification reaction 
mixture comprised the following mixture:  
 
Reagents     Volume  Final 
concentration 
DNA (~10ng/µl)    1µl    ~0.2ng/µl 
Forward primer (10pmol)   2µl   0.4pmol/µl 
Reverse primer (10pmol)   2µl   0.4pmol/µl 
10× PCR buffer  
(containing 15mM MgCl2)   5µl    1× 
dNTP mix (10mM each)   1µl    0.8mM   
Taq polymerase    0.25µl   0.025U/µl 
H2O     38.75   - 
Total volume    50µl   - 
 
Amplification of DNA by PCR was carried out in 0.2ml centrifuge tubes in an 
automatic thermocycler (DNA Engine TetradTM 2 Peltier Theramal Cycler, Bio-
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Rad Laboratories, Hemel Hempstead, UK). A negative control was prepared with 
every set of reactions in which DNA was replaced with H2O.  
  
The thermal cycler was programmed as follows: 
 Denaturation  96°C 1 min  1 cycle 
 Denaturation  96°C 1 min    
 Annealing  55°C 1 min  35 cycles 
 Extension  72°C 1 min 
 Final extension 72°C 10 min  1 cycle 
 
All PCR products were analysed by electrophoresis as described in Section 2.6. 
The forward and reverse amplification primers and product lengths for the P. 
aeruginosa MLST scheme are shown in Table 2.2.   
 
2.8 Purification of PCR product 
Prior to carrying out automated sequencing it was necessary to remove reagents 
remaining from the PCR reactions. This was carried out using either the 
MiniElute 96 UF PCR purification kit (QIAGEN) or the QIAquick PCR 
purification kit (QIAGEN). 
 
2.8.1 QIAquick PCR purification kit 
The method used was as described in the manufacturer’s protocol. 5 volumes of 
Buffer PB was added to 1 volume of the PCR sample and mixed. This was placed 
in a QIAquick spin column with a 2ml collection tube underneath. To bind the 
DNA, the spin column was centrifuged at 18,000×g for 1 min and the flow-
through was discarded. To wash, 0.7ml Buffer PE was added to the QIAquick 
column and centrifuged at 18,000×g for 1 min. The flow-through was discarded 
and the QIAquick column was placed back in the same tube and centrifuged at 
18,000 × g for an additional 1 min. The QIAquick column was placed in a clean 
1.5ml microcentrifuge tube. To elute DNA, 50µl H2O was added to the centre of 
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the QIAquick membrane and centrifuged at 18,000×g  for 1 min. The purified 
PCR product was stored at -20°C until required.  
 
2.8.2 MiniElute 96 UF PCR purification kit 
The amplified product was purified using MiniElute 96 UF PCR purification kit 
(QIAGEN) following the manufacturer’s protocol before being used in a 
sequencing reaction. A MiniElute purification plate was placed on top of a 
vacuum manifold and the PCR samples were pipetted onto the purification plate. 
A 800mbar vacuum as applied for 45-60 min or until the wells were completely 
dry. The MiniElute purification plate was placed on absorbent paper to remove 
any liquid that might remain at the bottom of the plate. 20µl of deionized H2O was 
added to each well and the plate was placed on a microplate shaker for 2 min at 
the recommended speed (600rpm). The purified PCR product was recovered by 
pipetting the elute out of each well into a clean PCR tube. The purified PCR 
product was stored at -20°C until required.  
 
2.9 P. acnes recA gene amplification and sequencing  
PCR amplification and sequencing of the P. acnes complete recA gene using 
primers PAR-1 and PAR-2 producing a 1,047 bp amplicon was as described 
previously (McDowell et al., 2005). Sequences for 46 of the P. acnes strains had 
been previously published (McDowell et al., 2005; McDowell et al., 2008). The 
complete sequences for a further 11 isolates were determined during the current 
study. 
 
Complete recA amplification and sequencing primers 
Primer PAR-1  5`-AGCTCGGTGGGGTTCTCTCATC-3`
Primer PAR-2  5`-GCTTCCTCATACCACTGGTCATC-3`
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Reagents    Volume  Final concentration 
DNA (~10ng/µl)   1µl    ~0.2ng/µl 
Primer PAR-1 (10pmol)  2µl   0.4pmol/µl 
Primer PAR-2 (10pmol)  2µl   0.4pmol/µl 
10× PCR buffer   5µl    1× 
dNTP mix    1µl    0.8mM   
Taq polymerase   0.25µl   0.025U/µl  
H2O    38.75   - 
Total volume   50µl   -
 
The thermal cycler was programmed as follows: 
 Denaturation  95°C 3 min  1 cycle 
 Denaturation  95°C 1 min    
 Annealing  55°C 30 sec  35 cycles 
 Extension  72°C 1.5 min 
 Final extension 72°C 10 min  1 cycle 
 
All PCR products were analysed by electrophoresis as described in Section 2.6.  
 
2.10 Automated sequencing 
 
2.10.1 DNA sequencing reaction 
Internal nested primers were designed using the same method as for the 
amplification primers (Table 2.1). Nucleotide sequences were determined with 
BigDye Terminator Ready Reaction Mix v3.1 (Perkin-Elmer Applied Biosystems, 
Foster City, USA) under standard sequencing conditions according to the 
manufacturer’s protocol.  
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Primer (3.2pmol/µl)   1µl 
10× Buffer     1.8µl 
Big Dye 10× CSA Buffer   1.8µl 
BigDye (PE Biosystems, California) 0.5µl 
PCR product (20ng/µl)   1µl 
Total     10µl 
  
The thermal cycler was programmed as follows: 
 Denaturation  96°C 1 min  1 cycle  
 Denaturation  96°C 10 sec    
 Annealing  55°C 5 sec  35 cycles 
 Extension  60°C 2 min 
   
2.10.2 Ethanol precipitation of sequencing reaction  
Unincorporated dye terminators were removed by precipitation with alcohol as 
follows. Place samples in a 96-well plate (ABgene, Epsom, UK). To each 10µl of 
PCR reaction, 10µl of sterile H2O and 50µl of 100% Ethanol/0.12M Sodium 
acetate (EtOH/0.12M NaOAc) were added. The mixture was centrifuged at 500×g 
for 1 min at room temperature. The sample was incubated at room temperature for 
60 min and then centrifuged at 2,800×g at 4°C for 60 min. The supernatant was 
removed and the 96-well plate was inverted and centrifuged on 3mm Whatman 
paper at 500×g for 1 min at 4°C. 150µl of 70% (vol/vol) ethanol (-20°C) was 
added and centrifuged at 2,800×g for 10 min at 4°C. The wash step was then 
repeated and dried samples were stored at -20°C until analysed by an ABI PRISM 
genetic analyser.  
  
2.10.3 Sequencing 
The reaction products were separated and detected on an ABI PRISM genetic 
analyser (PE Biosystems) using a standard sequencing module with a 
Performance Optimised Polymer and 5cm array. The sequences from both strands 
 - 63 -
Chapter 2  Materials and Methods 
 
of a given locus of the same isolate were aligned, trimmed to the desired length 
and edited using SeqMan II (DNA Star software, Madison, Wison).   
 
2.11 Allele and Sequence Type (ST) assignment 
After sequencing, each distinct allele within a locus was assigned an arbitrary 
number upon discovery. Each isolate was represented by a combination of seven 
numbers, the allelic profile, which was assigned a sequence type (ST). Subsequent 
isolates with an identical allelic profile were assigned the same ST identifier and 
considered to be isogenic as they were indistinguishable at all loci. Each ST was 
given an arbitrary number in order of analysis. Data for each isolate was uploaded 
onto the P. acnes MLST website (http://pubmlst.org/pacnes/) developed by Keith 
Jolley and sited at the University of Oxford, United Kingdom (Jolley et al., 2004).  
 
2.12 Immunofluorescence Microscopy (IFM) of P. acnes 
 
2.12.1 Production of Monoclonal Antibodies 
Monoclonal antibodies (MAbs) were generated by Dr. Andrew McDowell, using 
the protocol described previously (Tunney et al., 1999). Four BALB/c mice were 
immunised with killed whole cells (108 CFU/ml) of the P. acnes strain AT1 (type 
I; biotype 3), while a further four BALB/c mice were immunised with a 
combination of killed whole cells of P. acnes strains DW1 and ED2 (type II; 
biotype 2). Hybridoma cell lines producing P. acnes-specific MAbs were cloned 
by limiting dilution (Harlow & Lane, 1988).  
 
2.12.2 Immunofluorescence Microscopy (IFM) 
A modification of the IFM procedure described by Patrick et al. (Patrick et al., 
1995) was performed on pure cultures. Briefly, bacterial cultures were cultured for 
18 hours on anaerobic blood agar or BHI, and a suspension of 108 CFU/ml in 
0.01M phosphate-buffered saline (PBS, consisting of 0.15M NaCl, 0.0075M 
Na2HPO4, and 0.0025M NaH2PO4 · 2H) was prepared. Samples (10µl) were then 
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applied to multiwell slides, air dried, and fixed in 100% methanol for 10 min at -
20°C. Undiluted human AB serum (30µl) (Sigma-Aldrich Ltd.) was added as a 
blocking agent, and the slides were incubated at 37°C for 45 min. The slides were 
then washed in 0.01M PBS containing 0.5% (vol/vol) AB serum for 20 min. The 
appropriate undiluted MAb-containing supernatant (30µl) was added to each well 
of the slides and incubated for 45 min at 37°C. After a wash, as before, wells were 
incubated with a 1:100 dilution of a fluorescein isothiocyanate (FITC)-conjugated 
goat anti-mouse antibody (Sigma-Aldrich Ltd.) in a 0.1% Evans blue (Merck 
Sharp & Dome, Hoddesdon, England) counterstain (30µl) for 45 min at 37°C. 
Slides were then washed and mounted in glycerol-PBS containing an 
antiphotobleaching agent (Citifluor; Agar Scientific Ltd., Stansted, England), and 
examined by using a Leitz Dialux 20 fluorescence microscope. 
 
2.13 Random amplification of polymorphic DNA (RAPD) 
analysis of P. acnes 
 
RAPD analysis of P. acnes isolates were carried out as described previously 
(Mahenthiralingam et al., 1996). 
Primer 208 was used in the PCR reaction  5`-ACGGCCGACC-3` 
After optimisation of conditions, the following reaction mixture was used: 
 
Reagents    Volume  Final concentration 
DNA (~40ng/µl)   1µl    ~1.6ng/µl 
Primer 208 (10pmol)  4µl   1.6pmol/µl 
10× PCR buffer   2.5µl    1× 
dNTP mix    0.625µl   1mM  
10× Q solution   8µl   1.6×  
MgCl2 (25mM)   0.5µl   0.25M 
Taq polymerase (5U/µl)  0.2µl   0.04U/µl 
H2O    8.175   - 
Total volume   25µl   - 
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Amplification of DNA by PCR was carried out in 0.5ml centrifuge tubes in an 
automatic thermocycler (DNA Engine TetradTM 2 Peltier Theramal Cycler, Bio-
Rad Laboratories, Hemel Hempstead, UK). A negative control was prepared with 
each set of reactions in which DNA was replaced with H2O.  
 
The thermal cycler conditions were as follows: 
 94°C 5 min   
 40°C 5 min   4 cycles  
 72°C 5 min   
 94°C 1 min 
 40°C 1 min   30 cycles 
72°C 2 min 
72°C 10 min   1 cycle 
 
All PCR products were analysed by electrophoresis on 1.5% (w/v) agarose gels 
(Helena Biosciences Europe, Gateshead, UK) containing 1× Tris-borate-EDTA 
(TBE) buffer and ethidium bromide (Sigma-Aldrich Ltd, Poole, UK) to a final 
concentration of 0.025µg/ml. 10µl of product containing 20% (v/v) of glycerol 
loading buffer (Sambrook et al., 1989) were electrophoresed alongside 0.5µg of 
1Kb ladder (Fermentas, York, UK). Gels were run at 120V for 3hrs and the PCR 
fragments was visualised and photographed using a UVI-tec documentation 
system.  
 
The RAPD fingerprints were analysed both by eye and also by computer with 
GelCompar II softare (Applied Maths, Sint-Martens-Latem, Belgium).  
 
2.14 P. aeruginosa exoS and exoU gene amplification 
 
PCR assays were used to determine the distribution of the TTS genes exoS and 
exoU (Ajayi et al., 2003) using the primers shown in Table 2.3 and method as 
previously described (Winstanley et al., 2005).  
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Table 2.3 Oligonucleotide primers used for exoU and exoS PCR amplification
Primer Sequence Amplicon 
size (bp) 
Target Annealing 
temperature 
(°C) 
ExoS forward 5`-GCGAGGTCAGCAGAGTATCG-3` 
ExoS reverse 5`-TTCGGCGTCACTGTGGATGC-3` 118  exoS  58  
ExoU forward 5`-CCGTTGTGGTGCCGTTGAAG-3`  
ExoU reverse 5`-CCAGATGTTCACCGACTCGC-3`  134 exoU  58  
 
Amplification of DNA by PCR was carried out in 0.2ml centrifuge tubes in an 
automatic thermocycler (DNA Engine TetradTM 2 Peltier Theramal Cycler, Bio-
Rad Laboratories, Hemel Hempstead, UK). A negative control was prepared with 
every set of reactions in which DNA was replaced with H2O.  
 
Reagents    Volume   Final concentration 
DNA (~10ng/µl)   1µl    ~0.4ng/µl 
Forward primer (10pmol)  1µl   0.4pmol/µl 
Reverse primer (10pmol)  1µl   0.4pmol/µl 
10× PCR buffer    2.5µl    1× 
dNTP mix    1µl    0.8mM  
MgCl2 (25mM)   3µl   3.0mM 
Taq polymerase (5U/µl)  0.125µl  0.025U/µl 
Dimethyl sulphoxide (DMSO) 0.25µl   - 
H2O    15.125   - 
Total volume   25µl   - 
 
The thermal cycler conditions were as follows: 
 Denaturation  95°C 1 min  1 cycle 
 Denaturation  95°C 1 min    
 Annealing  58°C 1 min  30 cycles 
 Extension  72°C 2 min 
 Final extension 72°C 10 min  1 cycle 
 
All PCR products were analysed by electrophoresis on 1.5% (w/v) agarose gels 
(Helena Biosciences Europe, Gateshead, UK) containing 1× TAE buffer and 
ethidium bromide (Sigma-Aldrich Ltd, Poole, UK) to a final concentration of 
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0.025µg/ml. 5µl of product containing 20% (v/v) of glycerol loading buffer 
(Sambrook et al., 1989) were electrophoresed alongside 0.5µg of 1Kb ladder 
(Fermentas, York, UK). Gels were run at 120V and the PCR fragments was 
visualised and photographed using a UVI-tec documentation system. Presence of 
exoU and/or exoS genes were indicated by the presence of gel bands which 
correspond to the particular primers used.  
 
2.15 P. acnes rapid diagnostics 
 
2.15.1 Target gene selection and primer design 
Genes from the MLST scheme was selected as targets for the diagnostics assay. 
The gene most specific for P. acnes and which the amplification primers produced 
the smallest amplicon was selected. 
 
2.15.2 PCR conditions 
 
First round PCR conditions:  
Reagents     volume per reaction (µl) 
Buffer (Labmaster)    5µl 
dNTPs (10mM) (Bioline)    5µl 
Mg2+ (25mM) (Sigma)    3µl 
Q solution (QIAGEN)    10µl 
Combined primers (5µM each) (Invitrogen) 1µl 
H2O (Sigma)     5.75µl 
Taq polymerase (Supertherm)   0.25µl 
P. acne107 DNA (0.001pg/µl DNA)  20µl 
Total volume     50µl 
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The thermal cycler conditions were as follows: 
 Denaturation  96°C 1 min  1 cycle 
 Denaturation  96°C 1 min    
 Annealing  58°C 1 min  30 cycles 
 Extension  72°C 1 min 
 Final extension 72°C 10 min  1 cycle 
 
1µl of first round product was then transferred to a second real-time PCR reaction 
in a LightCycler® capillary. 
 
Second round PCR conditions: 
Reagents     volume per reaction (µl) 
Biogene master mix (with 2mM Mg)  5µl 
Combined primers     1µl 
Evagreen (Biotium Inc.)    0.5µl 
H2O      2µl 
Mg (25mM)     0.5 µl 
Template      1µl 
Total volume     10µl 
 
The thermal cycler conditions were as follows: 
 Denaturation  96°C 2 sec    
 Annealing  58°C 5 sec  30 cycles 
 Extension  72°C 10 sec 
 
2.15.3 DNA extraction methods 
A suspension of P. acnes cells harvested from an agar plate and a negative control 
was used to compare three DNA extraction different methods:  
1. High Pure Viral Nucleic Acid extraction kit (Roche Ltd, Sussex, UK) 
2. DNAMITE® kit (Microzone Ltd, Haywards Heath, West Sussex, UK) 
3. Chelex (Bio-Rad Laboratories, Hemel Hempstead, UK) extraction method  
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1. High  Pure Viral Nucleic Acid Kit 
Method was as manufacturer’s protocol. 25µl of P. acnes cell suspension was 
incubated at 37ºC for 30 min with 25µl of 100mg/ml of lysozyme (Sigma-Aldrich 
Company Ltd., Poole, UK) and 10µl of 1mg/ml lysostaphin (Sigma-Aldrich 
Company Ltd.). This mixture was then added to a 1.5ml microcentrifuge tube 
along with 200µl of Binding Buffer supplemented with Poly (A) and 50µl 
Proteinase K. This suspension was mixed and incubated for 10 min at 72ºC. The 
sample was then mixed with 100µl Binding Buffer. The High Pure Filter Tube 
and the Collection Tube were combined and the sample was pipetted into the 
upper reservoir. The tube was centrifuged at 8,000×g for 1 min. The Filter Tube 
was placed in a new Collection Tube. 500µl of Inhibitor Removal Buffer was 
added to the upper reservoir of the Filter Tube and centrifuged again at 8,000×g 
for 1 min. The Filter Tube was reinserted into a new Collection Tube and 450µl of 
Wash Buffer was added. This wash step was repeated again. The Filter Tube was 
centrifuged at 13,000×g for 10 seconds and the Filter Tube was inserted in a new 
1.5ml microcentrifuge tube. 50µl of Elution Buffer was added to the upper 
reservoir of the Filter Tube and centrifuged for 1 min at 8,000×g. The eluted 
nucleic acid was stored at 2-8ºC for later analysis. 
 
2. DNAMITE® DNA extraction kit 
Method was as manufacturer’s protocol. P. acnes cells harvested from an agar 
plate was added to a 1.5ml microcentrifuge tube. 0.5ml of Solution LA and 10µl 
of RNase solution was added to the tube. The mixture was incubated at room 
temperature for 10 min. 20µl of Proteinase K solution was then added and the 
mixture was incubated at 60ºC for 10 min. After incubation, 30µl of Solution PA 
was added and the mixture was inverted to mix. The microcentrifuge tube was 
centrifuged at the manufacturer’s recommendation of 10,000rpm for 5 min. 450µl 
of the supernatant was transferred to a new tube containing 450µl of Solution CA 
and the mixture was inverted to mix. This was left at room temperature for 5 min 
and then centrifuged at 13,000rpm for 7 min to pellet the DNA. The supernatant 
was then removed with a pipette. The DNA pellet was rehydrated with 50µl of TE 
buffer and left for 30min or overnight.  
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3. Chelex DNA extraction method 
A total of 25µl of P. acnes cell suspension was added to 150µl of 10% (w/v) 
chelex (Bio-Rad Laboratories, Hemel Hempstead, UK) in distilled water. This 
mixture was incubated at 100ºC on a heating block for 20 min, vortexing half way 
through the incubation period. At the end of the incubation period, the chelex was 
pelleted by centrifugation at 8,000×g and the supernatant was removed and 
retained for PCR assay. 
 
2.16 Bioinformatics 
 
2.16.1 Genome sequences  
The complete genome sequence of P. acnes KPA171202 used for the design of 
the MLST scheme was located at the following website: http://www.tigr.org 
 
2.16.2 Homology searches 
To investigate sequence similarity of sequences identified to those in the 
databases the following website was used: http://www.ncbi.nlm.nih.gov/BLAST 
 
2.16.3 Sequence analysis tools 
Assembly of sequence data, sequence alignments and subsequent cropping of 
sequences to the desired length were performed using the software SeqMan II 
(DNA Star).  
 
2.16.4 START v2 
Statistical analyses were carried out using the START v2 programme 
(http://www.pubmlst.org) (Jolley et al., 2001). The number of polymorphic 
nucleotide sites and the ratio of the number of nonsynonymous-to-synonymous 
substitutions (dN/dS ratio) for all seven loci were calculated. The dN/dS ratio 
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indicates any genes that might be undergoing strong diversifying or directional 
selection. 
 
2.16.5 LIAN v3.5 
Evidence of clonality or recombination among populations was estimated by 
assessing the level of linkage between alleles at different loci around the 
chromosome using the index of association (Ia) (Haubold & Hudson, 2000). An Ia 
not significantly greater than zero after 1,000 computer randomisations would 
suggest that loci within a monophyletic population is in linkage equilibrium 
(freely recombining), while a population with an Ia significantly greater than zero 
(p<0.001) is considered to be in linkage disequilibrium (clonal). 
 
2.16.6 MEGA v4.1 
Phylogenetic trees of the concatenated sequence of the seven housekeeping genes 
(3,135 bp) were constructed by the neighbour-joining method using Jukes-Cantor 
based algorithm (MEGA v4.1; http://www.megasoftware.net). The sequence input 
order was randomised, and bootstrapping resampling statistics were performed 
using 1,000 data sets for each analysis. A dendrogram using the unweighted pair 
group method with arithmetic averages (UPGMA) was also constructed (MEGA 
v4.1). 
 
2.16.7 SplitsTree v4.1 
Phylogenetic relationships were examined by split decomposition analysis using 
SplitsTree version 4.1 (www.splitstree.org) (Huson & Bryant, 2006). The split 
decomposition algorithm is a parsimony method that does not impose a branching 
or tree-like structure on the data set, but permits reticulations or a network 
structure that may be indicative of past recombination events. As a consequence, a 
split decomposition graph will look less tree-like and more net-like as the 
influence of recombination becomes stronger. 
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2.16.8 eBURST v3 
eBURST (based upon related sequence types) analysis was carried out using 
eBURST v3 programme (http://www.mlst.net) (Feil et al., 2004). Clonal groups 
were identified using the eBURST v3 clustering algorithm (http://www.mlst.net) 
(Feil et al., 2004), which divides strains into clonal complexes where each strain 
has at least six loci in common with at least one other member of the group. The 
algorithm can also identify the most likely (i.e. parsimonious) ancestral ST within 
each clonal complex. 
 
2.16.9 ClonalFrame v1.1 
ClonalFrame uses MLST data to infer the clonal relationships of bacteria and the 
position of homologous recombination events (Didelot & Falush, 2007), available 
at http://www2.warwick.ac.uk/fac/sci/statistics/staff/research/didelot.  
Network representation of the output was done using Graphviz 
(www.graphviz.org).  
 
2.16.10 PAUP v4 
Phylogenetic Analysis Using Parsimony (PAUP) assesses the degree of 
recombination by statistical comparisons between tree topologies for each MLST 
locus (Wilgenbusch & Swofford, 2003), available at http://paup.csit.fsu.edu. 
 
2.16.11GelCompar II 
Programme used to create phylogenetic analysis of Random Amplification of 
Polymorphic DNA (RAPD) gel banding patterns. (GelCompar II, Applied Maths, 
Sint-Martens-Latem, Belgium). 
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2.17 Reagents and Buffers 
 
2.17.1 1 × loading buffer 
5 × loading buffer     982.5µl 
(0.25M Tris, 1% (w/v) SDS, 50% (v/v) Glycerol, 0.05% Bromophenol Blue pH 
6.6) 
β-ME      17.5µl 
 
2.17.2 TE 
Tris-HCl (10mM), EDTA (1mM), pH 7.5-8 
 
2.17.3 5 × TAE 
Tris-base (2M), acetic acid (1M), EDTA (500mM) 
 
2.17.4 5 × TBE 
Tris-base (0.44M), Boric acid (0.44M), EDTA (10mM) 
 
2.17.5 BHI or BHI-blood agar plates 
VWR International, Lutterworth, UK 
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CHAPTER 3 MICROBIAL KERATITIS STUDY 
 
3.1 Introduction 
Microbial keratitis is infection of the cornea (Figure 1.1). It is a common 
ophthalmic emergency and its clinical outcome depends on prompt diagnosis and 
initiation of appropriate antibiotics. This potentially blinding infection is relatively 
rare in the absence of predisposing factors such as contact lens wear, ocular 
surface disease or trauma (Keay et al., 2006). Patients commonly present with a 
painful, red, watering eye and decreased visual acuity. A stromal infiltrate with 
overlying epithelial defect may be present. Deep ulcers may lead to corneal 
perforation requiring urgent corneal transplantation. The responsible microbial 
organism varies depending on the geographical location and climatic factors. In 
the UK, Staphylococcus spp., Pseudomonas spp. and Streptococcus spp. have 
been identified as common causative organisms (Tuft & Matheson, 2000). 
Tailored antimicrobial treatment depends on identification of the organism, which 
is currently dependent on obtaining corneal scrape samples and conventional 
culture techniques. Reports of culture positive rates vary widely from 50% to 86% 
(Alexandrakis et al., 2000; Bennett et al., 1998; Bourcier et al., 2003; Fong et al., 
2007; Neumann & Sjostrand, 1993; Schaefer et al., 2001; Wong et al., 2003). The 
consequence of such a low culture positive rate is that the majority of microbial 
keratitis cases are treated with broad spectrum antibiotics which the infecting 
organisms may not be sensitive to. This not only leads to poor visual prognosis for 
the patient but also raises issues of increased antimicrobial resistance.  
 
3.2 Aims 
1. To determine the incidence, predisposing risk factors and clinical features 
of patients with microbial keratitis.  
2. To identify the commonly isolated organisms and to determine the culture 
positive rate of current culture techniques. 
3. To determine whether prior use of antibiotics before corneal scrapes lead 
to reduced culture positive rate.  
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3.3 Methods 
A retrospective, non-comparative case note review of consecutive patients who 
had corneal scrapes for suspected microbial keratitis at the Birmingham and 
Midland Eye Centre over a 29-month period between April 2002 and August 2004 
was carried out. Patients were first identified through the hospital’s microbiology 
database and their medical records were reviewed. Cases were included if the 
patients had corneal scrapes taken for suspected microbial keratitis.  
 
The following information was collected for each case:  
• Age  
• Gender 
• Date of presentation 
• Whether the patient was admitted into the hospital for treatment 
• Length of stay in hospital if treated as an inpatient 
• Presenting signs and symptoms 
• Duration of symptoms at presentation 
• Therapy commenced before presentation 
• Past medical and ocular history 
• Predisposing risk factors 
• Drug history 
• Initial treatment 
• Gram staining, culture results and antibiotic sensitivities  
• Any change of treatment after microbiological results were available 
• Surgical procedures carried out as a consequence of the microbial keratitis  
 
Fisher’s exact test was performed using GraphPad InStat version 5.1 and 
GraphPad Prism version 4 (GraphPad Software, San Diego California USA, 
www.graphpad.com). P<0.05 was considered to be statistically significant.  
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3.4 Results and Discussion 
 
3.4.1 Epidemiological and clinical findings 
During the 29 months of the study, 288 patients (303 individual cases) were 
identified as having suspected microbial keratitis. 149 (52%) were female and 139 
(48%) were male with a median age of 43 years (range 5-92 years). 187 (61.7%) 
of patients self referred to the eye casualty department, 64 (21.1%) were referred 
by their General Practitioners, 26 (8.6%) were referred by an optician, 21 (6.9%) 
were referred by another hospital and 5 cases (1.7%) were referred by the 
hospital’s main Accident and Emergency department. 110 (36.3%) episodes 
required hospital admission for treatment, with a median stay of 7 days (range 1-
31 days). 193 (63.7%) were treated in the outpatients clinic.  
 
The incidence of suspected microbial keratitis cases was higher in the summer 
months (Figure 3.1). In 148 (48.8%) cases, the left eye only was affected, in 152 
(50.2%) cases, the right eye only was affected and in 3 (1%) cases, both eyes were 
affected. Symptoms included pain (79.5%), red eyes (67.7%), photophobia 
(33.7%), watery eyes (33.3%), blurred vision (18.5%), foreign body sensation 
(17.2%), discharge from the eyes (13.2%), decreased visual acuity (10.9%) and 
eyelid swelling (6.3%). The median time interval between the onset of symptoms 
and presentation to the hospital was 1 day (range 0-56 days). At the time of 
presentation, 92 (30.4%) had already been treated with topical antibiotics. 
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 Figure 3.1 Number of cases of suspected microbial keratitis and Central England Temperature during each month of the study.  
(CET data was obtained from the UK Met office) 
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3.4.2 Predisposing risk factors 
The predisposing risk factors were divided into ocular and systemic risk factors. 
Contact lens wear was by far the commonest predisposing risk factor and was 
observed in 103 (34.0%) of cases (Table 3.1). As shown in Figure 3.2, the 
majority of contact lens wearers in the study population were in the 20-29 and 30-
39 age groups. The large number of contact lens wearers in these age groups 
account for the high incidence of contact lens related keratitis cases. Another peak 
incidence of microbial keratitis is seen in the 60-69 age group and this is more 
likely to be associated with ocular surface disease and previous ocular surgery. 
Numerous other studies carried out in developed countries have also identified 
contact lens wear as the commonest predisposing factor to developing microbial 
keratitis (Bourcier et al., 2003; Dart, 1988; Keay et al., 2006; Schaefer et al., 
2001). Other ocular factors identified in this study include previous ocular surgery 
in 55 (18.2%) cases, previous microbial keratitis in 47 (15.5%) cases, trauma in 
33 (10.9%) cases, and previous herpes simplex virus eye infection in 14 (4.6%) 
cases. 58 (19.1%) cases had at least one systemic risk factor. Rheumatoid arthritis 
was the commonest systemic risk factor with 32 (10.6%) of cases with the 
disease. Diabetes was present in 28 (9.2%) cases, Sjögren’s syndrome in 5 (1.7%) 
cases, facial nerve palsy in 3 (1.0%) cases and Stevens-Johnson syndrome in 2 
(0.7%) cases. 
 
Although contact lens wear is the leading risk factor for microbial keratitis in the 
developed world, other risk factors predominate in the developing world. For 
example, in Soweto, South Africa, the commonest predisposing factors were 
found to be blepharitis and ocular trauma (Ormerod, 1987). A study carried out in 
South India identified ocular injury to be the main risk factor, present in 71% of 
cases (Bharathi et al., 2007). Contact lens-wear related cases contributed to only 
1% of the total microbial keratitis cases in this study (Bharathi et al., 2007).   
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Table 3.1 Ocular predisposing risk factors for developing microbial keratitis. 
 
Predisposing risk factor Number of cases %  
Contact lens wear 103 34.0 
Previous ocular surgery 
Previous microbial keratitis 
55 
47 
18.2 
15.5 
Trauma 33 10.9 
Previous herpes simplex virus 14 4.6 
 
 
 
Table 3.2 Systemic predisposing risk factors for developing microbial keratitis. 
 
Predisposing risk factor Number of cases % 
Rheumatoid arthritis 32 10.6 
Diabetes 28 9.2 
Sjögren’s syndrome 5 1.7 
Facial nerve palsy 
Stevens-Johnson syndrome 
3 
2 
1.0 
0.7 
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Figure 3.2 Microbial keratitis cases by age groups. All cases of microbial keratitis 
represented by solid line and contact lens related cases represented by broken line.  
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3.4.3 Microbiology results 
Of the 303 cases, at least one organism was identified in 114 (37.6%) cases using 
conventional culture methods. The culture positive rate in the current study is 
particularly low compared to previous studies, which have reported pick up rates 
ranging from 50% to 86%  (Alexandrakis et al., 2000; Bennett et al., 1998; 
Bourcier et al., 2003; Fong et al., 2007; Neumann & Sjostrand, 1993; Schaefer et 
al., 2001; Wong et al., 2003). Factors thought to contribute to low culture positive 
rate are the inclusion of sterile ulcers, poor sampling technique, use of topical 
anaesthetic agents or topical antibiotics prior to sampling (Badenoch & Coster, 
1982; Maske et al., 1986; Wong et al., 2003).  
 
In total, 91 (30.0%) of the 303 cases received topical antibiotics treatment without 
prior cultures. 29 (31.9%) were culture positive and 62 (67.4%) were culture 
negative. In the group which did not receive antibiotics before cultures were 
obtained (212 cases), 85 (40.1%) were culture positive and 127 (59.9%) were 
culture negative. There was no statistical difference in the culture positive rate 
between the two groups (P>0.05, Fisher’s exact test). Therefore prior 
administration of topical antibiotics did not significantly affect the detection rate 
of the causative organisms. This observation was surprising and data on a larger 
cohort of patients may identify a difference. Keay et al. also observed that there 
was no correlation between culture positive result and whether or not the patient 
had topical medication (Keay et al., 2006). 
 
Of the culture positive cases in this study, ten involved mixed bacterial organisms 
and two cases involved concomitant infection with a viral organism. In total, 127 
organisms including bacterial, viral and fungal were identified. 66 (52.0%) were 
Gram-positive bacteria and 55 (43.3%) were Gram-negative bacteria. The 
remaining consisted of viral and fungal infections (Figure 3.4). Pseudomonas spp. 
were the most commonly cultured organisms (23 cases, 18.9%) followed by 
Streptococcus spp. (20 cases, 16.4%), S. aureus (19 cases, 15.6%), Coagulase 
negative Staphylococcus (15 cases, 12.3%), Moraxella spp. (10 cases, 8.2%) and 
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Serratia spp. (9 cases, 7.4%). Amongst the contact lens related cases, 43.0% of 
the culture positive cases were caused by P. aeruginosa. The mean average time 
from scrape to a culture-positive result was 5.3 days (range 1-39) with 81.6% of 
the results available within 7 days. Pseudomonas spp. took an average of 4.2 days 
(range 2-9) to culture. One corneal scrape sample grew a Propionibacteria spp. 
strain, which took 10 days to culture. 
    
Similar distributions of Gram-positive to Gram-negative bacteria to the current 
study have been reported in South Florida (Alexandrakis et al., 2000). However, 
others have reported much higher rates of Gram-positive bacteria compared to 
Gram-negative bacteria in Melbourne, Australia (Keay et al., 2006), New Zealand 
(Wong et al., 2003), Switzerland (Schaefer et al., 2001) and France (Bourcier et 
al., 2003). A recent study in Taiwan however, did report higher rates of Gram-
negative bacteria (61%) than Gram-positive bacteria (32.4%) (Fong et al., 2007). 
This variation in the microbial spectrum could be explained by the different 
climatic conditions, the study population, the relative contribution of different risk 
factors, e.g. contact lens-wear and the laboratory culture techniques.  
 
Antibiotic sensitivity data was available for 80 (70.2%) of the 114 culture positive 
cases. Where data was available, the microbes were sensitive to at least one of a 
standard panel of antibiotics, which included ciprofloxacin, gentamicin, ofloxacin, 
ampicillin, cefuroxime, chloramphenicol, ceftazidine and methicillin. Antibiotic 
resistance was detected in 4 cases to cefuroxime, 3 cases each to gentamicin, 
chloramphenicol and fusidic acid, two cases to ofloxacin and one case to 
ciprofloxacin. No organism was found to be resistant to ampicillin or ceftazidine. 
Fluoroquinolone monotherapy has been the treatment of choice for many 
ophthalmologists in managing microbial keratitis (Allan & Dart, 1995; Hyndiuk et 
al., 1996; O'Brien et al., 1995). Resistance of systemic and ocular isolates to 
fluoroquinolones have been increasingly observed, possibly due to their 
widespread use even in minor infections (Alexandrakis et al., 2000; Garg et al., 
1999; Goldstein et al., 1999; Kunimoto et al., 1999).  
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 Figure 3.4 Spectrum of isolated organisms cultured from corneal scrapes in microbial keratitis cases. 
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3.4.4 Treatment 
The visual outcome of patients with microbial keratitis is largely dependant on the 
successful treatment with topical antibiotics. Empiric treatment with broad-
spectrum coverage is generally initiated until culture results confirm the causative 
organism and its antimicrobial susceptibility (McLeod et al., 1995). Broad-
spectrum coverage can be achieved by either using combination therapy with a 
cephalosporin and an aminoglycoside or monotherapy using a fluoroquinolone. In 
this study, the majority of episodes (203 cases, 67.0%) were commenced on 
conventional combination therapy (penicillin or cefuroxime combined with 
ofloxacin or gentamicin) whereas monotherapy with a fluoroquinolone 
(ciprofloxacin or ofloxacin) was used in only 31 (10.2%) cases. After culture 
results and antibiotic sensitivity data were available, the antibiotics regime was 
altered in 34 (29.8%) cases.  
 
3.4.5 Complications 
Despite intensive antimicrobial therapy in the treatment of microbial keratitis, 
severe cases can lead to devastating complications. In the current study, 
evisceration (removal of the eye) was required in six cases. Causative organisms 
included P. aeruginosa, S. aureus, Burkholderia multivorans, Moraxella 
nonliquefaciens, Serratia spp. and no growth in one case. One patient underwent 
penetrating keratoplasty (corneal transplant) for spontaneous perforation caused 
by P. aeruginosa and two cases of smaller perforations were treated with bandage 
contact lens and glue. One patient developed bacterial endophthalmitis, also 
caused by P. aeruginosa and three patients required tarsorrhaphy (surgical closure 
of the eye lids) to promote healing.  
 
3.5 Future work 
An important observation from the current study is that the culture positive rate of 
less than 40% is very low compared to previous studies. It is therefore important 
to ascertain why this difference is so significant and whether culture rates could 
be improved. Possible causes include lack of training for junior staff in taking 
 - 85 -
Microbial Keratitis Study 
 
corneal scrape samples, delay in transporting corneal scrape specimens to the 
laboratory, inadequate quantity of specimens and poor sensitivity of conventional 
culture methods. One way of overcoming the poor sensitivity and delay in 
obtaining culture positive results is by using molecular diagnostic techniques such 
as PCR. Assays can be designed to detect the commonly cultured organisms 
identified in this study. Real-time PCR protocols require only small amounts of 
corneal scrape specimen and can detect the causative organism within hours 
compared to days or weeks using conventional culture methods. 303 cases of 
microbial keratitis were included in this study. Long term follow up of these 
patients to investigate their visual outcome, potential complications from the 
keratitis infection and/or treatment and any recurrent infections would be useful 
data. They can then be used to identify factors that influence prognosis and 
effectiveness of different antibiotic treatment regimes.  
 
3.6 Conclusions  
The current study looked at clinical and microbiological data for 303 cases of 
suspected microbial keratitis at the Birmingham and Midland Eye Centre over a 
29-month period. Contact lens wear was found to be the most common 
predisposing factor for the development of microbial keratitis, followed by ocular 
surgery, previous microbial keratitis and ocular trauma. Using conventional 
culture methods, the culture positive rate was found to be under 40%, lower than 
recently reported studies (Alexandrakis et al., 2000; Bennett et al., 1998; Bourcier 
et al., 2003; Fong et al., 2007; Neumann & Sjostrand, 1993; Schaefer et al., 2001; 
Wong et al., 2003). This low culture positive rate could be attributed by sampling 
sterile ulcers, small amounts of sample, poor sampling technique, use of topical 
anaesthetic agents before sampling and possible delay in transporting the sample 
to the laboratory. Prior use of antibiotics did not appear to have a significant affect 
on the culture positive rate. However, inclusion of more keratitis cases may yield 
more reliable data. Pseudomonas spp., Streptococcus spp., S. aureus and 
Coagulase negative Staphylococcus were the most frequently cultured organisms. 
Low culture positive rate and prolonged time to culture result, indicates that more 
rapid and sensitive diagnostic tests are required for optimal management of this 
sight threatening eye infection.  
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CHAPTER 4 MULTILOCUS SEQUENCE TYPING ANALYSIS 
OF PROPIONIBACTERIUM ACNES 
 
4.1 Introduction 
P. acnes usually lives on the skin but has also been cultured from the conjunctiva, 
oral cavity, external ear canal and large intestine (Brook & Frazier, 1991). 
Although it usually remains a harmless commensal, it has been reported to cause 
serious clinical infections including sight threatening eye infections such as 
postoperative endophthalmitis (Aldave et al., 1999) and keratitis (Jones & 
Robinson, 1977; Perry et al., 1982; Wong et al., 2003; Zaidman, 1992).  
 
Johnson and Cummins first classified P. acnes into two distinct phenotypes, 
known as types I and II, based on serological agglutination tests and cell wall 
sugar analysis (Johnson & Cummins, 1972). RAPD analysis of P. acnes isolates 
identified two distinct profiles which correlated to type I and II strains (Perry et 
al., 2003). AFLP was able to identify three main clusters of P. acnes although 
their corresponding phenotypes were undetermined (Mohammadi et al., 2005). 
Analysis of the P. acnes recA gene and tly gene sequence has found that types I 
and II represent distinct phylogenetic lineages (McDowell et al., 2005). 
Furthermore, type I strains have been subdivided into groups IA and IB based on 
recA and tly sequences, monoclonal antibody (MAb) typing (McDowell et al., 
2005) and PFGE (Cohen et al., 2005). Very recently, a novel lineage of strains, 
known as type III, has been described, which appears to have different cellular 
morphology to type I and II strains (McDowell et al., 2008). Despite 
developments in our knowledge regarding P. acnes phylogeny, the genetic 
population structure of strains within the different lineages of the organism is 
poorly understood.  
 
MLST is a nucleotide sequence-based method enabling comparative 
characterisation of bacterial isolates at the molecular level (Maiden et al., 1998). 
As it is DNA sequence based, this method has the advantage of being a 
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reproducible and scalable typing system that is portable between laboratories 
(Urwin & Maiden, 2003). This chapter describes the development of an MLST 
scheme to characterise the population structure of a diverse collection of clinical 
P. acnes isolates and to determine whether certain genotypes are associated with 
particular diseases or geographical locations. 
  
4.2 Aims 
1. To develop an MLST scheme to type P. acnes isolates. 
2. Using this MLST scheme to examine the population biology of P. acnes 
and determine the level of recombination contributing to its diversity. 
3. To determine whether strains exhibit disease or geographical associations.  
4. Validate the P. acnes MLST scheme using 16S rRNA gene analysis, recA 
gene analysis, IFM and RAPD analysis.  
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4.3 Results and Discussion 
 
4.3.1 P. acnes MLST scheme 
 
4.3.1.1 P. acnes strains and selection of genes   
P. acnes consists of a single circular chromosome (2.5 Mb) containing 2,333 
putative genes (Bruggemann et al., 2004). The seven housekeeping genes selected 
for the MLST scheme and location within the KPA171202 genome are shown in 
Figure 4.1. To accurately validate the MLST scheme, a collection of P. acnes 
isolates from disparate geographical locations and diverse clinical diseases were 
selected for analysis (Table 4.1). A total of 125 P. acnes isolates were analysed, 
including the reference strains NCTC 737 (facial acne isolate) and KPA171202 
(DSM 16379; contaminated anaerobic culture). For the remaining 123 isolates, 
eight were cultured from brain abscess, kidney, bone, lymph node, cadaveric skin 
and blood samples. A total of 31 isolates were recovered from keratitis and 
endophthalmitis infections, while 56 isolates were from patients with acne. A 
further three isolates were recovered from fatal head granulomas, seven from 
microdiscectomy samples removed during sciatica surgeries and six from dental 
infections. Five isolates were from surgical skin wounds and seven isolates were 
recovered from prosthetic hip arthroplasties. 
 
4.3.1.2 MLST database 
The P. acnes MLST database (Figures 4.2a-c), developed by Keith Jolley (Jolley 
et al., 2004) is publicly available at http://www.pubmlst.org/pacnes. Information 
on the housekeeping genes, primer sequences for amplification and sequencing, 
PCR conditions, allelic profiles and sequence types (STs) of the 125 P. acnes 
strains are available on the database. The programme also allows investigators to 
input sequence data and generate allelic profiles and identify whether strains have 
STs that correspond to existing strains or represent new STs.  
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Figure 4.1 Gene map of the P. acnes chromosome with locations of the seven 
housekeeping genes in the MLST scheme (Bruggemann et al., 2004). The protein 
coding sequence (CDS) is shown in yellow and green, in different strand 
orientations. ‘Alien’ gene clusters exhibiting aberrant codon usage are shown in red. 
The blue circle represents G+C content variation from the mean value, 60% (with 
lower values pointing inwards) (Bruggemann et al., 2004). 
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Figure 4.2 Screen shots of online database for P. acnes MLST scheme 
(http://pubmlst.org/pacnes) hosted by Keith Jolley  (Jolley et al., 2004). (a) main 
page for the P. acnes MLST scheme (b) profiles database page and (c) primers and 
protocol used for amplification and sequencing. 
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(b) 
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 Table 4.1 MLST analysis of P. acnes isolates including their sources, geographical locations and recA phylotype status. 
Isolate name Source 
 
Date of 
isolation 
(mo-yr) 
 
 
 
Location 
                        
                          
Allelic profile 
 
aroE         atpD      gmk      guaA       lepA        recA      sodA 
ST 
 
recA 
phylotype 
 
eBURST 
group 
  
R19606       Brain abscess NA UK 1      1 1 1 1 1 1 1 ND 1
R18544              
    
    
    
    
              
              
              
              
Blood culture NA UK 1 1 1 3 1 1 2 4 ND 1
PRP-27 Acne NA Australia 1 1 1 3 1 1 1 6 ND 1
PRP-51 Acne NA Australia 1 1 1 3 1 1 1 6 ND 1
PRP-1 Acne NA Australia 1 1 1 3 1 1 1 6 ND 1
PRP-2 Acne NA Australia 1 1 1 3 1 1 1 6 ND 1
NCTC 737 Acne NA UK 1 1 1 3 1 1 1 6 IA 1 
R19618 Cadaveric skin NA UK 1 1 1 3 1 1 1 6 ND 1
XnL1 Fatal granuloma NA China 1 1 1 3 1 1 1 6 IA 1
XnT2 Fatal granuloma NA China 1 1 1 3 1 1 1 6 IA 1
XnH Fatal granuloma NA China 1 1 1 3 1 1 1 6 IA 1
JMK9b Surgical skin wound NA UK 1 1 1 3 1 1 1 6 IB 1 
PRP-10             
    
    
     
     
     
              
      
      
      
      
      
      
     
Acne Oct-2000 Greece 1 1 1 3 1 1 1 6 ND 1
PRP-17 Acne Jan-2000 Italy 1 1 1 3 1 1 1 6 ND 1
PRP-26 Acne Jan-2000 Italy 1 1 1 3 1 1 1 6 ND 1
PRP-30 Acne Jan-2000 UK 1 1 1 3 1 1 1 6 ND 1
PRP-46 Acne Jun-2000 UK 1 1 1 3 1 1 1 6 ND 1
PRP-13 Acne Sep-1999 UK 1 1 1 3 1 1 1 6 ND 1
PRP-69 Acne Apr-2000 UK 1 1 1 3 1 1 1 6 ND 1
PRP-68 Acne NA UK 1 1 1 3 1 1 1 6 ND 1
PRP-109 Acne NA UK 1 1 1 3 1 1 1 6 ND 1
PRP-111 Acne NA UK 1 1 1 3 1 1 1 6 ND 1
PRP-4 Acne NA UK 1 1 1 3 1 1 1 6 ND 1
PRP-52 Acne NA UK 1 1 1 3 1 1 1 6 ND 1
PRP-113 Acne NA UK 1 1 1 3 1 1 1 6 ND 1
1PV10 Acne NA UK 1 1 1 3 1 1 1 6 IA
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Isolate name Source 
 
Date of 
isolation 
(mo-yr) 
 
 
 
Location 
                        
                          
Allelic profile 
 
aroE         atpD      gmk      guaA       lepA        recA      sodA 
ST 
 
recA 
phylotype 
 
eBURST 
group 
  
PV13     Acne NA UK 1 1 1 3 1 1 1 6 IA 1
PV20     
     
     
     
     
     
     
      
      
      
     
      
       
       
       
              
              
             
             
             
             
             
             
             
    
Acne NA UK 1 1 1 3 1 1 1 6 IA 1
PV37 Acne NA UK 1 1 1 3 1 1 1 6 IA 1
PV41 Acne NA UK 1 1 1 3 1 1 1 6 IA 1
PV44 Acne NA UK 1 1 1 3 1 1 1 6 IA 1
PV58 Acne NA UK 1 1 1 3 1 1 1 6 IA 1
PV84 Acne NA UK 1 1 1 3 1 1 1 6 IA 1
PV93 Acne NA UK 1 1 1 3 1 1 1 6 IA 1
PV109 Acne NA UK 1 1 1 3 1 1 1 6 IA 1
PV113 Acne NA UK 1 1 1 3 1 1 1 6 IA 1
PV138 Acne NA UK 1 1 1 3 1 1 1 6 IA 1
P135 Acne NA UK 1 1 1 3 1 1 1 6 IA 1
W891 Dental NA UK 1 1 1 3 1 1 1 6 IA 1
W1973 Dental NA UK 1 1 1 3 1 1 1 6 IA 1
W3875 Dental NA UK 1 1 1 3 1 1 1 6 IA 1
W513 Dental NA UK 1 1 1 3 1 1 1 6 IA 1
P.acn11 Aqueous humour Sep-2003 France 1 1 1 3 1 1 1 6 ND 1
P.acn38 Aqueous humour Dec-2004 France 1 1 1 3 1 1 1 6 ND 1
P.acn12 Corneal scrape Oct-2003 France 1 1 1 3 1 1 1 6 ND 1
P.acn13 Corneal scrape Oct-2003 France 1 1 1 3 1 1 1 6 ND 1
P.acn14 Corneal scrape Oct-2003 France 1 1 1 3 1 1 1 6 ND 1
P.acn15 Corneal scrape Oct-2003 France 1 1 1 3 1 1 1 6 ND 1
P.acn25 Corneal scrape Apr-2004 France 1 1 1 3 1 1 1 6 ND 1
P.acn28 Corneal scrape Jun-2004 France 1 1 1 3 1 1 1 6 ND 1
P.acn34 Corneal scrape Aug-2004 France 1 1 1 3 1 1 1 6 ND 1
P.acn26 Eye May-2004 France 1 1 1 3 1 1 1 6 ND 1
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Isolate name Source 
 
Date of 
isolation 
(mo-yr) 
 
 
 
Location 
                        
                          
Allelic profile 
 
aroE         atpD      gmk      guaA       lepA        recA      sodA 
ST 
 
recA 
phylotype 
 
eBURST 
group 
  
P.acn23      Vitreous humour Mar-2004 France       1 1 1 3 1 1 1 6 ND 1
PRP-29    
    
    
    
    
    
    
      
      
     
            
              
              
      
     
      
      
             
            
     
     
            
     
    
     
Acne Oct-1999 Spain 1 1 1 3 1 1 1 6 ND 1
PRP-23 Acne Oct-1999 Spain 1 1 1 3 1 1 1 6 ND 1
PRP-7 Acne Sep-2000 Sweden 1 1 1 3 1 1 1 6 ND 1
PRP-64 Acne Sep-2000 Sweden 1 1 1 3 1 1 1 6 ND 1
PRP-8 Acne Sep-2000 Sweden 1 1 1 3 1 1 1 6 ND 1
PRP-9 Acne Sep-2000 Sweden 1 1 1 3 1 1 1 6 ND 1
PRP-59 Acne Sep-2000 Sweden 1 1 1 3 1 1 1 6 ND 1
PRP-101 Acne NA USA 1 1 1 3 1 1 1 6 ND 1
PRP-105 Acne NA USA 1 1 1 3 1 1 1 6 ND 1
PRP-99 Acne NA USA 1 1 1 3 1 1 1 6 ND 1
P.acn16 Corneal scrape Oct-2003 France 1 5 1 3 1 1 1 7 IA 1
P.acn27 Aqueous humour Jun-2004 France 1 5 1 3 1 1 1 7 ND 1
P.acn21 Vitreous humour Feb-2004 France 1 1 1 6 1 1 1 8 ND 1
PRP-3 Acne NA UK 8 1 1 3 1 1 1 11 ND 1
PV77 Acne NA UK 11 1 1 3 1 1 1 13 IA 1
P6 Acne NA UK 1 1 6 3 1 1 1 18 IA 1
P9 Acne NA UK 1 1 6 3 1 1 1 18 IA 1
R17684 Neck lymph node NA UK 1 1 1 14 1 1 1 21 ND 1
P.acn22 Corneal scrape Feb-2004 France 4 1 1 3 1 1 1 24 ND 1
PRP-60 Acne Oct-1999 UK 5 1 1 3 1 1 1 25 ND 1
PRP-72 Acne Jun-2000 UK 5 1 1 3 1 1 1 25 ND 1
P.acn29 Corneal scrape Jun-2004 France 5 1 1 3 1 1 1 25 ND 1
PRP-78 Acne NA Japan 1 1 1 3 7 1 1 32 ND 1
PRP-62 Acne Jan-2000 Italy 1 1 1 9 1 1 1 33 ND 1
PV139 Acne NA UK 12 1 1 3 1 1 1 34 IA 1
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Isolate name Source 
 
Date of 
isolation 
(mo-yr) 
 
 
 
Location 
                        
                          
Allelic profile 
 
aroE         atpD      gmk      guaA       lepA        recA      sodA 
ST 
 
recA 
phylotype 
 
eBURST 
group 
  
PRP-107     Acne NA UK 1 7 1 3 1 1 1 36 ND 1
Asn7b Microdiscectomy  NA UK 1 1 1 3 8 1 1 38 IB 1 
R18395       
             
             
              
              
             
              
             
             
               
               
              
   
     
     
            
             
   
            
            
             
             
Kidney NA UK 1 2 1 2 1 1 1 2 ND 2
R19133 Bone (tibia) NA UK 1 3 1 2 1 1 1 3 ND 2
P.acn10 Corneal scrape Sep-2003 France 1 1 1 5 1 1 4 9 IB 3
P.acn24 Aqueous humour Apr-2004 France 1 1 1 5 1 1 4 9 IB 3
P.acn33 Aqueous humour Aug-2004 France 1 1 1 5 1 1 4 9 IB 3
P.acn35 Corneal scrape Sep-2004 France 1 1 1 5 1 1 4 9 IB 3
P.acn39 Aqueous humour Dec-2004 France 1 1 1 5 1 1 4 9 ND 3
WMK9  Surgical skin wound NA UK 1 1 1 4 1 1 4 10 IB 3 
MMG9 Surgical skin wound NA UK 1 1 1 4 1 1 4 10 IB 3
TON9 Surgical skin wound NA UK 1 1 1 4 1 1 4 10 IB 3
Asn2 Microdiscectomy NA UK 1 1 1 4 1 1 4 10 IB 3
Asn3 Microdiscectomy NA UK 1 1 1 4 1 1 4 10 IB 3
R18466 Neck lymph node NA UK 1 1 1 4 1 1 4 10 ND 3
KPA171202a Contaminated culture 
 
NA DSMZ 1 1 1 4 1 1 4 10 ND 3 
PRP-81 Acne NA Japan 1 1 1 4 1 1 4 10 ND
 
3 
W1392 Dental NA UK 1 1 1 4 1 1 4 10 IB 3 
W1998 Dental NA UK 1 1 1 4 1 1 4 10 IB 3 
P.acn20 Corneal scrape Jan-2004 France 1 1 1 4 1 1 4 10 IB 3 
P.acn32 Aqueous humour Jul-2004 France 1 1 1 4 1 1 4 10 ND 3 
P.acn37 Eye Nov-2004 France 1 1 1 4 1 1 4 10 ND 3 
P.acn40 Corneal scrape Jan-2005 France 1 1 1 4 1 1 4 10 ND 3 
CK17 Prosthetic hip NA Sweden 1 1 1 4 1 1 4 10 IB 3 
LED2 Prosthetic hip Mar-1999 UK 1 1 1 4 1 1 4 10 IB 3 
 RM9 Surgical skin wound Jan-2000 UK 1 1 1 4 1 1 4 10 IB 3
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 Isolate name Source 
 
Date of 
isolation 
(mo-yr) 
 
 
 
Location 
                        
                          
Allelic profile 
 
aroE         atpD      gmk      guaA       lepA        recA      sodA 
ST 
 
recA 
phylotype 
 
eBURST 
group 
  
PRP-102    Acne NA USA 1 1 1 4 1 1 4 10 ND 3 
P.acn31              
             
             
              
Aqueous humour Jul-2004 France 1 1 1 13 1 1 4 27 IB 3
P.acn17 Corneal scrape Nov-2003 France 1 1 1 5 3 1 5 22 IB -
P.acn18 Corneal scrape Nov-2003 France 1 1 1 5 3 1 5 22 IB -
Asn1 Microdiscectomy NA UK 1 1 9 4 1 1 11 37 IB -
PV66c Acne NA UK 9 1 5 8 6 3 8 12 IA 4 
PRP-38      
      
              
             
             
             
          
          
           
              
               
               
               
             
              
Acne NA UK 9 1 4 8 6 3 8 29 ND 4
PRP-39 Acne NA UK 9 1 4 8 6 3 8 29 ND 4
R18473 Blood culture NA UK 2 4 2 4 2 2 3 5 ND 5
RB1B Prosthetic hip Jan-1998 UK 13 4 2 4 2 2 3 15 II 5
P.acn19 Corneal scrape Dec-2003 France 3 4 2 4 2 2 3 23 II 5
PRP-47 Acne Oct-2000 Greece
 
1 4 2 4 2 2 3 31 ND 5
JP1B Prosthetic hip Jan-1998 UK 15 4 2 4 2 2 3 35 II 5
KC1 Prosthetic hip Jun-1999 UK 3 4 2 10 4 2 6 14 II -
ED1 Prosthetic hip Oct-1996 UK 14 4 2 4 4 2 6 16 II 6
P.acn30 Vitreous humour Jul-2004 France 6 4 2 4 4 2 6 26 II 6
Asn13 Microdiscectomy NA UK 7 6 3 11 5 4 9 17 III 7
Asn11 Microdiscectomy NA UK 7 6 3 7 5 4 9 19 III 7
Asn12 Microdiscectomy NA UK 7 6 3 12 5 4 9 20 III 7
P.acn36 Corneal scrape Nov-2004 France 7 6 3 7 5 4 7 28 ND 7
Asn10 Prosthetic hip NA UK 7 6 7 7 5 4 9 30 III 7
a Strain purchased from the German Collection of Microorganisms and Cell Cultures (DSMZ) 
b Type IB by recA sequencing but eBURST group 1 based on MLST (highlighted in blue) 
cType IA by recA sequencing but eBURST group 4 based on MLST (highlighted in blue) 
NA, not available 
ND, not determined
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4.3.1.3 Allelic variation  
Allelic information for the seven alleles was calculated using START v2 (Section 
2.16.4). The total length of the concatenated sequence of all the alleles was 3,135 
bp. The mean allele length was 448 bp with sizes ranging from 400 bp (gmk) to 
493 bp (guaA) (Table 4.2). The total number of housekeeping gene alleles ranged 
from four (recA) to 14 (aroE), with an average of 9.2 per locus. This provided the 
potential to distinguish > 5 x 106 different genotypes. All alleles for a given locus 
were found to be of equal lengths for all the isolates examined. The degree of 
sequence diversity within the housekeeping genes was relatively low with the 
proportion of polymorphic sites ranging from 0.9% (recA) to 8.3% (aroE) with an 
average of 4.2%.  
 
Within this MLST scheme the recA gene was the most highly conserved locus 
investigated with only four distinct alleles and four polymorphic sites in the 463 
bp fragment analysed. Previous work, however, focused on the complete 1,047 bp 
recA gene which generated a greater number of alleles and polymorphic regions 
for phylogenetic study and clustering isolates into distinct lineages (McDowell et 
al., 2005; McDowell et al., 2008). In the context of the MLST scheme, the recA 
locus was not critical for analysis and the phylogenetic data and clustering 
produced using the remaining six loci was similar to that produced when recA was 
included. A greater number of isolates will have to be examined, however, before 
it can be assumed that the gene section of recA used in the MLST scheme does 
not add any additional information to the population study of P. acnes.  
 
4.3.1.4 Selective pressure of MLST loci 
MLST loci should ideally encode proteins that are under stabilising selection for 
conservation of metabolic function (Maiden, 2006). The ratio of non-synonymous 
(dN) to synonymous (dS) changes is frequently used to assess the degree of 
selection operating on a particular locus (Rocha et al., 2006). Synonymous (silent) 
substitutions are usually considered neutral, or the potential to have a much 
smaller effect on fitness than non-synonymous (replacement) substitutions. A low 
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ratio (dN/dS <1) signifies strong purifying (“stabilizing”) selection and a high ratio 
(dN/dS >1) signifies selection for diversification (“positive selection”) (Rocha et 
al., 2006).  
 
The dN/dS ratio was calculated for the seven loci using START v2 (Table 4.2). For 
all loci the dN/dS ratios were less than 1, demonstrating that no strong selective 
pressure was operating on the genes selected, validating their suitability for 
inclusion in the P. acnes MLST scheme. recA and aroE were noted to have dN/dS 
values of 0.334 and 0.576, respectively, which were relatively high compared to 
the other loci. This is not unusual and has been previously observed in MLST 
schemes developed for other organisms including Candida albicans and 
Camplylobacter spp. (Miller et al., 2005). It has been postulated that for closely 
related strains within a bacterial species, housekeeping genes with a high dN/dS 
value are a consequence of a delay in the removal of slightly deleterious non-
synonymous mutations which may remain for a period of time before purifying 
selection (Rocha et al., 2006).  Also, in the case of recA, the higher dN/dS  ratio 
may reflect the small number of polymorphic sites within the segment analysed 
(two synonymous and two non-synonymous substitutions) which may generate an 
artificially high value.  
 
4.3.2 Analysis of P. acnes isolates for sequence types (STs) 
A total of 38 different STs were assigned to the 125 P. acnes isolates under 
investigation (Table 4.1). All allelic profiles and STs are available on the P. acnes 
MLST database (http://pubmlst.org/pacnes). Upon analysis, ST-6 (n=61; 48.8%), 
ST-10 (n=18; 14.4%) and ST-9 (n=5; 4.0%) were found to be the predominant 
allelic profiles (Figure 4.3). All other 35 STs were more evenly spread (at low 
frequency) across the remaining 41 isolates, with 30 having a unique ST (Figure 
4.3). The most well described P. acnes strain NCTC 737 (type IA) belonged to 
ST-6, while KPA171202 (type IB), used for genome sequencing of P. acnes 
(Bruggemann et al., 2004), belonged to ST-10.   
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 Table 4.2 Characteristics of the seven gene loci used in the P. acnes MLST scheme 
 
Gene Size of fragment sequenced (bp) 
No. of distinct 
alleles 
No. of polymorphic 
sites 
Proportion of 
polymorphic sites (%) 
Mean G+C 
content (%) 
 
dN/dS
aroE 424      14 35 8.3 61.4 0.5756
atpD 453      7 16 3.5 58.5 0.1510
gmk 400      8 17 4.3 60.1 0.0868
guaA 493      14 29 5.9 61.5 0.0254
lepA 452      8 15 3.3 58.6 0.1180
recA 463      4 4 0.9 58.5 0.3342
sodA 450      10 19 4.2 58.2 0.0605
Mean       448 9 19 4.2 50.8 0.1931
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4.3.2.1 Recombination occurring across loci 
One of the preferred characteristics of housekeeping loci for inclusion in an 
MLST scheme is that they are equally distributed around the chromosome so that 
any recombinogenic events do not involve two loci. The P. acnes MLST scheme 
has three housekeeping genes which are relatively close together (Figure 4.1). The 
gmk gene is 7,495 bp downstream of the aroE gene and atpD is 49,470 bp 
downstream of the gmk gene.  
 
To determine whether a recombinational event has occurred involving two or 
even three of these genes simultaneously, the allele numbers for each ST are 
compared between these genes. If two genes are so closely related as to cause a 
single recombinational event to change both alleles, then the two allelic numbers 
would usually only be associated with each other. For example, comparing gmk 
and aroE allelic numbers (Table 4.3), gmk allele 3 is always associated with aroE 
allele 7. The converse is not true as aroE allele 7 is also associated with gmk allele 
7. The close association of these two allelic numbers is also shared with lepA and 
recA genes even though they are extremely spread out from each other. The close 
association in this instance is explained by the fact that these STs belong to the 
same clonal complex (eBURST group 7, Section 4.3.3.1). It is therefore unlikely 
that the close position of aroE to gmk has led to a single recombinogenic event 
involving both genes. This is further supported by clonal frame analysis of the P. 
acnes MLST data (Figure 4.4) (more details in Section 4.3.3.4). Figure 4.4 shows 
the inferred events at the node that ST-35 branches off. Frequent substitutions, 
likely to represent recombination, are shown to occur at aroE but not at gmk. Now 
looking at atpD and gmk genes which are 49,470 bp apart, atpD allele 4 and gmk 
allele 2 are the only two allelic numbers that always occur together. It is possible 
that a single recombinogenic event has led to both genes being genetically altered. 
However, these allelic numbers are exclusively associated with recA allele 2 and 
all belong to eBURST groups 5 or 6. Again, this suggests that this association is 
more likely to be due to the genetic relatedness of these genotypes rather than 
single recombinogenic events leading to their change.  
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Table 4.3 Allelic profiles and eBURST groups for each ST shown. aroE, atpD and 
gmk are highlighted to identify any recombinogenic events involving these three 
genes. 
 
 
aroE atpD guaA lepA recA sodA ST eBURST group gmk 
1 1 1 1 1 1 1 1 1 
1 1 1 3 1 1 2 4 1 
1 1 1 3 1 1 1 6 1 
1 5 1 3 1 1 1 7 1 
1 1 1 6 1 1 1 8 1 
8 1 1 3 1 1 1 11 1 
11 1 1 3 1 1 1 13 1 
1 1 6 3 1 1 1 18 1 
1 1 1 14 1 1 1 21 1 
4 1 1 3 1 1 1 24 1 
5 1 1 3 1 1 1 25 1 
1 1 1 3 7 1 1 32 1 
1 1 1 9 1 1 1 33 1 
12 1 1 3 1 1 1 34 1 
1 7 1 3 1 1 1 36 1 
1 1 1 3 8 1 1 38 1 
1 2 1 2 1 1 1 2 2 
1 3 1 2 1 1 1 3 2 
1 1 1 5 1 1 4 9 3 
1 1 1 4 1 1 4 10 3 
1 1 1 13 1 1 4 27 3 
9 1 5 8 6 3 8 12 4 
9 1 4 8 6 3 8 29 4 
2 4 2 4 2 5 2 3 5 
13 4 2 4 2 5 2 3 15 
3 4 2 4 2 5 2 3 23 
1 4 2 4 2 2 3 31 5 
15 4 2 4 2 2 3 35 5 
14 4 2 4 4 2 6 16 6 
6 4 2 4 4 2 6 26 6 
7 6 3 11 5 4 9 17 7 
7 6 3 7 5 4 9 19 7 
7 6 3 12 5 4 9 20 7 
7 6 3 7 5 4 7 28 7 
7 6 7 7 5 4 9 30 7 
3 4 2 10 4 2 6 14 - 
1 1 1 5 3 1 5 22 - 
1 1 9 4 1 1 11 37 - 
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Figure 4.4 ST-35 clonal frame shot showing aroE recombination but no change in 
gmk. The seven housekeeping gene fragments of the P. acnes MLST scheme are 
represented by blocks on the x axis (numbers represent nucleotides). Each 
substitution is indicated by a cross. The curved line at each locus indicates the 
inferred probability for recombination on a scale from 0 to 1 (y axis). 
 
 
 
 
 
 
 
 
 
 
 
 
  AAguaAgmk   
 
 
 
 aroE atpD- 104 -lep rec sodA
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4.3.3 Phylogenetic analysis 
Bacterial genomes evolve by a number of different mechanisms, including point 
mutation, genome rearrangement, deletion, duplication, bacteriophage lysogeny, 
transposition, slippage mutation in DNA sequence repeats and homologous and 
non-homologous recombination (Feil et al., 1999; Feil et al., 2000; Lawrence & 
Hendrickson, 2003; Smith et al., 1993). Recombination can result when bacterial 
DNA enters the host cell via conjugation, transformation or transduction (Smith et 
al., 1991; Smith et al., 1993; Spratt, 2004). These numerous different evolutionary 
mechanisms by which bacteria evolve can present problems when attempting to 
infer relationship between strains, which often rely on comparing DNA sequence 
differences.  
 
Point mutations happen approximately randomly and therefore, in the absence of 
other genetic exchange processes, allow reliable determination of clonal 
relationships using standard phylogenetic methods (Didelot & Falush, 2007). 
However, even in housekeeping genes, homologous recombination between 
bacteria within the same population can change several nucleotides at once 
(Milkman & Crawford, 1983). Therefore, inaccurate relationships between strains 
may be inferred as these homologous recombinational events are over-weighted 
by nucleotide-based phylogenetic methods in comparison to point mutations 
(Schierup & Hein, 2000). Using these methods, two related isolates which differ 
at only one locus, can appear unrelated if the variant locus is especially divergent. 
To take this into account, a variety of methods have been adapted and new ones 
have been developed to analyse genetic relationships using allelic profiles (Feil et 
al., 2004; Jolley et al., 2001; Spratt et al., 2004). Other statistical analysis 
methods have been designed to infer bacterial clonal relationships based on DNA 
sequences that accounts for both point mutation and homologous recombination 
(Didelot & Falush, 2007). Here, a variety of phylogenetic methods have been 
applied to the P. acnes MLST data to study its population biology, taking into 
account of point mutations and homologous recombination.  
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4.3.3.1 eBURST analysis of STs 
MLST analysis of several bacterial species support the view that large proportions 
of a population belongs to a limited number of clusters of closely related 
genotypes or clonal complexes (Dingle et al., 2001; Enright & Spratt, 1998; 
Enright et al., 2000; Enright et al., 2001; Maiden et al., 1998; Meats et al., 2003). 
One theory for the emergence of clonal complexes is that a founding genotype 
increases in frequency in the population to become a predominant clone, either as 
a consequence of a fitness advantage or of random genetic drift (Feil & Spratt, 
2001). As the founding genotype increases in frequency, it gradually diversifies, 
to result in a clonal complex. In terms of MLST, this observation is represented by 
descendants of the founder initially having identical allelic profile to the founder. 
Over time, variants in which one of the seven alleles has changed, either by point 
mutation or recombination, will appear. These genotypes, which differ from the 
founder at only one of the seven MLST loci, are called single-locus variants 
(SLVs). SLVs will eventually diversity further, to produce variants that differ at 
two of the seven loci (double-locus variants [DLVs]), at three of the loci (triple-
locus variants [TLVs]), and so on (Feil et al., 2004).  
 
Using MLST data, the eBURST v3 (based upon related sequence types) clustering 
algorithm (http://www.mlst.net) divides bacterial populations into groups of 
closely related strains (clonal complexes), predicts the founding (ancestral) 
genotype of each clonal complex, and displays the patterns of recent evolutionary 
descent of all other strains from their respective founder (Feil et al., 2004; Turner 
et al., 2007). The STs within an eBURST group are considered to belong to a 
single clonal complex if they share identical alleles at six or seven of the seven 
MLST loci with at least one other ST in the group. For each clonal complex, the 
primary founder is predicted on the basis of parsimony as the ST that has the 
largest number of SLVs. In groups that are composed of only a limited number of 
STs, it may not be possible to assign a primary founder. The frequency of a given 
ST in the study population is not used to assign founders; however, founders often 
correspond to the most predominant STs (Feil et al., 2004).  
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Using the stringent eBURST criteria of assigning STs to the same clonal complex 
based on having six of seven loci, seven eBURST groups and thus, clonal 
complexes, encompassing 38 STs, were assigned to the 125 P. acnes isolates. 
Figure 4.5 illustrates the eBURST diagram generated, showing the seven 
eBURST groups and 3 singletons which did not fall into any eBURST group. Due 
to the criteria of only designating STs as belonging to the same eBURST group if 
they have six or more loci in common, the eBURST groups described here 
correspond to clonal complexes.  
 
ST-6 and ST-19 are assigned the founding genotypes of their corresponding 
clonal complexes, with bootstrap values of 100% and 88% respectively (Tables 
4.4a-g). The predicted founder for eBURST group 3 was ST-10. However, ST-10 
had the same number of SLVs and DLVs as the remaining two STs in the group. 
Therefore, the bootstrap value was only 7%, confirming that it cannot be the 
ancestral genotype for that clonal complex.  
 
Figure 4.6 is the same eBURST analysis but this time showing DLVs in addition 
to SLVs. Numerous blue lines connect isolates within eBURST group 1, 
suggesting that frequent recombinogenic events occur within this clonal complex. 
eBURST groups 2 and 3 also have numerous DLVs within group 1. Spratt et al. 
suggested that older clonal complexes exhibit extensive diversification with a 
complicated structure of descending genotypes whilst a clearly apparent founder, 
with only a few SLV and DLVs, typify young BURST groups (Spratt, 2004). This 
would suggest that eBURST group 1 is a relatively mature clonal complex whilst 
groups 5, 6 and 7 are relatively junior clonal complexes. The eBURST diagram 
displaying the DLV (Figure 4.6) is effectively showing how the groups would 
cluster if the group definition was less stringent and STs were grouped together if 
they shared five or more alleles. Groups 1, 2 and 3 would cluster as one BURST 
group and the remaining four groups stay in the same cluster, clearly showing the 
diversity between each group. This is interesting because if the previous 
assumption that groups 5, 6 and 7 were relatively new clonal complexes was true, 
then why do they not have DLVs within group 1? One possibility is that the 
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current study population of 125 P. acnes isolates does not include ancestral 
genotypes which all these seven groups descend from.  
 
Singletons ST-22 and ST-37 are DLVs of group 3 genotypes, suggesting that they 
have diversified from this group or from a common clone. In the same way, ST-14 
is a DLV of group 6 strains, providing evidence for a common ancestor between 
these strains. ST-12 and ST-29 (eBURST group 4) do not have DLVs with any 
other groups suggesting their distinct nature from the other clusters and the 
inaccurate assumption that these are type IA strains based on recA gene and tly 
gene analyses (Section 4.3.6.2).   
 
As previously mentioned, phylogenetic analysis of MLST data based on 
concatenated sequences of the seven loci can be misleading. Closely related 
strains can appear unrelated if considerable amount of recombination has occurred 
at only one of the loci. This can be observed in the current study population. In 
Section 4.3.3.2, a phylogenetic dendrogram based on the concatenated sequences 
of the seven housekeeping genes using the Neighbour-Joining method is shown 
(Figure 4.7). Based on this dendrogram, isolates which have been clustered 
together as eBURST group 3 (i.e. ST-9, ST-10 and ST-27), appear to be distantly 
related. In fact, ST-9 and ST-27 appear to be more closely related to eBURST 
group 1, 2 and 4 isolates than to ST-10. This inference is most likely incorrect as 
based on recA gene analysis, ST-9, ST-10, ST-27, ST-22 and ST-37 were all 
classed as type IB isolates and eBURST groups 1, 2 and 4 were classed as type IA 
isolates. More detailed comparison between MLST analysis and recA gene 
sequencing is discussed in Section 4.3.6.2.     
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Table 4.4 a-g. The seven clonal complexes derived from eBURST analysis showing 
the frequency of each ST within the study population and the frequency of SLVs and 
DLVs. No TLV were identified. Predicted founder for each clonal complex is 
highlighted in blue. The level of confidence in founding genotypes is indicated by 
the bootstrap value. 
  
(a) eBURST group 1 
(No. of isolates = 80 No. of STs = 16 Predicted founder = ST-6) 
 
ST Frequency SLV DLV ST Bootstrap 
6 61 15 0 100% 
25 3 5 10 2% 
24 1 5 10 3% 
13 1 5 10 4% 
11 1 5 10 7% 
34 1 5 10 11% 
21 1 4 11 1% 
8 1 4 11 3% 
1 1 4 11 5% 
33 1 4 11 9% 
7 2 2 13 0% 
38 1 2 13 0% 
36 1 2 13 0% 
32 1 2 13 0% 
18 2 1 14 0% 
4 1 1 14 0% 
 
(b) eBURST group 2 
(No. of isolates = 2 No. of STs = 2 Predicted founder = none) 
 
ST Frequency SLV DLV ST Bootstrap 
3 1 1 0 N/A 
2 1 1 0 N/A 
 
(c) eBURST group 3 
(No. of isolates = 24 No. of STs = 3 Predicted founder = ST-10) 
 
ST Frequency SLV DLV ST Bootstrap 
10 18 2 0 7% 
9 5 2 0 8% 
27 1 2 0 14% 
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(d) eBURST group 4 
(No. of isolates = 3 No. of STs = 2 Predicted founder = none) 
 
ST Frequency SLV DLV ST Bootstrap 
29 2 1 0 N/A 
12 1 1 0 N/A 
 
 
(e) eBURST group 5 
(No. of isolates = 5 No. of STs = 5 Predicted founder = multiple candidates) 
 
ST Frequency SLV DLV ST Bootstrap 
23 1 4 0 17% 
5 1 4 0 16% 
15 1 4 0 22% 
35 1 4 0 31% 
31 1 4 0 46% 
 
 
(f) eBURST group 6 
(No. of isolates = 2 No. of STs = 2 Predicted founder = none) 
 
ST Frequency SLV DLV ST Bootstrap 
26 1 1 0 N/A 
16 1 1 0 N/A 
 
 
(g) eBURST group 7 
(No. of isolates = 5 No. of STs = 5 Predicted founder = ST-19) 
 
ST Frequency SLV DLV ST Bootstrap 
19 1 4 0 88% 
20 1 2 0 1% 
17 1 2 0 3% 
28 1 1 0 0% 
30 1 1 0 0% 
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 Figure 4.5 eBURST diagram showing the clusters of related STs and individual unlinked STs of 125 P. acnes isolates. Seven clonal complexes 
are identified and labelled. Each ST is represented by a circle with the number beside the circle. The frequency of each ST within the analysed 
population is indicated by the area of the circle. ST-6 and ST-19 were the founders of their respective clonal complexes. SLVs shown in pink. 
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 Figure 4.6 eBURST diagram showing the clusters of related STs and individual unlinked STs of 125 P. acnes isolates. Seven clonal complexes 
are identified and labelled. Each ST is represented by a circle with the number beside the circle. The frequency of each ST within the analysed 
population is indicated by the area of the circle. ST-6 and ST-19 were the founders of their respective clonal complexes. SLVs shown in black 
and DLVs shown in blue. 
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 - 112 -
Chapter 4  P. acnes MLST 
 
4.3.3.2 Phylogenetic Trees 
Phylogenetic analysis was carried out as described in Section 2.16.6. Figure 4.7 
shows an unrooted phylogenetic tree of the 38 P. acnes STs based on 
concatenated sequences of the seven loci. STs belonging to the same eBURST 
group have been highlighted for comparison. eBURST groups 1, 2 and 4 formed a 
distinct lineage based on the concatenated phylogenetic tree and included isolates 
previously identified as type IA based on recA and tly gene analysis and IFM 
(McDowell et al., 2005; McDowell et al., 2008). Although the cluster formed by 
ST-12 and ST-29 (eBURST group 4) have been designated as type IA, they 
formed a distinct cluster away from the other type IA isolates found in eBURST 
groups 1 and 2. The cluster consisting of ST-27, ST-9 and ST-22 were identified 
to be type IB isolates but clustered away from the other type IB isolates (ST-10 
and ST-37). It is possible that this has occurred through exchange of genetic 
material through recombination at certain loci between type IA and a selection of 
type IB isolates. However, based on eBURST analysis, all type IB isolates 
clustered together in group 3. The next lineage correlated with eBURST group 7 
and included isolates identified as type III. The final lineage identified consisted 
of type II isolates and corresponded to eBURST groups 5 and 6. Based on 
eBURST analysis, ST-14, ST-22 and ST-37 were singletons i.e. they did not 
belong to any eBURST groups. However, their type designation corresponded to 
the clustering on the phylogenetic tree.   
 
Another way of determining the phylogenetic relationship between STs is to 
generate an Unweighted Pair Group Method with Arithmetic mean (UPGMA) 
tree. Figure 4.8 shows an unrooted UPGMA tree based on the allelic profiles of 
the 38 STs. Again, the STs that belong to the same eBURST groups are 
highlighted. As would be expected, this phylogenetic tree correlates with the 
eBURST groups much more consistently, as both methods are based on the allelic 
profiles of the STs rather than the concatenated DNA sequences of the seven loci. 
Interestingly, the clonal complex which includes ST-12 and ST-29 clustered away 
from all other type IA and IB isolates, even though it has been identified as type 
IA based on recA gene analysis and IFM (McDowell et al., 2005; McDowell et 
al., 2008). It is possible that this cluster is another subgroup of type I isolates, 
 - 113 -
Chapter 4  P. acnes MLST 
 
different to that of type IA and IB. Unlike the phylogenetic tree based on 
concatenated sequences, where strains belonging to eBURST groups 5 and 6 were 
found in the same lineage, the UPGMA tree based on allelic profiles separated 
these into the two groups.   
 
Phylogenetic analysis of individual genes using the Neighbour-Joining method 
with 1,000 bootstrapping replications (Figures 4.9a-g) shows that most of the 
genes give significant resolution forming distinct lineages. recA, however, appears 
to provide the least differentiated tree with a mean sequence diversity between all 
the recA alleles of 0.43%, though it is still able to distinguish between the three 
main lineages, type I, II and III. In contrast, the sequence diversity of the 
remaining six genes varies from 1.1% to 2.18%, providing sufficient resolution to 
distinguish between the P. acnes lineages I, II and III. The sodA gene is the only 
locus where type IA and IB strains do not cluster together on a phylogenetic tree. 
Therefore, differentiating between types IA and IB strains appears to be 
dependent on sodA.      
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Figure 4.7 Unrooted phylogenetic dendogram of the 38 P. acnes STs, analysed by 
Neighbour-Joining method based on concatenated sequences (with Jukes-Cantor-
based algorithm and 1000 bootstrapping replications). * denotes STs not belonging 
to a SLV eBURST group but to a DLV eBURST group. 
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 Figure 4.8 Unrooted UPGMA dendrogram, based on allelic profiles of the 38 P. acnes STs with Jukes-Cantor-based algorithm. * denotes STs not 
belonging to a SLV eBURST group but to a DLV eBURST group. 
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Figure 4.9 (a-g) Unrooted phylogenetic dendrogram, analysed by Neighbour-Joining 
method based sequences of each of the seven loci (with Jukes-Cantor-based 
algorithm and 1,000 bootstrapping replications). Allelic numbers are labelled next to 
the allele name. (a) aroE, (b) atpD, (c) gmk, (d) guaA, (e) lepA, (f) recA and (g) sodA 
 
 
(a) aroE 
Overall mean sequence diversity = 1.81% 
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(b) atpD  
Overall mean sequence diversity = 1.1% 
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(c) gmk 
Overall mean sequence diversity = 1.68% 
 
 gmk-4
 gmk-5
 gmk-9
 gmk-6
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(d) guaA 
Overall mean sequence diversity = 2.18% 
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(e) lepA 
Overall mean sequence diversity = 1.1% 
 lepA-3
 lepA-6
 lepA-7
 lepA-8
 lepA-1
 lepA-2
 lepA-4
 lepA-5
98
87
40
0.002  
 
 
 
(f) recA 
Overall mean sequence diversity = 0.43% 
 recA-3
 recA-4
 recA-1
 recA-2
39
0.0005  
 
 
 
(g) sodA 
Overall mean sequence diversity = 1.36% 
 sodA-5
 sodA-11
 sodA-4
 sodA-8
 sodA-7
 sodA-9
 sodA-1
 sodA-2
 sodA-3
 sodA-6
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4.3.3.3 Splits decomposition analysis 
Phylogenetic relationship between STs was also examined by split decomposition 
analysis using SplitsTree v4.1 (Huson & Bryant, 2006). The split decomposition 
algorithm is a parsimony method that does not impose a branching or tree-like 
structure on the data set, but permits reticulations or a network structure that may 
be indicative of past recombination events. As a consequence, a split 
decomposition graph will look less tree-like and more net-like as the influence of 
recombination becomes stronger. As described by Huson, a ‘split’ is a partition of 
the taxa into two subsets and in a split network, every edge is associated with a 
split of the taxa (Huson, 1998). The length of an edge is proportional to the weight 
of the associated split, which corresponds to the length of a branch in a 
phylogenetic tree (Huson, 1998).  
 
Figure 4.10 shows splits decomposition analysis of concatenated sequences of the 
38 STs and Figure 4.11 shows splits decomposition analysis based on allelic 
profiles. Strains belonging to the same eBURST group are also shown for 
comparison. It is evident from both splits trees that there are distinct clusters of 
STs connected by the network structure, which is fairly consistent with the clonal 
complexes generated by BURST analysis (Section 4.3.3.1). The splits trees are 
also very similar to the phylogenetic trees in Section 4.3.3.2.    
 
 
 - 120 -
 Figure 4.10 Splits decomposition analysis based on concatenated sequences of the seven housekeeping genes of the 38 STs. ST-14, ST-22 and 
ST-37 not belonging to an eBURST group. 
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Figure 4.11 Splits decomposition analysis based on allelic profiles of the 38 STs. ST-
14, ST-22 and ST-37 not belonging to an eBURST group. 
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4.3.3.4  Clonal frame analysis 
ClonalFrame v1.1 is a model-based method of using MLST data to infer the 
lonal relationships of bacteria and determine whether a subset of isolates share a 
and 
events in the evolutionary process that led to the observed pattern of DNA 
sequence variation. 
 
P. acnes MLST data was assessed using ClonalFrame and Figure 4.12 is a 
network representation of the output using Graphviz and Figure 4.13 is a 
majority-rule consensus tree (i.e. a linear representation of the data). Figure 4.12 
shows inferred ancestral nodes in black and the location of isolates in red, with 
each line indicating a single isolate. Nodes whose ST is not found amongst the 
study population are shown as an empty circle. The ancestral node of each 
network component is indicated by a darker circle.  
 
The output diagram suggests that the ancestral node in this network has not yet 
been identified and that numerous genotypes that have descended from this 
 have also not been identified using the current study population. 
Based on eBURST analysis, ST-6 and ST-19 were the founding genotypes for 
their respective clonal complexes. Clonal frame analysis, however, does not put 
particular weight on ST-19 and only regard it as a descendant strain of ST-30 (the 
ancestral node for that group). ST-6 is inferred as an ancestral node, with two 
descendent nodes and numerous isolates branching from it. The ClonalFrame-
generated network has similarities with both the Neighbour-Joini
generated from concatenated sequences and also eBURST analysis which is based 
on allelic profiles. For example, ST-9, ST-22 and ST-27 cluster away from ST-10 
and ST-37 (despite the fact that they are all type IB strains based on recA gene 
analysis). This is consistent with the Neighbour-Joining tree but very different to 
what is implied by eBURST analysis, which clusters ST-9, ST-10 and ST-27 into 
the same clonal complex (eBURST group 3). Based on clonal frame analysis, ST-
5 is the ancestral node to a group which includes ST-31, ST23, ST-5 and ST-15. 
c
common ancestry (Didelot & Falush, 2007). It takes into account of both point 
mutation and homologous recombination and attempts to infer the parameters 
common ancestor
ng dendrogram 
3
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ST-35 also gives rise to another separate group consisting of ST-16, ST-14 and 
ST-26. These two distinct groups are identified as two clonal complexes by 
tion 4.3.3.1, eBURST analysis implies that eBURST groups 
, 6 and 7 were relatively new clonal complexes but it was interesting that they 
did not form any DLVs with any other groups. This can be explained by the 
er both phylogenetic analysis 
ased on concatenated sequences and eBURST analysis which is solely based on 
allelic profiles. It is able to clearly represent true relatedness between strains 
eBURST analysis (eBURST groups 5 and 6). However, Neighbour-Joining 
method combines these two groups and there is no obvious distinction from the 
phylogenetic dendrogram.  
 
As mentioned in Sec
5
current ClonalFrame network, which indicates that there are common ancestors to 
these groups which have not been identified using the current study population (as 
shown by the empty circles). Most importantly, the inferred ancestral node for the 
whole network (darker circle) has not been analysed by MLST.  
 
The ClonalFrame network clearly has advantages ov
b
within a group but also infer genetic relatedness and common ancestry between 
groups. Although eBURST has the ability to correctly identify clonal complexes 
and cluster together related strains, it does not provide any information as to how 
theses complexes may be related to each other and therefore how they have 
evolved over time.  
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igure 4.12 A network representation of the ClonalFrame output using Graphviz. 
he network shows inferred ancestral nodes in black and the location of isolates in 
ed, with each line indicating a single isolate. Each isolate has the genotype of the 
ode it is connected to. Nodes whose ST is not found amongst the study population 
are shown as an empty circle
F
T
r
n
. The ancestral node of each network component is 
indicated by a darker circle. Only one isolate representing each ST is shown (i.e. 38 
isolates representing the 38 different STs). 
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Figure 4.13 Majority-rule consensus tree produced from the ClonalFrame program 
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4.3.3.5 Sequence diversity 
 
the mean average nucleotide distance within each clonal complex (as determined 
by eBURST analysis) and between selected clonal complexes were determined 
using the Jukes-Cantor method in Mega v4. A total of 3,135 nucleotides were 
compared. The results are shown in Table 4.5. The overall percentage of sequence 
diversity between all 38 STs is 1.1%.  
 
Sequence diversity within clonal complexes is very small, ranging from 0.03% to 
0.41% (Table 4.5a) demonstrating their close genetic relatedness. The diversity 
between all type I isolates (when eBURST groups 1, 2, 3 and 4 are combined) is 
also low at 0.26% (Table 4.5b). This is also true for type II isolates (eBURST 
groups 5 and 6 combined) which only has a mean nucleotide difference of 0.29%. 
This shows that although these groups are divided into clonal complexes, they 
actually show very little nucleotide difference. However, there is an obvious 
increase in the sequence divergence between type I, type II and type III strains 
(Table 4.6b), verifying their status as distinct lineages. This has also been shown 
in previous studies looking at complete recA gene and tly gene sequence analysis. 
McDowell et al. demonstrated that comparison of the 1,047 bp recA genes and the 
777 bp tly genes between two reference strains, NCTC 737 (type I strain) and 
NCTC 10390 (type II strain), revealed 99% and 98% sequence identity 
respectively (McDowell et al., 2005). eBURST group 1 strains were identified 
previously as type IA and groups 5 and 6 were identified as type II strains. recA 
gene analysis between a type I strain (NCTC 737) and the recently identified type 
III strains showed 98.9% identity (McDowell et al., 2008). 99.1% identify were 
found between type II strain (NCTC 10390) and the same type III strains 
(McDowell et al., 2008).   
To determine the genetic diversity within populations and between populations,
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Table 4.5 (a) Nucleotide divergence within clonal complexes. 
eBURST groups Strain type Nucleotide divergence (%)
1 IA 0.06% 
2 IA 0.10% 
3 IB 0.41% 
4 Novel cluster 0.03% 
5 II 0.28% 
6 II 0.15% 
7 III 0.11% 
 
 
Table 4.5 (b) Nucleotide divergence between clonal complexes. 
 
eBURST groups Strain type Nucleotide divergence (%)
1 & 2 IA 0.08% 
1, 2 & 3 IA & IB 0.19% 
1, 2, 3 & 4 IA, IB & novel cluster 0.26% 
5 & 6 II 0.29% 
1, 2, 3, 4, 5 & 6 I & II 1.77% 
1, 2, 3, 4 & 7 I & III 1.81% 
5, 6 & 7 II & III 1.61% 
All groups I, II & III 1.10% 
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4.3.4 Association between STs, clonal complexes and disease 
Amongst the P. acnes collection of isolates examined using MLST, ST-6 was 
found to e putative 
ancestral genotype for eBURST group 1 and was an ancestral node using clonal 
frame anal is particular genotype appears very succes t was isolated 
from a variety of sources (acne, skin wounds, fatal granulom tal infections) 
across four continents (Table 4.1). It is currently unclear, however, whether this 
simply reflects a greater opportunity to cause infection due to an elevated 
prevalence, or if it relates to increased virulence and capacity to cause disease. 
The well described and used reference strain NCTC 737, which belongs to ST-6, 
as isolated from a patient with facial acne in London, 1920. This indicates that 
the strain is stable and possibly possesses phenotypic characteristics which 
 survival in disparate environments. Further studies of the ST-6 
genotyp therefore 
warranted. It was interesting to note that signifi ere 
recovered cne skin than fro ny other infection sites (odds ratio 6.0219; 
95% C.I. 2.76-13.13). Despite this trend, identical or simila re also found 
in isola er cl  lists the cl fections from 
whic isolates w tured from in order of prevalence. The 
numbe in each eB group is shown an orresponding 
phylotype based on recA gene se  is indicated below  from acne 
infectio a large prop %) of the culture n. As a large 
number of these isolates are ST-6, which belong to eBURST group 1, it would 
explain to a certain extent why there is such a large proportion of ST-6 isolates in 
the study collection.    
There does not appear to be an overall association between ST or clonal complex 
and clinical manifestation. eBURST group 1 (type IA) strains appear to be 
responsible for a wide range of infections. eBURST group 3 (type IB) strains are 
also not restricted to one infection site, however, it does not occur more frequently 
in acne infections than other infections (unlike type IA strains). Isolates in groups 
2, 4, 5, 6 and 7 are too few to make conclusive comments regarding their 
distribution amongst different clinical diseases. However, four out of six eBURST 
 be the predominant strain (49%). It was also identified as th
ysis. Th sful as i
as, den
w
facilitate its
e in terms of its pathogenicity and antibiotic resistance are 
cantly more ST-6 isolates w
 from a m a
r STs we
tes from oth inical sources. Table 4.6 inical in
h the P. acnes ere cul
r of isolates URST d the c
quencing  it. Isolates
n make up ortion (46 collectio
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group 7 (type III) isolates were recovered from microdiscectomy procedures, with 
the other two isolated from keratitis and hip infections.  
erent countries the current study P. acnes collection was 
erived from. 54% of the isolates were isolated from different centres around the 
 
Looking more closely at eye infection, the majority of P. acnes cultured from 
corneal scrape from keratitis infections were from eBURST group 1 and 3 (type 
IA and type IB, respectively) (Table 4.6). Interestingly, five out of eight aqueous 
humour isolates from endophthalmitis infections clustered in eBURST group 4 
(novel cluster). As mentioned previously, this novel group is phylogenetically 
distinct from type IA and IB strains. The remaining three aqueous humour isolates 
clustered in eBURST group 1. Further investigation in aqueous humour samples is 
warranted to investigate whether this strain is particularly common in this usually 
sterile environment. There were only two vitreous humour isolates (from 
endophthalmitis infections) within the study collection. Both belonged to 
eBURST group 1 (type IA).    
 
Although a few clinical manifestations of P. acnes appear to be more related to 
certain genotypes or clonal clusters, no one infection site is associated with only 
one clonal complex and vice versa. Any association will require more numbers of 
isolates from that infection site, ideally from different countries, to be 
investigated. A previous study using RAPD analysis to distinguish between 
different clinical P. acnes isolates also did not find any clear correlation between 
clinical source and genotype (Perry et al., 2003).  
 
Table 4.7 lists the diff
d
UK including Cardiff, Belfast, London, Birmingham and Leeds. eBURST 1 (type 
IA) strains were found in all the ten countries. eBURST group 3 (type IB) strains 
were found in Europe, USA and Japan. eBURST groups 5 and 6 (type II) and also 
eBURST group 7 (type III) strains were restricted to European countries although 
numbers are too few to draw any definite conclusions.   
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Table 4.6 Clinical disease distribution of clonal complexes and strain type (ST-22 and ST-37 are included in eBURST group 3 and ST-14 is 
included o m a ot l ti
ghted i
 
 
 in eBURST group 7 for ease f co parison). The two type strains 
endophthalmitis) are highli
re n  included in the table. Eye infections (microbia
n light grey.  
kera tis and 
Clonal complexes and corresponding P. acnes strain type 
   
eBURST 
1 
eBURST 
2 
eBURST 
3 
eBURST 
4 
eBURST 
5 
eBURST 
6 
eBURST 
7 
Total no. 
of isolates % Clinical disease 
Type IA Type IA Type IB 
Novel 
cluster Type II Type II Type III   
Acne    50 0 2 3 1 0 0 56 45.5%
Corneal scrape (from keratitis) 10 0 6 0 1 0 1 18 14.6% 
Aqueous humour (from endophthalmitis) 3 0 0 5 0 0 0 8 6.5% 
Microdisc  0   etomy (from sciatica operations) 1 0 3  0 0 4 8 6.5%
Hip  0   0 0 3  2 1 1 7 5.7%
Dental  0   4 0 2  0 0 0 6 4.9%
Skin woun  0   d 1 0 3  0 0 0 4 3.3%
Fatal gran  0   uloma 3 0 0  0 0 0 3 2.4%
Vitreous humour (from endophthalmitis) 2 0 0 0 0 1 0 3 2.4% 
Neck lymp  0   h nodes 1 0 1  0 0 0 2 1.6%
Eyes 1  0    0 1  0 0 0 2 1.6%
Blood cu 1  0  lture  0 0  1 0 0 2 1.6% 
Cadaveric skin 1  0   0 0  0 0 0 1 0.8% 
Brain abscess 1  0   0 0  0 0 0 1 0.8% 
Kidney 0  0   1 0  0 0 0 1 0.8% 
Bone 0  0   1 0  0 0 0 1 0.8% 
Total no. of is 79  8 3 olates in each group  2 21  5 2 6 12  
% 6.5%  64.2% 1.6% 17.1% 4.1% 1.6% 4.9%  
 Table 4.7 Geographical distribution of clonal complexes and strain type (ST-22 and ST-37 are included in eBURST group 3 and ST-14 is 
included in eBURST group 7 for ease of comparison). The two type strains are not included in the table. 
 
 
Clonal complexes and corresponding P. acnes strain type 
   
eBURST 1 eBURST 2 eBURST 3 eBURST 4 eBURST 5 eBURST 6 eBURST 7 Total no. of isolates % Country 
Type IA Type IA Type IB Novel Type II  Type II Type III   cluster 
UK 66 3.7% 41 2 11 3 3 1 5 5
Paris 16 0 12 0 1 1    1 31 25.2%
Sweden 5 0 1 0 0 0      0 6 4.9%
Australia  4 0 0 0 0 0      0 4 3.3%
USA 3 0 1 0 0 0      0 4 3.3%
China 3 0 0 0 0 0      0 3 2.4%
Italy 3 0 0 0 0 0      0 3 2.4%
Spain 2 0 0 0 0 0      0 2 1.6%
Greece 1 0 0 0 1 0      0 2 1.6%
Japan 1 0 1 0 0 0      0 2 1.6%
Total no. of isolates in each group 79 3 5 2  3  2 26 6 12
% 64.2% 1.6% 21.1% 2.4% 4.1% 1.6% 4.9%   
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.3.5 Analysis of recombination  
nal populations evolve diversity by the accumulation of 
utatio ile non-clonal populations evolve re through recombination 
ecies. There are several w  in which the level of 
bination within a population can be measured. Here, the index of 
ngruence, split decomposition e analysis, 
ine whether the study population is clonal or 
binogenic.   
 In  of association 
ated by calculating 
IA) values (Haubold & Hudson, 2000) using LIAN 3.5 as 
cribe  S ion .16.5. An IA value not significantly greater than 0 after 
 a single species 
ulati m phyletic) are in linkage equilibrium (freely recombining), while 
 value significantly greater than 0 (P<0.001) are in linkage 
P. 
. I 5 isolates were included and was 
each ST was included. This indicates 
as a whole is clonal. Within eBURST group 1 (type IA strains), the IA 
ined that 
s detected. Similarly, eBURST group 7 
trains) had an IA value of -0.0996 (P=1) also indicating a freely 
bining population structure. IA values for the remaining 5 eBURST groups 
ined due to too few STs in each group. However, the LIAN 
 was able to conclude that eBURST groups 3 and 5 did not show 
icant lin  disequilib
Bacteria existing as clo
point m
within or between sp
recom
association, gene tree co
have been applied to determ
recom
 
4.3.5.1
The level of linkage between alleles at 
index of association (
des
1,000 computer random
pop
a population with an 
disequilibrium (clonal) (Sm
 
Table 4.8a shows the 
acnes
0.4768 (P <0.001) when a representative of 
that the population is in linkage disequi
of P. acnes 
value was found to be -0.1357 (P=1) and the analysis programme determ
no significant linkage disequilibrium wa
(type III s
recom
could not be determ
program
signif
 
ns, wh  mo
ays
 and clonal fram
dex
d in
on (
A
different loci was estim
ect
ono
 2
isations indicates that loci within
IA
ith et al., 1993).  
IA values calculated for the different eBURST groups of 
 value was 0.538 (P <0.001) when all 12
librium and thus the population structure 
kage rium.  
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Hence it appears that the population structure of P. acnes is composed of 
subgroups within which there is evidence of frequent recombination occurring but 
A
onstrating no significant linkage disequilibrium and 
erefore frequent recombination between the two lineages. Another explanation 
 eBURST groups 1, 2 and 3 is that they 
are descendents of the same ancestor and few evolutionary changes occurred as 
BURST groups 1 and 5 (IA value 
IA value 0.3509, P<0.001) and between 
groups 1 and 7 (IA 0.5094, P<0.01). This clearly demonstrates significant 
not between subgroups. This is further illustrated by calculating IA values of 
different combinations of eBURST groups (Table 4.8b). An IA value of -0.1167 
(P=1) was calculated when eBURST groups 1 and 2 were combined. This 
suggests that there is frequent recombination occurring within the two groups, 
which were both identified as type IA strains by recA gene sequencing analysis. 
Combining eBURST groups 1 and 3 (i.e. comparing type IA and IB strains), the I  
value was -0.11 (P=1) dem
th
for the lack of genetic exchanged between
these subgroups evolved.  
 
When eBURST groups 1 (type IA strains) and 4 (novel cluster) were combined 
however, the IA value increased to 0.2179 (p<0.001) thus providing additional 
evidence for eBURST group 4 as a novel cluster. The presence of linkage 
disequilibrium was also evident between e
0.4867, P<0.01), between groups 1 and 6 (
phylogenetic distinction between type I, type II and type III strains. Groups 5 and 
6, both consisting of type II strains, did not show significant linkage 
disequilibrium (IA value -0.074, P=0.991) and therefore frequent recombination 
occurred between the two groups.    
 
Calculation of IA values has demonstrated that while recombination was evident 
amongst the clonal complexes (and thus between the strain types I, II and III) and 
also between eBURST groups 1 and 2 (i.e. type IA and type IB strains), linkage 
disequilibrium was detected between all other eBURST groupings, suggesting that 
P. acnes comprise of distinct phylogenetic subgroups with frequent recombination 
within these subgroups 
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Table 4.8 (a) Index of Association (IA) values of all 125 P. acnes isolates, for ST 
representatives and for each eBURST group to measure recombination within 
groups. An IA not significantly greater than zero suggests that the population is in 
linkage equilibrium (LD) and is therefore freely recombining, whilst an IA value 
nificantly greater than zero is considered to be clonal (Haubold & Hudson, 2000). 
Single eBURST 
groups 
No. of 
isolates Strain type 
IA 
value P value 
Linkage 
disequilibrium 
All isolates 125  0.538 P<0.001 LD 
ST representatives 38  0.4768 P<0.001 LD 
eBURST group 1 16 IA -0.1357 P=1 No LD 
eBURST group 2 2 IA NAD - - 
eBURST group 3 3 IB NAD - No LD 
eBURST group 4 2 Novel NAD - - 
eBURST group 5 5 II NAD - No LD 
eBURST group 6 2 II NAD - - 
eBURST group 7 5 III -0.0996 P=1 No LD 
 
 
 
 
 
 
Table 4.8 (b) IA values of combined eBURST to measure recombination between 
groups. 
Combined 
eBURST groups 
No. of 
isolates Strain type 
IA 
value P value 
Linkage 
disequilibrium 
Groups 1 & 2 18 IA -0.1167 1 No LD 
Groups 1 & 3  19 IA & IB  -0.11 1 No LD 
Groups 1 & 4 18 IA & IC 0.2179 <0.01 LD 
Groups 1 & 5 21 IA & II 0.4867 <0.01 LD 
Groups 1 & 6 18 IA & II 0.3509 <0.01 LD 
Groups 1 & 7 21 IA & III 0.5094 <0.01 LD 
Groups 5 & 6 7 II -0.1833 0.056 No LD 
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4.3.5.2 Degree of congruence among loci 
s 
c 
the Shimodaira Hasegawa (SH) test which creates maximum likelihood (ML) for 
 an ar y o e tre her. F y 
clonal evolving population all the trees should the same topol
with  recombination occ h y would ery 
uent) ble 4.9 ws congruence tests for each gene tree 
r gen tree topo es and random tree data. P value is the 
e tree re signifi ifferent. P<0.05 (indicated by *) shows 
ifica differen  the tree topologies and so the genes 
 stric clonal. So although most of the  acnes genes appear 
 signi ant chang  
 
The second test, which compares these same trees with random trees, attempts to 
determine the extent of congruence. The degree of congruence between trees was 
L) of the ML tree for each locus with those of the ML topologies obtained for the 
h o d igu g)
v omparisons among the diff  tree all within the 99th 
percentile of randoml e are c idered si ly 
different and therefore incongruent. The 99th percentiles in Figures 4.14a-g are 
i  dotte es. If  L value of the ML tree of the gene is 
i higher n thi en con and sign ntly 
r .  
 
Comparison between all seven P. acnes MLST genes produced likelihood 
differences that fell outside the 99th percentile of the random distribution (Figures 
4.14a-g), indicating significant congruence between gene trees. Therefore, P. 
acnes as a whole population is not recombinogenic. However, the SH test showed 
that there was significant incongruence between a few of the gene trees 
The degree of recombination can also be assessed by statistical comparison
between tree topologies for each MLST locus using PAUP v4 (Phylogeneti
Analysis Using Parsimony) (Wilgenbusch & Swofford, 2003). The first analysis is 
each of the genes d comp es the topolog f on
 have 
e to anot or a purel
ogy regardless 
of the gene, since  no urring, t eir ancestr  be v
consistent (congr . Ta  sho
compared to othe e logi
probability that th s a cantly d
that there is sign nt c ines 
compared are not tly P.
clonal, some have fic es. 
measured for each of the loci by comparing the differences in log likelihood (∆-ln 
other loci and wit 200 rand mly generate trees (F re 4.14a- . If the ∆-ln L 
alues for the c erent ML s f
y distributed trees, th n they ons gnificant
ndicated by red d lin  the ∆-ln
nline with or  tha s line, th it is in gruent ifica
ecombinogenic
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constructed from different loci, whereas the randomisation test showed that there 
was still some phylogenetic signal that had not been lost by recombination.  
as been suggested to reflect barriers to 
enetic exchange between different subgroups within the population (Feil et al., 
2001).    
 
So overall, based on PAUP analysis, P. acnes appears to be a mostly clonal 
population with some significant recombination occurring (as shown by SH test) 
but the extent of this recombination is not so high as to be freely recombining as 
the evolutionary relatedness of the STs is still significantly preserved and 
congruent (as shown by randomisation test). Another explanation for the observed 
recombination within nucleotide sequences with congruence between gene trees is 
the existence of ecologically distinct subgroups of the P. acnes population. The 
sequence diversity of Haemophilus influenza (H. influenza) is considerable, as 
shown by PAUP analysis (Feil et al., 2001). Like P. acnes, all of the H. influenza 
MLST gene trees showed some congruence. The greater level of congruence 
within this H. influenza population h
g
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Ta
an -ln L 
is value 
is the probability that the trees are significantly different. P <0.05 (indicated by *) 
shows that there are significant differences in the tree topologies and so the genes 
 
ble 4.9 Congruence tests for each gene tree compared to other gene tree topologies 
d random tree data. –ln L is the inverse log likelihood of the ML value and ∆
the difference in this log likelihood value from comparing the tree to itself. P 
compared are not strictly clonal. 
aroE    atpD    
                 
Tree -ln L ∆-ln L P  Tree -ln L ∆-ln L P 
aroE 807.31222 (best)    aroE 769.80655 42.4136 0.001* 
atpD 847.44625 40.13402 0.001*  atpD 727.39295 (best)   
gmk 828.71035 21.39812 0.022*  gmk 732.6117 5.21874 0.426 
guaA 865.27895 57.96673 0.001*  guaA 769.26288 41.86992 0.000* 
lepA 828.71035 21.39812 0.022*  lepA 732.6117 5.21874 0.426 
recA 828.71035 21.39812 0.022*  recA 733.27356 5.88061 0.411 
sodA 828.71035 21.39812 0.022*  sodA 733.27356 5.88061 0.411 
         
gmk     guaA    
                 
Tree -ln L ∆-ln L P  Tree -ln L ∆-ln L P 
aroE 691.96979 40.80596 0.000* aroE 1017.44552 157.50512 0.000* 
atpD 655.92472 4.76089 0.499  atpD 969.27297 109.33256 0.000* 
gmk 651.16383 0 0.911  gmk 962.50152 102.56111 0.001* 
guaA 685.70199 34.53816 0.002*  guaA 859.94041 (best)   
lepA 651.16383 (best)    lepA 962.50152 102.56111 0.001* 
recA 660.29054 9.12671 0.262  recA 973.2177 113.2773 0.001* 
sodA 660.29054 9.12671 0.262  sodA 965.13495 105.19455 0.000* 
             
lepA    recA    
                 
Tree -ln L ∆-ln L P  Tree -ln L ∆-ln L P 
aroE 758.12809 36.80695 0.005*  aroE 666.29151 7.16423 0.033* 
atpD 734.67598 13.35484 0.132  atpD 662.00563 2.87835 0.245 
gmk 729.99302 8.67188 0.33  gmk 659.12728 0 0.842 
guaA 760.05409 38.73295 0.005*  guaA 666.29152 7.16424 0.037* 
lepA 721.32114 (best)    lepA 659.12728 0 0.976 
recA 729.99302 8.67188 0.33  recA 659.12728 (best)   
sodA 721.56663 0.24549 0.847  sodA 659.12728 0 0.91 
         
sodA         
             
Tree -ln L ∆-ln L P      
aroE 849.02513 96.85518 0.000*      
atpD 834.30977 82.13982 0.001*      
gmk 824.31159 72.14163 0.002*      
guaA 813.11328 60.94333 0.000*      
lepA 802.50044 50.33049 0.000*      
recA 824.31206 72.14211 0.002*      
sodA 752.16995 (best)        
 - 138 -
Chapter 4  P. acnes MLST 
 
Figure 4.14a-g. Congruence analysis of each P. acnes MLST housekeeping gene. 
99th percentiles are indicated by the dotted line. (a) aroE, (b) atpD, (c) gmk, (d) 
guaA, (e) lepA, (f) recA and (g) sodA. 
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(e) 
Congruence of lepA ML tree with trees generated from other 
MLST loci and 200 random trees
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(f) 
Congruence of recA ML tree with trees generated from other 
MLST loci and 200 random trees
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(g) 
Congruence of sodA ML tree with trees generated from other 
MLST loci and 200 random trees
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4.3.5.3 Splits decomposition analysis 
determining the extent of recombination and mutation on evolution of organisms.
Output data generated by ClonalFrame using P. acnes MLST are shown in Table 
4.10. Rho/Theta is the ratio of recombination versus mutation, and therefore 5.65 
mutation events occur for very recombination event in the study population. 
Inverse delta value is the mean size of the recombination fragment which is 405 
bp which suggests that when recombination events occurs, it is more likely to 
involve the whole allele if not the gene that is recombining rather than small 
intragenic regions. This is confirmed by examining the site of the polymorphisms 
that occur at each allele. Alignment of sequences of each allele shows that 
polymorphisms usually occur across the alleles rather than at specific regions of 
an allele (data not shown). The r/m value is the impact of recombination versus 
mutation. If the value is 1, then it implies that the impact of recombination is the 
same as mutation. r/m value is 0.840 which means that mutation is still the 
dominant force in evolution than recombination but only marginally. Therefore, 
based on clonal frame analysis, recombination appears to have an important role 
in the evolution of P. acnes even though it is not the major mechanism. However, 
Evidence for recombination having played a role in shaping the genetic diversity 
within P. acnes was displayed by split decomposition analysis of the concatenated 
data set for each ST (Section 4.3.3.3). The extent of recombination within a 
population is reflected by the degree of networks computed by the split 
decomposition programme. As opposed to a clonal tree-like structure, P. acnes 
isolates were interconnected by multiple pathways and formed parallelogram 
structures indicative of recombinational exchanges (Figures 4.10 and 4.11). 
eBURST group 4 (ST-12 and ST-29 cluster) formed the least network connections 
with the other lineages, suggesting infrequent recombination with other strains in 
this population.  
 
4.3.5.4 Clonal frame analysis 
As described in section 4.3.3.4, ClonalFrame v1.1 attempts to infer clonal 
relationships between strains using MLST data. It is also a useful analysis tool for 
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the confidence intervals indicate that the true values could vary across a wide 
range.   
 
 
 
Table 4.10 Output data produced by the ClonalFrame program 
 
Output data Value 95% confidence interval 
Theta 12.373 5.479-19.893 
nu 0.0234 0.0154-0.0323 
R 1.962 0.655-3.767 
delta 0.00247 0.000514-0.000514 
R/m 0.840 0.281-1.650 
Rho/theta 0.177 0.0451-0.424 
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4.3.5.5
The estimation of recombination rates was carried out by comparisons between 
STs belonging to the same clonal complex. Clonal complexes were identified 
where each ST shares at leave six identical alleles with at least one other isolate in 
the group (S
of the ch of the nd those tive 
ancestral e. If the varia  differed from its ancestral genotype at 
multiple nu ites, it was  as a recombin eil et al., 
2001). If the difference occurred at only a single nucleotide site, then a point 
mutation or a recombinational event involving a single ve brought 
about the variant (Feil et al., 2 hese possibilitie uished by 
eeing whether the variant allele appeared elsewhere in the dataset, because an 
allele introduced by recombination may not be present elsewhere in the dataset, 
whereas a point mutation is likely to produce a novel allele (Feil et al., 2000).  
 
The seven eBURST groups were analysed separately for the presence of 
recombinational events and point mutations. As eBURST groups 1 and 7 were the 
only groups with identifiable founding genotypes, their analyses are presented in 
Table 4.11 and 4.12. The other groups did not have enough STs within each group 
for the eBURST program to assign ancestral genotypes or the STs had equal 
numbers of SLVs. For these groups, the alleles of the ST with the most number of 
isolates were designated as the typical allele and the other alleles were designated 
as variant alleles. As shown in Table 4.11, there were a total of 15 allelic variants 
within eBURST group 1. Of these, 3 differed from the allele typical of the clonal 
complex by two or more polymorphisms and were therefore considered 
recombinational imports. The remaining 12 allelic variants differed from the 
typical of the clonal complex at a single nucleotide site, which is indicative of 
point mutation. These single nucleotide changes were confirmed likely to be due 
to point mutations by the fact that these alleles were novel alleles and were not 
present in any other strains in the study population. In eBURST group 7, there 
were two recombinational and two point mutational events. Examination of all 
seven eBURST groups revealed 28 allelic variants in total, with 12 
 Point mutation versus recombination 
ection 4.3.3.3). Comparisons were then made between the sequences 
 alleles in ea SLVs a in the corresponding puta
genotyp nt allele
cleotide s  defined a Ftional event (
 site, may ha
001). T s were disting
s
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recombinational events and 16 point mutational events. This gives an estimate of 
the ratio of recombinational events to mutational events per ~450 bp gene 
fragment of 12:16 (1:1.33), i.e. point mutation has generated new alleles at a 
frequency 1.33 times as high as recombination (this is similar to the estimation 
using ClonalFrame of 1.565, Section 4.3.5.4). 
 
Because recombinational imports in relatively diverse species usually introduce 
multiple polymorphisms, whereas a point mutation only brings about a single 
polymorphism, the ratio of recombinational events to mutational events does not 
realistically reflect the impact of these two processes on sequence divergence. 
Guttman and Dykhuizen suggested that a more accurate method is to estimate the 
probability that an individual nucleotide site will change by recombination 
compared with the probability that it will change by mutation (Guttman & 
Dykhuizen, 1994). 
 
The per-site recombination to mutations (r/m) parameter can be estimated by 
counting the number of polymorphisms introduced by recombination and 
mutation. In this analysis, 87 polymorphisms were introduced by the 12 
recombinational imports, and a maximum of 16 were introduced by point 
mutation (r/m is 5.4:1). Therefore, a particular nucleotide site within a P. acnes 
housekeeping gene is at least 5 times as likely to change by recombination as it is 
to change by mutation. This differs from the conclusion drawn from ClonalFrame 
analysis (Section 4.3.5.4) where changes are more likely to be brought about by 
point mutation than by recombination. This could be explained by the fact that the 
above calculations were done by the detection of polymorphisms between 
genotypes belonging to the same clonal complex whereas ClonalFrame 
calculations were carried out on polymorphisms detected between all the 
genotypes within the study population.  
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ble 4.11 Polymorphic sites within each of the variant alleles for eBURST group 1. 
he ST designation and allele numbers are shown. ST-6 is the founder of the group 
d is shown at the top in red. The polymorphic sites are shown for ST-6 alleles and 
in the other alleles, only those sites that differ fr
 
Ta
T
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om this sequence are shown. The 
polymorphic sites are numbered above the sequences in vertical format. 
 
 
 
a 4roE    1 1 3 1
 
guaA     3 3
  8 1 1 3 2 4
 
   2 0 8
 3  4 3 4 1 2
 
   4 3 1
S CT-6 Allele 1 C C T T G
 
ST-6 Allele 3 G A C
S .T-24 Allele 4 . . . C .
 
ST-1 Allele 1 . G .
S .T-25 Allele 5 . T . . .
 
ST-8 Allele 6 . . T
ST-11 Allele .8 T . . C .
 
ST-33 Allele 9 A . .
S TT-13 Allele 11 . . . C A
 
ST-21 Allele 14 . . .
S
 
T-34 Allele 12 . T C C .
      
       
       
      
       
 
      
       
atpD   2 3    
 
lepA   1 3
  
 
   0 8    
 
   1 7
  
 
 
  1 8    
 
   0 5
 
S
 
T-6 Allele 1 G G    
 
ST-6 Allele 1 G C
 
S
 
T-7 Allele 5 A .    
 
ST-32 Allele 7 A .
 
S
 
T-36 Allele 7 . T    
 
ST-38 Allele 8 . A
 
 
      
       
  
  
gmk 
      
      
     
 
      
  3
   
 
 
sodA   4 
   
 
 
  2     
 
   4 
  
 
 
  0
 
   
 
   2 
  
S
 
T-6 Allele 1 G
 
   
 
ST-6 Allele 1 A 
  
S
 
T-18 Allele 6 A
 
   
 
ST-4 Allele 2 G 
  
 
 
 
  
 
 - 147 -
Chapter 4  P. acnes MLST 
 
 
 
olymorphic sites within each of the variant alleles for eBURST group 7. 
a  
 
 
gmk     
Table 4.12 P
The ST designation and allele numbers are shown. ST-19 is the founder of the group 
nd is shown at the top in red. The polymorphic sites are shown for ST-19 alleles and
in the other alleles, only those sites that differ from this sequence are shown. The 
polymorphic sites are numbered above the sequences in vertical format. 
   
     4   
      4  
S le     T-19 Al le 3 c   
S le     T-30 Al le 7 A   
       
   
g 3
    
uaA     3 4
 3  2 4 5 7
 6 1 7  4 9
ST-19 Allele T C7 G G T
ST-17 Allele  C T11 A . A
ST-20 Allele  .12 . T . .
       
     
s 4  
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4.3.6  Validation of the P. acnes MLST scheme 
d 
RAPD.   
4.3.6.1 Comparison of MLST with 16S ib s a RNA gene analysis 
16S rRN  a lev  o th 5 olates included in the MLST 
scheme io rrie y e et al. (McDowell et al., 2005; 
McDowell et al., 2008). The selection of esentatives of type 
IA, IB, III is tes. A 1,484 p ra plified with the universal 
16S rR -based rimers UFPL a  R L Figure 4.15 is an UPGMA 
dendrog he ne 6  r N  uences. The ST and eBURST 
groups d f T a ,  s the phylotype based on the 
complet  gene analysis, are also shown. The eleven isolates were subdivided 
into thre  lin es based on 16 rRNA gene analysis. Lineage I included 
eBURST oups 1, and 4 which rresponded to type IA and IB strains by recA 
typing. A is s able to differentiate isolate PV66 (novel 
luster) from the other type IA and IB strains, where recA gene analysis could not 
ection 4.3.6.2). Lineage II was represented by JP1B and corresponded to 
eBURST group 5 and type II by recA analysis. Lineage III represented eBURST 
group 7 and correlated to type III strains. Overall, it appears that 16S rRNA gene 
analysis is able to reliably differentiate between types I, II and III strains as well 
as the novel cluster represented by isolate PV66. However, there was not enough 
sequence diversity between type IA and IB strains to separate these into distinct 
groups. The 16S rRNA gene analysis data was in concordance with the eBURST 
group clustering generated by MLST data and thus validated the MLST scheme. 
However, MLST provides much more discrimination as shown by the different 
STs which have identical 16S rRNA gene sequences.  
 
In order to validate the P. acnes MLST scheme and its ability to resolve clonal 
groupings, phylogenetic analysis of the MLST data was compared to several other 
typing methods including 16S rRNA gene and recA gene sequencing, IFM an
 
 r o om l 
A gene nalysis of e en f e 12  is
had prev usly been ca d b  McDow ll 
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The overall mean sequence identity of the 16S rRNA gene was found to be 
99.52% between the five representative sequences of the eleven isolates, 
 et al., 2008). Although sequence analysis of the 
6S rRNA gene is widely recognised as a powerful method for determining the 
most appropriate method of choice for distinguishing between related members of 
confirming their close relationship. In contrast, when a P. acnes type III isolate 
was compared with the sequence from P. propionicus strain DSM 43307 
(GenBank accession no. AJ003058), much greater differences were observed 
(95.8-95.9% identity) (McDowell
1
phylogenetic relationships for distinguishing between bacteria, it may not be the 
a genus or species (Vandamme et al., 1996). Microbes with 16S rRNAs that are 
≤98.7% identical are considered members of different species, because such 
strong variation in 16S rRNA correlate with <70% DNA-DNA similarity 
(Achtman & Wagner, 2008). However, the opposite is not necessarily true and 
distinct species have been found to have 16S rRNAs that are >98.7% identical 
(Achtman & Wagner, 2008).  
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Figure 4.15 UPGMA dendrogram of the P. acnes 16S rRNA gene sequence (1,000 bootstrap replications). STs and eBURST groups generated 
by the MLST scheme and the phylogenetic p u recA
 
grou ing sing complete  gene sequencing 
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4.3.6.2
P
clusters or lineages based on phylogenetic analysis of the 
al.
whether these phylogenetic types could be
125 isolates used in MLST schem
determ
analysis (Table 4.1). The differentiation of 
lineages based on 
with the line
4.3.3.1). eBURST analysis revealed that genotypes from 
belonged to eBURST groups 
belonged to eBURST gr
very closely related clonal com
strains belonging to type II
P. acnes
date, only five isolates
described suggesting it m
During this study, however, a further strain
28), isolated
strains. 
 
There were a tota
mean sequence identity between thes
com
MLST schem
 
While the known phylotype data for 
clustering based on analysis of the ML
exceptions were observed. Firstly, three acne
(n=2) form
these s
 A gene analysis 
reviously, it has been shown that P. acnes is composed of a number of distinct 
 gene (McDowell et 
, 2005; McDowell et al., 2008). It was therefore important to determine 
e, the recA phylotype of 58 isolates was 
ined based on complete recA gene (1,04 p) seque  
P. acnes isolates into distinct groups or 
recA sequence analysis (IA, IB, II & III) was mostly congruent 
ages or clonal complexes resolved from MLST data analysis (Section 
P. acnes type IA 
1, 2 and 4 (Figure 4.16) and P. acnes type IB 
oup 3. Strains of P. acnes type II were found to form two 
plexes or eBURST clusters (groups 5 and 6), while 
I, a recently proposed new phylogenetic group within 
 (McDowell et al., 2008) formed a single eBURST cluster (group 7). To 
 of this novel cluster, known as type III, have been 
ay represent a minor lineage (McDowell et al., 2005). 
 was identified (isolate 463040-03; ST-
 from a corneal scrape sample, which clustered with other type III 
l of five different variants of the complete recA sequence. The 
e five sequences is 99.21%. This is 
parable to the 99.57% sequence identity of the four recA alleles used in the 
e (Figure 4.9f).   
P. acnes isolates correlated well with their 
ST data, a small number of notable 
 isolates with ST-12 (n=1) and ST-29 
ed a highly distinct cluster (eBURST group 4), even though one of 
trains (PV66) was previously classified as a type IA organism based on 
rec
 confirm
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ed using MLST data. Of the 
recA
ncing and phylogenetic
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recA and tly gene sequencing (McDowell et al., 2005). Multiple methods of 
analysing MLST data have shown that ST-12 and ST-29 form a distinct cluster 
ping genes is more appropriate and accurate so that sequence data from 
tential recombinogenic events that might occur at 
other loci. 
awat from the other P. acnes strains. Splits decomposition analysis shows 
recombination occurring between these two STs but not between these and other 
P. acnes STs. Phylogenetic analysis of the 16S rRNA gene also differentiated 
PV66 from other type I strains (Section 4.3.6.1). Therefore, this novel cluster does 
not clearly fall into any of the four previously confirmed phenotypes (IA, IB, II 
and III).  
 
The second discrepancy between the two methods is that two of the isolates did 
not show concordance between MLST and recA gene analysis data. Isolates Asn7 
(ST-38) and JMK9 (ST-6) were found to cluster in eBURST group 1 with other 
type IA strains. However, based on complete recA sequence, they were 
characteristic of type IB organisms. Both isolates were cultured and sequenced 
twice in order to eliminate the possibility of labelling or contamination error. The 
cause of this discrepancy may have come about from a recombinational event 
occurring at the recA gene between type IA and IB strains, resulting in a type IA 
strain acquiring a type IB recA gene segment. These results illustate, therefore, the 
potential limitations that can arise when using a restricted number of gene loci in 
the construction of bacterial phylogenies. Therefore, analysis of multiple 
housekee
each gene is buffered against po
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Figure 4.16 Neighbour-Joining dendrogram of the complete P. acnes recA gene. 
Phylotype based on recA gene analysis and corresponding eBURST groups are 
indicated. 
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4.3
IFM using type-specific based monoclonal antibodies (MAbs) generated by 
McDowell et al. (McDowell et al., 2005; McDowell s used to 
validate the P. acnes MLST scheme. 76 P. acnes isolates were examined with the 
MAbs QUBPa1 and QUBPa2, which label P. acnes type IA and II, respectively, 
as well as QUBPa3, which reacts with all P. acnes strains (method in Section 
2.12). Types I and II displayed classical coryneform morphology i.e. clubs, 
‘tadpole’ forms and short bifid forms (Figure 4.17a and b). Previous analysis of 
reference strains NCTC 737 (type IA strain) and NCTC 10390 (type II strain) 
revealed lengths that ranged from 0.84 to 2.56µm and 0.89 to 2.80µm, 
respectively (McDowell et al., 2005). Type III strains, however, consisted of 
individual cells of variable length and long slender filaments, ranging from 1.20 to 
21.8µm in length, that formed very large tangled aggregates (Figures 4.17c and d) 
(McDowell et al., 2008). In addition, no labelling with QUBPa1 and QUBPa2, 
which react with proteinaceous and carbohydrate/glycolipid-containing antigen on 
types IA and II, respectively, was observed for the type III isolates.  
 
A selection of P. acnes isolates from eBURST groups 1 and 2 were all shown to 
be type IA strains based on IFM analysis. All eBURST groups 5 and 6 strains 
were identified as type II strains and all eBURST group 7 strains were identified 
as type III strains.   
 
Previous study has shown that a characteristic phenotype of type IB organisms is 
the absence of  reaction with MAb QUBPa1 (labels type IA) and weak–to-no 
reaction with the MAb QUBPa2 (labels type II), which is believed to reflect 
differences in the composition of their cell wall compared to type IA strains 
(McDowell et al., 2005). MLST data shows that the group of type IB isolates 
upon which this observation was made (W1392; W1998; CK17; LED2; RM9; 
MMG9; TON9; WMK9) are clonal with an identical allelic profile (ST-10). In 
fact, the type IB group is represented by five distinct STs (ST-9, ST-10, ST-22, 
ST-27 & ST-37) which make up eBURST group 3. IFM analysis of other 
eBURST group 3 genotypes identified in this study (ST-9, ST-22, ST-27 and ST-
.6.3 Immunofluorescence Microscopy (IFM) analysis  
 et al., 2008) wa
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37) found that these organisms will react with MAb QUBPa1, but not QUBPa2. 
Therefore, it would appear that failure to label with QUBPa1 is a phenotypic 
characteristic of the ST-10 genotype of type IB but not other strains in the type IB 
lineage. This illustrates that, while useful, immunological typing with MAbs is 
unpredictable due to the emergence of antigenic variants that do not react.  
 
In the study population, a novel cluster comprising three isolates (one ST-12 and 
two ST-29) was identified, which make up eBUSRT g tes within 
this group displayed dual labelling with MAbs that normally react with either 
types IA (QUBPa1) or II (QUBPa2), further highlighting their distinct nature 
(McDowell et al., 2005). It will be important to ascertain if any other phenotypic 
characteristics that distinguish this group from the other P. acnes clusters exist.  
roup 4. All isola
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Figure 4.17a-d Micrographs of P. acnes immunolabelled with a mouse MAb and an 
r-stained with Evans 
blue and viewed with a combined red/green filter (×100 magnification). 
 
 
(b) Reference strain NCTC 10390 (type II) immunolabelled with MAb QUBPa2. 
 
FITC-conjugated anti-mouse antibody. Bacteria were counte
 
(a) Reference strain NCTC 737 (type IA) immunolabelled with MAb QUBPA1. 
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(c) Asn10 (type III) immunolabelled with MAb QUBPa3. 
 
 
 
 
(d) Asn12 (type III) immunolabelled with MAb QUBPa3. 
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4
In o  PCR 
s 
isolates as described in Section 2.13. The same RAPD primer (RAPD-208) was 
applied to P. avidum, P. propionicus and P. granulosum for comparison. Figure 
4.18 is an unrooted UPGMA dendrogram using band based Dice correlation 
coefficient based on RAPD genotyping profiles. The percentage similarity 
between the bands is displayed next to the dendrogram branch. All the PCR 
reactions and gels were run on the same occasion to eliminate any differences in 
laboratory condition which may generate errors in the banding patterns.  
 
RAPD analysis using RAPD-208 primer was able to distinguish P. avidum, P. 
propionicus and P. granulosum from P. acnes. Although P. granulosum gave 
markedly different profiles with less than 40% similarity t
species, P. propionicus and P. avidum appear to be much more closely related to 
P. acnes at 70% and 73% similarities, respectively. Type II isolates appear to have 
this group also clustered with a ST-28 (type III) strain and a ST-6 (type IA) strain 
(highlighted in red in Figure 4.18). Similarly, type III strains (ST-17, ST-19 and 
ST-20) have clustered together but along with a ST-6 (type IA) strain and a ST-22 
(type IB) strain. Type IA and IB strains are distributed randomly throughout the 
dendrogram, indicating that there are too few band differences for the two types to 
be reliably discerned by RAPD analysis. A previous study using a different RAPD 
primer (primer 1254) to investigate 46 clinical P. acnes strains was able to 
identify two distinct profile types (Perry et al., 2003). One profile type included 
the reference strain NCTC 737 which is a type I strain and the other included the 
reference strain NCTC 10390, a type II strain. The investigators were unable to 
distinguish between type IA and IB strains using RAPD. They also noted that 
strains isolated from different clinical sources were distributed amongst the RAPD 
profiles. It is evident from the current study and from previous work that MLST is 
a much superior genotyping technique at differentiating between closely related 
strains than RAPD typing.  
.3.6.4 Random Amplification of Polymorphic DNA (RAPD) typing  
rder to provide comparisons betw en MLST and a repetitive elemente
typing technique, RAPD typing was carried out on a selection of 92 P. acne
o those of the other 
clustered together (ST-23, ST-26, ST-31, ST-15, ST-35 and ST-14). However, 
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Figure 4.18 UPGMA dendrogram analysis of RAPD profiles from P. avidum, P. 
prop tes. 
 
 
ionicus, P. granulosum and a selection of 92 P. acnes isola
36.81% 
82.47% 
91.72% 
90.91% 
86.36% 
88.89% 
90.91% 
72.65% 
92.10% 
91.57% 
70.32% 
88.19% 
94.89% 
76.55% 
94.12% 
77.66% 
98.17% 
94.12% 
94.45% 
P. avidum  
P. propionicus 
P. granulosum 
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4.4 Future work 
MLST has reliably identified distinct clonal complexes which encompass closely 
related strains. ST-6 has been identified as the founder genotype for the clonal 
complex consisting of the largest number of different STs. ST-6 is also the most 
frequently found genotype in this study population of 125 P. acnes isolates. Is this 
observation due to the frequent occurrence of ST-6 strains on healthy skin and 
therefore more likely to be cultured from infection? Or it is a more virulent strain 
possessing antibiotic resistance traits and other virulent factors that make it 
“fitter” than the other strains? Perhaps it is a combination of the two factors that 
allow it to dominate over the other genotypes. One way of answering this question 
is to culture P. acnes from the skin of healthy carriers with no previous history of 
P. acnes strains isolated from the cheek, acne infection. MLST analysis of 
forehead and back of three healthy carriers with no previous history of acne was 
carried out in the current study. Two of the carriers harboured only ST-6 strains 
from the different swab sites and a ST-19 strain was cultured from the cheek of 
the third carrier (data not shown). Previous ST-6 strains were determined to be 
type IA and ST-19 strains to be type III. Although this data is limited, it does 
show that ST-6 is not the only ST found on healthy carrier skin. A much larger 
collection of P. acnes from different parts of the body from healthy carriers of 
different ethnic origin, of different age groups and from different countries, would 
provide valuable information about how this successful strain has evolved.   
 
Further studies of different P. acnes strains, especially the ST-6 genotype in terms 
of its pathogenicity and antibiotic resistance would also provide insight into 
whether certain strains are more likely to cause disease and hence dominate the 
collection of clinical strains. MLST analysis of virulence genes rather than 
housekeeping genes may provide further discrimination of lineages within the 
population structure of P. acnes. Although RAPD analysis using a single primer 
in the current study did not provide accurate and reliable discrimination of P. 
acnes compared to other typing methods, further optimisation and using 
alternative primers may provide more useful information, allowing for a cheaper 
alternative to MLST.  
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4
s, which means such methods are 
not easily transferred between laboratories. Furthermore, due to the nature of its 
cell wall, in situ lysis of P. acnes can be problematic during PFGE experiments 
which may further impact on reproducibility. Typing of strains based on the 
analysis of unambiguous DNA sequence content rather than genome organisation 
or restriction fragments is much more robust, reliable and transferable between 
laboratories. On this basis, MLST schemes provide the opportunity for 
unequivocal typing and characterisation of bacterial pathogens which is critical 
for epidemiological studies.  
 
The discriminatory power of the P. acnes MLST scheme, and its capacity to 
estimate levels of homologous recombination, has now enabled the genetic 
population structure of this organism to be understood in a way previous typing 
methods have not facilitated. The ability of bacteria to exchange genetic material 
is of clinical interest, and can confer resistance to antimicrobials, increased 
virulence and vaccine immunity. All of the lineages within P. acnes had a 
population structure compo f very ely related genotypes. The relatively 
small degree of sequence diversity observed within the seven core housekeeping 
genes of these phylotypes, even where allele sharing by recombination was 
evident (which tends to break up clonal complexes), could be explained by clonal 
expansion of adapted genotypes (purifying selection) followed by the emergence 
of minor variants through recombination and/or de novo mutation.  
 
In conclusion, the MLST scheme reported here has proved a valuable tool for 
high-level strain identification and epidemiological investigation of P. acnes
method has confirmed the previously described phylogenetic groups of the 
 and identified an additional novel cluster. There appears to be no 
.5 Conclusions 
To date, a small number of different genetic fingerprinting schemes for P. acnes 
have been described, including RAPD (Kunishima et al., 2001; Perry et al., 2003) 
and PFGE (Cohen et al., 2005; Oprica & Nord, 2005; Ting et al., 1999). One 
common problem with such techniques is the inherent variability that often arises 
when attempting to match gel banding pattern
sed o  clos
. The 
organism
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association between these distinct groups and clinical manifestation of the 
 
infection, nor the geographical location of these strains. Continued application of 
the scheme to P. acnes isolates from individuals in different localities and 
asymptomatic carriers will further promote our understanding of the organism’s 
genetic population structure and its role in disease. 
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CHAPTER 5 PROPIONIBACTERIUM ACNES RAPID 
DIAGNOSTICS  
 
5.1 Introduction 
P. acnes is an anaerobic organism capable of causing a variety of different clinical 
infections including postoperative endophthalmitis (Aldave et al., 1999) and 
keratitis (Jones & Robinson, 1977; Perry et al., 1982; Wong et al., 2003; 
Zaidman, 1992). P. acnes endophthalmitis can be difficult to identify as the 
organism resides within the capsular bag of the eye and is therefore difficult to 
culture. P. acnes also has a very slow growth rate and may take up to 10 days to 
culture using conventional culture techniques (Aldave et al., 1999; Clark et al., 
1999). This delay in diagnosis may lead to inappropriate antibiotic treatment and 
poor visual outcome.  
 
To overcome the low culture positive rate, molecular diagnostic tests have been 
developed to aid the diagnosis of postoperative endophthalmitis. Most of these 
PCR assays use universal primers targeting the bacterial 16S rRNA genes, with 
subsequent identification of the pathogen using RFLP analysis or DNA 
sequencing of the amplified products (Knox et al., 1999; Lohmann et al., 2000; 
Okhravi et al., 2000). A major drawback of this approach is the cost and time 
involved in the identification of the organism. To overcome this, PCR specifically 
targeting the P. acnes 16S rRNA gene has been developed to identify P. acnes 
directly from vitreous and aqueous humour, and the explanted intraocular lens of 
patients with chronic postoperative endophthalmitis (Buggage et al., 2003; Hykin 
et al., 1994; Lai et al., 2006). This approach has also been applied to detect P. 
acnes in vitreous humour of sarcoidosis patients (Yasuhara et al., 2005), from an 
abscess caused by a vascular prosthesis (Le Page et al., 2003) and from prosthetic 
hip infections (Tunney et al., 1999).  
 
Chapter 4 explored the population biology of P. acnes using housekeeping genes 
and identified distinct clonal complexes. However, there was no obvious 
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correlation found between a particular clone or clonal complex and the clinical 
manifestation. Therefore, a PCR assay for the diagnosis of P. acnes 
endophthalmitis infection does not need to target a specific genotype. All seven 
housekeeping genes used in the MLST scheme were amplified from all the P. 
acnes isolates in the study population. Therefore, any of these genes are potential 
targets for PCR assays for the detection of P. acnes from clinical samples. 
Molecular identification of organisms based on specific gene targets, such as the 
MLST housekeeping genes, enables a higher degree of specificity than methods 
which rely on the use of universal or broad-range primers.  
 
Higuchi et al. developed a system whereby PCR products could be detected as 
they accumulate during a standard PCR reaction (Higuchi et al., 1992; Higuchi et 
al., 1993). This real-time PCR has the advantage of detecting microbial DNA in a 
much shorter time than standard PCR protocols as it does not require gel 
electrophoresis and allows quantification of copy numbers. An additional 
advantage of the real-time PCR system is that analysis can be carried out without 
opening the reaction tubes, thus reducing the risk of contamination of the 
laboratory with the amplified PCR products (Woodford & Johnson, 2004). 
Current real-time PCR technology relies on two methods of obtaining fluorescent 
signal following the synthesis of PCR products. One approach utilises fluorescent 
dyes to bind to double-stranded DNA which once bound, increase their intensity 
of fluorescence. The second method uses fluorescent reporter probes which are 
sequence specific and quantify only the DNA containing the probe sequence 
(Woodford & Johnson, 2004).     
 
5.2 Aims 
1. To develop a PCR assay for the detection of P. acnes using one of the 
seven housekeeping genes from the MLST scheme.  
2. To determine the PCR assay’s sensitivity and specificity using real-time 
PCR technology.  
3. To determine the optimal DNA extraction method for P. acnes. 
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5.3 Results and Discussion 
 
5.3.1 Specificity of PCR assay  
PCR reactions using primers targeting the seven P. acnes housekeeping genes 
were carried out as described in Section 2.15.2. To determine the specificity of 
each housekeeping gene to P. acnes, PCR reactions were carried out on the four 
cutaneous Propionibacterium spp. (P. acnes, P. avidum, P. granulosum and P. 
propionicus) and four other organisms commonly cultured from eye infections (P. 
aeruginosa, S. aureus, coagulase negative Staphylococcus and S. pneumoniae). 
Each PCR mixture contained 20ng of genomic DNA and a negative control 
without any bacterial DNA was also included. The presence of PCR products was 
determined by gel electrophoresis on agarose gels. Table 5.1 shows the specificity 
of each gene to P. acnes.  
 
Three genes (gmk, guaA and recA) were found to be specific for P. acnes and 
were not amplified from any of the other P. acnes species or the other bacterial 
organisms tested. Of the three genes, the smallest PCR product generated by the 
nested primers used in the MLST scheme was chosen (Table 4.2) because this 
would allow more rapid PCR cycling. Therefore, the gmk gene was chosen to be 
used in the rapid diagnostics assay for the detection of P. acnes.  
 
Real-time PCR technique was applied to different organisms using methods 
described in Section 2.15 to detect the presence of the gmk gene. It was detected 
in three different P. acnes strains (including the P. acnes type strain NCTC 737) 
and could not be detected in P. avidum, P. granulosum, P. propionicus, S. aureus, 
P. aeruginosa, S. pneumoniae or coagulase negative Staphylococcus. 1ng/µL of 
bacterial DNA was used in each sample. 
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Table 5.1 Amplification of housekeeping genes using primers from the P. acnes 
MLST scheme. gmk, guaA and recA are the only genes found to be specific for P. 
acnes.  
 
 aroE atpD gmk guaA lepA recA sodA 
P. acnes + + + + + + + 
P. avidum + + - - + - + 
P. granulosum - + - - - - + 
P. propionicus - + - - + - + 
S. aureus - - - - - - - 
P. aeruginosa - - - - - - - 
Coagulase negative 
Staphylococcus 
- - - - - - - 
S. pneumoniae - - - - - - - 
Negative control - - - - - - - 
 
 
 
 
 
 - 167 -
Chapter 5  P. acnes Rapid Diagnostics 
 
5.3.2 Melting-curve analysis 
The real-time PCR method used in the current study relied on the green 
fluorescent nucleic acid dye, Evagreen (Biotium Inc.) to produce the fluorescent 
signal. Evagreen exhibits very low levels of fluorescence when free in solution 
but this level increases by up to 1000-fold when the dye is bound to DNA. The 
dye has the ability to bind to any double-stranded DNA generated by the PCR. 
Although this has the advantage that the same dye can be used to detect any 
amplified product, the disadvantage is that non-specific PCR products such as 
“primer dimers” also generate a signal.   
 
Melt-curve analysis can be applied when fluorescent dyes are used as reporters in 
real-time PCR (Ririe et al., 1997). The temperature is gradually increased from 
one at which the PCR product is known to be double-stranded to one at which all 
DNA strands are fully dissociated. As the temperature is increased, the amount of 
fluorescence is measured, and the temperature at which the maximum decrease in 
fluorescence (or “melting peak”) occurs is noted. Melting peaks are visualised on 
plots of –dF/dT against T (F = fluorescence and T = temperature). If there are 
multiple PCR products, then more than one melting peak may appear, depending 
on their physical properties. The temperature of the melting peak corresponds to 
the point at which half of the DNA is associated. At this point, the population of 
molecules will consist of fully dissociated, partially associated and fully 
associated DNA strands. Primer artefacts, such as primer dimers can usually be 
identified from the target DNA, since they generally have melting-peak 
temperature ranges quite different from each other (Woodford & Johnson, 2004). 
 
Real-time PCR reactions using primers targeting the P. acnes gmk gene were 
carried out on serial dilutions of P. acnes genomic DNA (0.1pg/ml to 1ng/ml). 
Melt-curve analysis of the real-time PCR reaction using Evagreen carried out on 
the LightCycler® system (Roche) is shown in Figure 5.1. It shows that the limit of 
detection of the assay (i.e. the sensitivity) was 0.1pg/ml although a reliable level 
of detection would be 1pg/ml. There is only one melting-peak at 92ºC confirming 
that there was a single PCR product and no primer dimers. 
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 Figure 5.1 Real-time PCR melt curves of the PCR products of P. acnes gmk gene. 5 different concentrations of P. acnes type strain NCTC 737 
and a negative control containing water were analysed. The reporter was Evagreen. There is a single peak at 92ºC.   
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5.3.3 Quantitative real-time PCR 
Standard PCR relies on end-point analysis and is therefore non-quantitative in 
nature. Real-time PCR overcomes this problem by detecting the amount of 
amplification of a PCR product at a set point in time during each cycle rather than 
detecting the amount of PCR product accumulated after a fixed number of cycles. 
An amplification curve can be generated which is the plot of fluorescence signal 
versus cycle number. Quantification in real-time PCR is calculated by 
measurement of the number of cycles (threshold cycle, CT) required for the 
fluorescent signal to cross a threshold level. This threshold is usually set at three 
standard deviations above the baseline level. Crossing threshold values are 
inversely proportional to log10 of the initial target DNA concentration. 
Quantification values for unknown samples can then be calculated from standard 
curves constructed using the data obtained from known dilutions of the target 
DNA (Woodford & Johnson, 2004).  
 
Figure 5.2 shows the amplification plot generated for the real-time PCR 
amplification of the gmk gene using five serial dilutions of genomic DNA from P. 
acnes type strain NCTC 737. The log of the change in fluorescence is plotted 
against the number of PCR cycles. The plot shows that the higher the starting 
copy number of target DNA, the sooner a significant increase in fluorescence is 
observed. From this amplification plot, CT values for each starting DNA 
concentration are plotted against the log concentration of the initial target DNA 
forming a standard curve (Figure 5.3). Quantification of unknown amounts of 
DNA can be estimated using this standard curve.  
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 Figure 5.2 Real-time PCR amplification plot of the gmk gene carried out on P. acnes type strain NCTC 737 using Evagreen as the reporter.  Five 
serial dilutions of the genomic DNA are shown. The log of the change in fluorescence is plotted against cycle number. 
 CT
   - 1  71 -
 Figure 5.3 Real-time PCR standard curve showing CT values (threshold cycle) plotted against the log concentration of genomic DNA. 
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5.3.4 Rapid real-time PCR 
Some real-time PCR instruments (e.g. LightCycler®) enable fast and accurate 
temperature transitions and are therefore commonly used for rapid diagnostic 
purposes (Woodford & Johnson, 2004). In the current assay to detect gmk in the 
P. acnes sample, the first round conventional thermal cycler takes about 1 hour 45 
minutes to complete. A single cycle in the second round real-time assay takes 
around 20 seconds, allowing the second round assay to be completed within 18 
minutes. Therefore the total assay time including handling can be completed 
within about 2 hours 30 minutes, excluding the DNA extraction step. Rapid 
cycling is achieved because standard heating blocks and PCR tubes are not used 
in these systems. In the LightCycler, turbulent air is used to control the 
temperature and glass capillaries act as the reaction vessels. Rapid temperature 
transitions and short holds also produce better annealing accuracy due to less 
mispriming, as the sample spends less time at the lower temperatures (Woodford 
& Johnson, 2004). The real-time PCR method described here to detect P. acnes is 
therefore much more sensitive and rapid than the standard culture method 
employed in most clinical laboratories, which can take up to ten days.  
 
5.3.5 Comparison of extraction methods 
Extraction of genomic DNA from P. acnes can be problematic. The 
phenol/chloroform method has been proven to be very effective at extracting large 
amounts of clean, genomic DNA from P. acnes and this was the method used for 
obtaining DNA for the MLST study. However, for the purpose of developing a 
rapid diagnostics protocol for detecting P. acnes DNA from small amounts of 
clinical sample, a more efficient and less hazardous method needs to be 
established. Therefore, three different DNA extraction protocols were compared 
1) HiPure Viral Nucleic Acid extraction kit, 2) DNAmite DNA extraction kit and 
3) Chelex extraction method (methods described in Section 2.15.3).  
 
A suspension of P. acnes cells harvested from an agar plate was subjected to each 
DNA extraction protocol. The extracted nucleic acids were then diluted in ten-fold 
 - 173 -
Chapter 5  P. acnes Rapid Diagnostics 
 
series and assayed for the presence of gmk. The target was detected in neat, 10-1, 
and 10-2 dilutions extracted using the Chelex extraction method and DNAmite kit 
but only in neat and 10-1 dilutions of DNA’s extracted by the HiPure Viral 
Nucleic Acid extraction kit. Therefore, the Chelex extraction method and the 
DNAmite kit appear to yield the best DNA for use with the gmk PCR assay. These 
methods have the advantage of being less time consuming and involve less 
hazardous chemicals than the phenol/chloroform DNA extraction method. 
 
5.4 Future work 
The real-time PCR assay developed here for the detection of the P. acnes gmk 
gene has been found to be specific for P. acnes. This assay needs to be applied to 
a much larger number of P. acnes strains and non-P. acnes strains to consolidate 
this finding. To further test the sensitivity of the assay in clinical samples, known 
numbers of P. acnes organisms can be spiked into sterile aqueous or vitreous 
samples, the genomic DNA extracted using the Chelex extraction protocol or the 
DNAmite kit and then subjected to real-time PCR to detect the gmk gene. This 
will allow the different DNA extraction protocols to be compared and also enable 
the sensitivity of the PCR assay on clinical samples to be determined. Once the 
optimal conditions are determined, the assay can be applied to aqueous and 
vitreous samples from suspected endophthalmitis cases. Half of the obtained 
sample could undergo conventional culture techniques and the remaining tested 
using the real-time PCR assay, allowing comparison between the two diagnostic 
techniques. False positive results from contamination of PCR samples are always 
possible and precautions must be in place to reduce the likelihood of this.  
 
Multiplex PCR allows the simultaneous detection of several organisms using 
multiple sets of primers specific for each organism. A multiplex PCR assay could 
be designed to detect the common ophthalmic infections such as P. acnes. S. 
aureus, P. aeruginosa, S. pneumoniae and coagulase negative Staphylococcus. 
Once optimised, this could be applied to aqueous and vitreous samples to 
diagnose endophthalmitis and corneal scrape specimens from microbial keratitis.  
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5.5 Conclusions 
MLST analysis of a diverse collection of P. acnes from differing clinical sites and 
geographical locations strongly suggest that particular strains or clonal complexes 
are not associated with disease type. Therefore, diagnostic assays designed to 
detect P. acnes from endophthalmitis infections do not have to differ from those 
targeting P. acnes from other infections. Real-time PCR technology employed 
here to detect the gmk housekeeping gene has proven to be specific for P. acnes, 
as it did not detect any of the other cutaneous Propionibacterium spp. (P. avidum, 
P. granulosum and P. propionicus) or other common eye infection organisms (S. 
aureus, P. aeruginosa, S. pneumoniae and coagulase negative Staphylococcus). 
The real-time PCR assay was also extremely sensitive, detecting levels of P. 
acnes genomic DNA at concentrations as low as 0.1pg/ml. Another important 
advantage of the real-time system is its ability to quantify the amount of amplified 
DNA at each PCR cycle. The standard first round of PCR and the real-time 
second round PCR can both be completed within two and a half hours. This 
means that the detection of P. acnes from a clinical sample can be achieved well 
within a day. This is an enormous reduction in diagnostic time compared to 
conventional culture methods which can take up to ten days.  
 
Compared to previously described PCR assays which use universal bacterial 16S 
rRNA gene (Knox et al., 1999; Lohmann et al., 2000; Okhravi et al., 2000), the 
current real-time assay to detect a P. acnes specific gene (gmk) does not require 
the need to identify the PCR product using DNA sequencing. This reduces both 
the cost and time required to complete the diagnostic process.  
 
PCR diagnostics not only has the advantage of being much more rapid and 
sensitive than conventional culture methods, but it is also unaffected by prior 
antibiotic use. Further study comparing different DNA extraction methods on 
clinical samples spiked with P. acnes is warranted. The development of a 
multiplex PCR assay to detect organisms that commonly cause ophthalmic 
infections would further improve the management of these conditions.  
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CHAPTER 6 MULTILOCUS SEQUENCE TYPING ANALYSIS 
OF PSEUDOMONAS AERUGINOSA  
 
6.1 Introduction 
P. aeruginosa is a Gram-negative rod and considered an opportunistic pathogen 
capable of infecting a variety of hosts (Lavenir et al., 2007; Pukatzki et al., 2002; 
Rahme et al., 2000). It is particularly problematic in cystic fibrosis (CF) patients 
(Saiman & Siegel, 2004), in burned, mechanically ventilated and 
immunocompromised individuals (McManus et al., 1985; Richard et al., 1994). It 
can cause numerous serious infections including septicaemia, pneumonia, 
endocarditis, otitis, keratitis and endophthalmitis (Eifrig et al., 2003; Jackson et 
al., 2003; Kashkouli et al., 2007; Kielhofner et al., 1992). P. aeruginosa keratitis 
is much more common in contact lens wearers and can lead to permanent damage 
of the cornea if appropriate treatment is not instigated immediately (Mondino et 
al., 1986; Rattanatam et al., 2001; Wilhelmus, 1996). Other sight-threatening 
complications include development of secondary glaucoma and cataract (Lotti & 
Dart, 1992). 
 
P. aeruginosa has been considered by some to have a panmictic population 
structure (Denamur et al., 1993; Picard et al., 1994). A panmictic-epidemic 
population structure has been suggested by others (Dinesh et al., 2003; Lomholt et 
al., 2001; Morales et al., 2004; Pirnay et al., 2002; Romling et al., 1994). Kiewitz 
et al. proposed a net-like structure with high frequencies of recombination among 
different P. aeruginosa genotypes (Kiewitz & Tummler, 2000). Curran et al. 
developed an MLST scheme to characterise P. aeruginosa strains and 
demonstrated that P. aeruginosa has a non-clonal population structure (Curran et 
al., 2004). These results are in contrast to another P. aeruginosa MLST scheme 
which supported a clonal population structure (Vernez et al., 2005). This might be 
explained by the small sample size (n=34) and the possibility of over-
representation of epidemic clones. Genotyping of P. aeruginosa using microarray 
showed that the majority of strains belonged to a few dominant clones widespread 
in disease and environmental habitats (Wiehlmann et al., 2007).  
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The type III secretion system (TTSS) is present in several Gram-negative bacilli 
(Galan & Collmer, 1999). Using the TTSS, P. aeruginosa is able to produce and 
secrete virulence factors directly into the cytoplasm of host cells (Ajayi et al., 
2003). The effector proteins  (secreted toxins) comprise of ExoS, ExoT, ExoU and 
ExoY  (Finck-Barbancon et al., 1997; Frank, 1997; Frithz-Lindsten et al., 1997; 
Hauser et al., 1998; Yahr et al., 1996; Yahr et al., 1998). The genes that encode 
these effector proteins are distributed throughout the P. aeruginosa genome and 
are characterised by variable traits (Stover et al., 2000). The TTSS has been 
identified in nearly all clinical and environmental isolates but individual isolates 
and populations of isolates from distinct disease sites appear to differ in their 
effector genotype (Feltman et al., 2001). Although exoY and exoT are present in 
nearly all clinical P. aeruginosa isolates, the majority possess only exoS or exoU, 
not both (Feltman et al., 2001; Finck-Barbancon et al., 1997; Hauser et al., 1998). 
P. aeruginosa strains have been classified based on the genotypic expression of 
these toxins. Invasive strains tend to express ExoS (Fleiszig et al., 1997), whereas 
non-invasive or cytotoxic strains express ExoU (Finck-Barbancon et al., 1997; 
Hauser et al., 1998).  
 
6.2 Aims 
1. To characterise the population structure of a collection of clinical and 
environmental P. aeruginosa isolates using MLST. 
2. To evaluate whether P. aeruginosa strains from eye infections represent a 
particular subgroup. 
3. To determine whether P. aeruginosa eye infection strains between two 
geographical locations (UK and China) could be distinguished using 
MLST. 
4. To determine the TTSS genotype of P. aeruginosa from eye infections.  
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6.3 Results and Discussion  
 
6.3.1 P. aeruginosa strains and MLST scheme 
MLST analysis of 117 P. aeruginosa isolates from eye infections (115 corneal 
scrapes from keratitis and 2 vitreous humour from endophthalmitis) was carried 
out using methods previously described (Curran et al., 2004). Sequences for each 
allele were uploaded onto the P. aeruginosa MLST website 
(http://pubmlst.org/paeruginosa), developed by Keith Jolley (Jolley et al., 2004). 
Allelic profiles and STs were also assigned using the database. MLST data on a 
selection of 166 P. aeruginosa isolates from other clinical infections were 
available on the website. MLST and clinical data for all 283 isolates are shown in 
Table 6.1.  
 
Allelic information based on the study population, for the seven alleles, was 
calculated using START v2 (Section 2.16.4). The total length of the concatenated 
sequence of the seven alleles was 2,882 bp. The mean allele length was 412 bp 
with sizes ranging from 366 bp (nuoD) to 498 bp (aroE) (Table 6.2). The number 
of alleles for each housekeeping gene ranged from 30 (nuoD) to 59 (acsA) with a 
mean average of 42. All alleles for a particular locus were found to be of equal 
lengths for all the study population isolates. The degree of sequence diversity 
within the housekeeping genes were relatively high, with the proportions of 
polymorphic sites ranging from 8.6% (guaA) to 17.5% (aroE) with a mean 
average of 11.8%.     
 
As discussed in Section 4.3.1.4, the ratio of non-synonymous (dN) to synonymous 
(dS) changes is used to assess the degree of selection operating on a gene (Rocha 
et al., 2006). A low ratio (dN/dS<1) indicates strong purifying (“stabilising”) 
selection. For all the loci used in the P. aeruginosa MLST scheme, the dN/dS<1 
were less than 1, confirming their suitability as housekeeping genes for the 
scheme (Table 6.2). 
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 Table 6.1 Summary of 283 P. aeruginosa isolates with MLST data, eBURST groups, exoU and exoS gene genotype and serotype. 
Isolates are grouped together based on eBURST groups. Those isolates not belonging to an eBURST are listed in order of their ST. 
(Abbreviations: N/A, not available, PME, agglutination with PME serum only) 
 
Allelic profile 
Isolate name Date of isolation 
Source of 
isolate Location acsA       
  
aroE guaA mutL nuoD ppsA trpE
ST eBURST group exoS exoU serotype 
8277             N/A Sputum Durham, UK 11 5 1 7 9 8 7 14 1 N/A N/A N/A 
PSA054                
             
             
             
             
             
             
             
             
             
                 
             
             
                
                
                
                
N/A Corneal scrape Manchester, UK 11 5 1 7 9 4 7 17 1 + - O:1
PS-7 N/A Sputum Birmingham, UK 11 5 1 7 9 4 7 17 1 N/A N/A N/A 
E4SIB2 Sep-99 Sputum BC, Canada 11 5 1 7 9 4 7 17 1 N/A N/A N/A 
10478 N/A Sputum Birmingham, UK 11 5 1 7 9 4 7 17 1 N/A N/A N/A 
P10118 N/A Sputum Birmingham, UK 11 5 1 7 9 4 7 17 1 N/A N/A N/A 
8808 N/A Sputum Cardiff, UK 11 5 1 7 9 4 7 17 1 N/A N/A N/A 
9922 N/A Sputum London, UK 11 5 1 7 9 4 7 17 1 N/A N/A N/A 
10099 N/A Sputum Manchester, UK 11 5 1 7 9 4 7 17 1 N/A N/A N/A 
9273 N/A Sputum Portsmouth, UK 11 5 1 7 9 4 7 17 1 N/A N/A N/A 
M2 Apr-94 Sputum BC, Canada 6 5 1 7 9 4 7 187 1 N/A N/A N/A 
PSA029 N/A Corneal scrape Liverpool, UK 6 5 1 7 9 4 7 187 1 + - O:1
8970 N/A Sputum Sheffield, UK 6 5 1 7 9 4 7 187 1 N/A N/A N/A 
B8SIB1 Jul-92 Sputum BC, Canada 11 5 1 3 9 4 7 202 1 N/A N/A N/A 
PSA039 N/A Corneal scrape Liverpool, UK  11 5 1 7 46 4 7 318 1 + - O:1 
PSA047 N/A Corneal scrape Bristol, UK 6 5 1 7 4 4 7 321 1 + - O:1
PSA048 N/A Corneal scrape Bristol, UK 11 5 1 7 9 25 7 322 1 + - O:1
PSA076 N/A Corneal scrape Newcastle, UK 9 5 1 7 9 4 7 339 1 + - O:1
PSA110 N/A Corneal scrape Beijing, China 112 5 1 7 4 4 7 380 1 + - N/A
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 Allelic profile 
Isolate name Date of isolation 
Source of 
isolate Location acsA       
  
aroE guaA mutL nuoD ppsA trpE
ST eBURST group exoS exoU serotype 
7627             N/A Sputum Croydon, UK 6 5 6 7 4 6 3 11 2 N/A N/A N/A 
8281             
             
               
             
             
             
             
             
             
             
             
             
               
             
             
                
             
             
             
             
N/A Sputum N/A 12 5 6 7 4 6 7 15 2 N/A N/A N/A 
F2 Mar-95 Sputum BC, Canada 6 5 6 7 4 6 7 27 2 N/A N/A N/A 
PSA028 N/A Corneal scrape Manchester, UK 6 5 6 7 4 6 7 27 2 + - O:1
4587 N/A Sputum Boston, UK 6 5 6 7 4 6 7 27 2 N/A N/A N/A 
6954 N/A Sputum Glasgow, UK 6 5 6 7 4 6 7 27 2 N/A N/A N/A 
8184 N/A Sputum London, UK 6 5 6 7 4 6 7 27 2 N/A N/A N/A 
6338 N/A Sputum N/A 6 5 6 7 4 6 7 27 2 N/A N/A N/A 
8101 N/A Sputum Stourbridge, UK 6 5 6 7 4 6 7 27 2 N/A N/A N/A 
8386 N/A Sputum Wrexham, UK 6 5 6 8 2 6 7 122 2 N/A N/A N/A 
8122 N/A Sputum Glamorgan, UK 6 5 6 8 21 6 7 128 2 N/A N/A N/A 
7874 N/A Sputum Leeds, UK 6 5 6 7 2 6 7 129 2 N/A N/A N/A 
M4 Oct-96 Sputum BC, Canada 6 5 37 7 4 6 7 161 2 N/A N/A N/A 
PSA069 N/A Corneal scrape Manchester, UK 99 5 6 7 4 6 7 334 2 + - O:1
D278 N/A Sputum N/A 36 27 35 3 4 13 7 144 3 N/A N/A N/A 
B4 Oct-94 Sputum BC, Canada 36 27 28 3 4 13 7 179 3 N/A N/A N/A 
PSA055 N/A Corneal scrape Bristol, UK 36 27 28 3 4 13 7 179 3 + - O:6
A1 Jul-83 Sputum BC, Canada 36 27 28 31 4 13 7 180 3 N/A N/A N/A 
H3 Sep-82 Sputum BC, Canada 36 27 28 31 4 15 7 188 3 N/A N/A N/A 
P1 Jul-97 Sputum BC, Canada 36 27 35 31 4 13 7 200 3 N/A N/A N/A 
PS-96 N/A Sputum Birmingham, UK 88 27 28 3 4 13 7 353 3 N/A N/A N/A 
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 Allelic profile 
Isolate name Date of isolation Source of isolate Location acsA       
  
aroE guaA mutL nuoD ppsA trpE
ST eBURST group exoS exoU serotype 
4785             N/A Sputum Boston, UK 7 22 5 3 3 14 19 101 4 N/A N/A N/A 
S2            
            
            
            
               
            
             
             
             
             
             
             
             
             
             
             
             
             
             
             
             
             
Dec-97 Sputum BC, Canada 28 38 5 3 3 14 19 159 4 N/A N/A N/A 
9028 N/A Sputum Poole, UK 28 5 5 3 3 14 19 171 4 N/A N/A N/A 
G1 1987 Sputum BC, Canada 28 22 5 3 3 14 19 175 4 N/A N/A N/A 
NIL:2427/06 2006 Urine Poland 28 22 5 3 3 14 19 175 4 N/A N/A N/A 
PSA046 N/A Corneal scrape London, UK 28 22 5 3 3 14 19 175 4 + - O:4
9956 N/A Sputum Trent, UK 28 22 5 3 3 14 19 175 4 N/A N/A N/A 
S1 May-88 Sputum BC, Canada 28 22 5 21 3 14 19 201 4 N/A N/A N/A 
10258 N/A Sputum London, UK 6 5 11 3 4 23 1 146 5 N/A N/A N/A 
RN64944 Jan-03 Sputum Hungary 11 20 1 65 45 4 10 343 5 N/A N/A N/A 
PS-227 N/A Sputum Birmingham, UK 6 5 11 81 4 23 1 374 5 N/A N/A N/A 
10105 N/A Sputum Manchester, UK 6 5 11 3 4 6 1 680 5 N/A N/A N/A 
10108 N/A Sputum Birmingham, UK 6 5 40 3 4 23 1 681 5 N/A N/A N/A 
8711 N/A Sputum Cardiff, UK 6 5 11 3 4 4 1 683 5 N/A N/A N/A 
565 2002 Bronchial lavage Russia 38 11 3 13 1 2 4 235 6 N/A N/A O:11 
P3303 2002 N/A Brazil 38 11 3 13 1 2 4 235 6 N/A N/A N/A 
06-116 2002 N/A Hungary 38 11 3 13 1 2 4 235 6 N/A N/A O:11 
3389 2003 N/A Russia 38 11 3 13 1 2 4 235 6 N/A N/A O:11 
1913 2003 N/A Russia 38 11 3 13 1 2 4 235 6 N/A N/A O:11 
2074 2003 N/A Russia 38 11 3 13 1 2 4 235 6 N/A N/A O:11 
05-176 2004 Soft tissue infection Serbia 38 11 3 13 1 2 4 235 6 N/A N/A O:11 
3107 2004 Sputum Russia 38 11 3 13 1 2 4 235 6 N/A N/A O:11 
MB197 2005 Blood culture Hungary 38 11 3 13 1 2 4 235 6 N/A N/A O:11 
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 Allelic profile 
Isolate name Date of isolation Source of isolate Location acsA       
  
aroE guaA mutL nuoD ppsA trpE
ST eBURST group exoS exoU serotype 
49010             2005 Bronchial lavage Hungary 38 11 3 13 1 2 4 235 6 N/A N/A N/A 
NIL:3220/05             
             
             
             
             
             
             
             
             
             
             
             
                
                
                
                
                
                
                
                
                
                
2005 Bronchial lavage Poland 38 11 3 13 1 2 4 235 6 N/A N/A N/A 
05-380 2005 N/A Hungary 38 11 3 13 1 2 4 235 6 N/A N/A O:11 
NIL:3816/05 2005 N/A Poland 38 11 3 13 1 2 4 235 6 N/A N/A N/A 
NIL:1900/06 2006 Bronchial lavage Poland 38 11 3 13 1 2 4 235 6 N/A N/A N/A 
06-150 2006 Soft tissue infection Hungary 38 11 3 13 1 2 4 235 6 N/A N/A O:11 
NIL:1186/06 2006 Urine Poland 38 11 3 13 1 2 4 235 6 N/A N/A N/A 
NIL:155/06 2006 Urine Poland 38 11 3 13 1 2 4 235 6 N/A N/A N/A 
NIL:4586/07 2007 Blood culture Poland 38 11 3 13 1 2 4 235 6 N/A N/A N/A 
NIL:2997/07 2007 Soft tissue infection Poland 38 11 3 13 1 2 4 235 6 N/A N/A N/A 
NIK:2913/07 2007 Urine Poland 38 11 3 13 1 2 4 235 6 N/A N/A N/A 
NIL:3459/07 2007 Urine Poland 38 11 3 13 1 2 4 235 6 N/A N/A N/A 
NIL:652/07 2007 Urine Poland 38 11 3 13 1 2 4 235 6 N/A N/A N/A 
PSA010 Mar-04 Corneal scrape Birmingham, UK 38 11 3 13 1 2 4 235 6 - + N/A
PSA098 N/A Corneal scrape Beijing, China 38 11 3 13 1 2 4 235 6 - + N/A
PSA117 N/A Corneal scrape Beijing, China 38 11 3 13 1 2 4 235 6 - + N/A
PSA033 N/A Corneal scrape Bristol, UK 38 11 3 13 1 2 4 235 6 - + O:11
PSA050 N/A Corneal scrape Bristol, UK 38 11 3 13 1 2 4 235 6 - + O:11
PSA031 N/A Corneal scrape London, UK 38 11 3 13 1 2 4 235 6 - + O:11
PSA078 N/A Corneal scrape London, UK 38 11 3 13 1 2 4 235 6 - + O:11
PSA025 N/A Corneal scrape Manchester, UK 38 11 3 13 1 2 4 235 6 - + O:11
PSA016 Sep-04 Corneal scrape Birmingham, UK 82 11 3 13 1 2 4 304 6 - + N/A
PSA053 N/A Corneal scrape London, UK 95 11 3 13 1 2 4 323 6 - + O:11
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 Allelic profile 
Isolate name Date of isolation Source of isolate Location acsA       
  
aroE guaA mutL nuoD ppsA trpE
ST eBURST group exoS exoU serotype 
PSA061                N/A Corneal scrape London, UK 4 11 3 13 1 2 4 342 6 - + O:11
8382             
             
             
                
                
                
            
             
             
             
             
             
             
             
             
             
             
N/A Sputum London, UK 4 4 16 24 1 6 3 109 7 N/A N/A N/A 
95149 2004 Bronchial lavage Hungary 4 4 16 12 1 6 3 253 7 N/A N/A N/A 
NIL:1185/2006 2006 Urine Poland 4 4 16 12 1 6 3 253 7 N/A N/A N/A 
PSA006 N/A Corneal scrape Birmingham, UK 4 4 16 12 1 6 3 253 7 - + N/A 
PSA045 N/A Corneal scrape London, UK 4 4 16 12 1 6 3 253 7 - + O:10
PSA044 N/A Corneal scrape Newcastle, UK 4 4 16 12 1 6 3 253 7 - + O:10
PSA038 N/A Corneal scrape London, UK 93 4 16 12 1 6 3 317 7 - + O:11
5757 N/A Sputum France 6 6 4 3 3 4 7 9 8 N/A N/A N/A 
8420 N/A Sputum N/A 6 6 4 3 20 4 7 118 8 N/A N/A N/A 
PSA005 Jul-04 Corneal scrape Birmingham, UK 6 28 4 3 3 4 7 252 8 + - N/A 
PS-39 N/A Sputum Birmingham, UK 6 5 36 63 4 30 2 231 9 N/A N/A N/A 
PS-70 N/A Sputum Birmingham, UK 6 5 36 63 4 49 2 370 9 N/A N/A N/A 
PS-257 N/A Sputum Birmingham, UK 6 5 36 63 4 30 59 376 9 N/A N/A N/A 
10106 N/A Sputum Manchester, UK 36 5 29 7 4 10 7 170 10 N/A N/A N/A 
PS-16 N/A Sputum Birmingham, UK 36 53 29 7 4 10 7 367 10 N/A N/A N/A 
PS-169 N/A Sputum Birmingham, UK 36 53 29 7 4 10 58 373 10 N/A N/A N/A 
PS-2 N/A Sputum Birmingham, UK 87 70 79 80 53 48 1 366 11 N/A N/A N/A 
PS-36 N/A Sputum Birmingham, UK 90 70 79 80 53 48 1 368 11 N/A N/A N/A 
PS-95 N/A Sputum Birmingham, UK 90 70 29 80 53 48 1 372 11 N/A N/A N/A 
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 Allelic profile 
Isolate name Date of isolation 
Source of 
isolate Location acsA       
  
aroE guaA mutL nuoD ppsA trpE
ST eBURST group exoS exoU serotype 
PA0062             Jun-02 Hospital sink Leeds, UK 3 5 5 4 4 4 3 54 12 N/A N/A N/A 
P12-Q             
             
             
             
             
                
               
               
               
               
             
             
             
             
             
                
                
                
                
                
                
1993 N/A France 17 5 5 4 4 4 3 111 12 N/A N/A O:12 
06-117 2002 N/A Hungary 17 5 5 4 4 4 3 111 12 N/A N/A O:12 
NIL:1010/06 2006 Urine Poland 17 5 5 4 4 4 3 111 12 N/A N/A N/A 
8722 N/A Sputum Belfast, UK 17 5 5 4 4 4 3 111 12 N/A N/A N/A 
8756 N/A Sputum France 17 5 5 4 19 4 3 113 12 N/A N/A N/A 
PSA020 N/A Corneal scrape London, UK 13 4 5 5 12 7 15 308 13 - + O:11
PSA072 N/A Corneal scrape Liverpool, UK 6 4 5 5 12 7 15 345 13 - + O:11
PSA018 N/A Corneal scrape Manchester, UK 33 59 60 3 1 6 4 306 14 - + O:11
PSA022 N/A Corneal scrape Manchester, UK 5 59 60 3 1 6 4 310 14 - + O:11
PSA049 N/A Corneal scrape Manchester, UK 14 5 10 7 4 13 7 260 15 + - O:6
PSA085 N/A Corneal scrape Beijing, China 14 63 10 7 4 13 7 264 15 N/A N/A N/A 
2620 2003 N/A Poland 17 5 12 3 14 4 7 244 16 N/A N/A N/A 
NIL:1659/06 2006 N/A Poland 17 5 12 3 14 4 7 244 16 N/A N/A N/A 
NIL:261/06 2006 Urine Poland 17 5 12 3 14 4 7 244 16 N/A N/A N/A 
NIK:981/06 2006 Urine Poland 17 5 12 3 14 4 7 244 16 N/A N/A N/A 
NIL:2498/07 2007 Urine Poland 17 5 12 3 14 4 7 244 16 N/A N/A N/A 
PSA107 N/A Corneal scrape Beijing, China 17 5 12 3 14 4 7 244 16 + - N/A
PSA120 N/A Corneal scrape Beijing, China 17 5 12 3 14 4 7 244 16 + - N/A
PSA122 N/A Corneal scrape Beijing, China 17 5 12 3 14 4 7 244 16 + - N/A
PSA043 N/A Corneal scrape London, UK 17 5 12 3 14 4 7 244 16 + - O:2
PSA051 N/A Corneal scrape London, UK 17 5 12 3 14 4 7 244 16 + - O:2
PSA073 N/A Corneal scrape London, UK 13 5 12 3 14 4 7 336 16 + - O:2
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 Allelic profile 
Isolate name Date of isolation 
Source of 
isolate Location acsA       
  
guaA mutL nuoD ppsA trpE
ST eBURST group exoS exoU serotype aroE
PS-175             N/A N/A N/A Sputum Birmingham, UK 85 1 59 6 1 33 42 237 17 N/A 
PS-82             
                
             
             
               
             
             
             
             
                
             
             
             
             
                
                
                
                
                
             
N/A Sputum Birmingham, UK 5 1 59 6 1 33 42 238 17 N/A N/A N/A 
PSA012 Sep-04 Corneal scrape Birmingham, UK 11 20 1 65 45 4 10 343 18 + - N/A 
PSA111 N/A Corneal scrape Beijing, China 11 20 1 65 4 4 10 381 18 + - N/A
PA0052 Aug-02 Sputum Lincoln, UK 11 5 12 12 1 6 3 45 19 N/A N/A N/A 
PA0060 Jun-02 Sputum Wycombe, UK 11 19 12 12 1 6 3 52 19 N/A N/A N/A 
PSA081 N/A Corneal scrape Beijing, China 3 5 72 13 2 4 26 355 20 + - N/A 
PSA083 N/A Corneal scrape Beijing, China 3 5 6 13 2 4 26 356 20 + - N/A
PS-4 N/A Sputum Birmingham, UK 16 5 5 74 2 10 10 350 21 N/A N/A N/A 
PS-98 N/A Sputum Birmingham, UK 16 5 5 79 2 10 10 354 21 N/A N/A N/A 
PA0045 Oct-02 Blood culture Wolverhampton, UK 4 5 16 3 1 4 13 38 22 N/A N/A N/A 
PA0053 Aug-02 Urine Lincoln, UK 4 5 16 3 1 17 13 46 22 N/A N/A N/A 
PSA066 N/A Corneal scrape London, UK 97 20 11 3 3 3 7 331 23 + - PME
PS-6 N/A Sputum Birmingham, UK 22 20 11 3 3 3 7 348 23 N/A N/A N/A 
9572 N/A Sputum Poole, UK 17 5 1 3 13 6 7 148 24 N/A N/A N/A 
9185 N/A Sputum London, UK 11 5 1 3 13 6 7 682 24 N/A N/A N/A 
9946 N/A Sputum Shrewsbury, UK 11 5 1 3 13 6 7 682 24 N/A N/A N/A 
PSA067 N/A Corneal scrape London, UK 98 5 57 13 1 40 3 332 25 - + O:8
PSA077 N/A Corneal scrape London, UK 11 5 57 13 1 40 3 340 25 - + O:8
PSA042 N/A Corneal scrape London, UK 94 7 63 13 8 7 8 320 26 - + O:11
PSA075 N/A Corneal scrape London, UK 33 7 63 13 8 7 8 338 26 - + O:11
PSA070 N/A Corneal scrape London, UK 6 20 1 3 4 4 2 132 27 + - O:6
8440 N/A Sputum Carmarthen, UK 6 20 1 3 4 4 2 132 27 N/A N/A N/A 
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 Allelic profile 
Isolate name Date of isolation 
Source of 
isolate Location acsA       
  
aroE guaA mutL nuoD ppsA trpE
ST eBURST group exoS exoU serotype 
PSA064                N/A Corneal scrape Bristol, UK 5 20 1 3 4 4 2 329 27 + - O:6
PSA058                
                
               
                
                
                
                
               
               
                
             
             
             
             
             
            
             
             
            
             
             
N/A Corneal scrape London, UK 35 1 25 6 6 7 5 325 28 - - PME
PSA062 N/A Corneal scrape London, UK 38 1 25 6 6 7 5 327 28 - - PME
8297 N/A Sputum Portsmouth, UK 13 8 9 3 1 9 9 16 29 N/A N/A N/A
PSA105 N/A Corneal scrape Beijing, China 13 8 9 3 1 6 9 316 29 - + N/A
PSA109 N/A Corneal scrape Beijing, China 13 8 9 3 1 6 9 316 29 - + N/A
PSA037 N/A Corneal scrape London, UK 13 8 9 3 1 6 9 316 29 - + O:11
PSA032 N/A Corneal scrape Manchester, UK 13 8 9 3 1 6 9 316 29 - + O:11
PSA021 N/A Corneal scrape Bristol, UK 13 8 9 3 1 17 15 309 30 - + O:1
PSA024 N/A Corneal scrape Bristol, UK 13 8 9 3 1 17 15 309 30 - + O:11
PSA023 N/A Corneal scrape Manchester, UK 13 8 9 3 1 17 4 311 30 - + O:11
8237 N/A Sputum London, UK 10 4 5 10 1 6 3 13 N/A N/A N/A 
PA0020 Feb-03 Sputum Stafford, UK 6 4 1 11 4 7 10 18 N/A N/A N/A 
PA0021 Feb-03 Sputum Dudley, UK 14 9 10 6 6 10 5 19 N/A N/A N/A 
PA0022 Feb-03 Sputum Cheshire, UK 15 5 11 3 1 7 11 20 N/A N/A N/A 
PA0024 Jan-03 Sputum Bedford, UK 16 5 12 11 1 2 1 21 N/A N/A N/A 
PA0025 Jan-03 Tissue Sample Northampton, UK 6 4 4 3 3 11 2 22 N/A N/A N/A 
PA0027 Jan-03 Urine Tyne and Wear, UK 18 4 5 5 5 4 4 23 N/A N/A N/A 
PA0034 Dec-02 Blood culture London, UK 15 10 11 3 2 7 12 28 N/A N/A N/A 
PA0039 Nov-02 Intravenous Line London, UK 18 13 13 11 11 4 14 32 N/A N/A N/A 
PA0041 Nov-02 Sputum Luton, UK 4 5 16 3 3 7 3 34 N/A N/A N/A 
PA0042 Oct-02 Sputum Glasgow, UK 22 14 17 3 3 6 7 35 N/A N/A N/A 
PA0044 Oct-02 Blood culture Leeds, UK 23 16 11 4 4 6 3 37  N/A N/A N/A 
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 Allelic profile 
Isolate name Date of isolation 
Source of 
isolate Location acsA       
  
aroE guaA mutL nuoD ppsA trpE
ST eBURST group exoS exoU serotype 
PA0046             Oct-02 Blood culture Folkestone, UK 18 5 5 3 1 6 13 39 N/A N/A N/A 
PA0047 Sep-02 Tissue Sample Chelsea, UK 4 5 16 11 11 7 14 40  N/A N/A N/A 
PA0055 Jul-02 Blood culture Newcastle, UK 6 5 4 13 1 4 4 48  N/A N/A N/A 
PA0061             
             
             
            
             
             
             
             
             
             
             
             
             
             
            
             
             
             
Jun-02 Sputum Brighton, UK 11 5 19 4 4 4 3 53 N/A N/A N/A 
PA0063 Jun-02 Blood culture Bedford, UK 27 5 20 13 1 2 8 55 N/A N/A N/A 
PA0064 Jun-02 Tissue Sample Telford, UK 13 17 5 14 3 6 19 56 N/A N/A N/A 
PA0068 May-02 Tissue Sample London, UK 28 4 17 15 4 4 3 60 N/A N/A N/A 
PA0069 May-02 Sputum Gloucester, UK 13 4 9 3 1 6 11 61 N/A N/A N/A 
PA0071 Apr-02 Urine Ormskirk, UK 5 4 21 5 12 10 15 63 N/A N/A N/A 
PA0074 Mar-02 Blood culture Dorset, UK 30 10 23 5 4 2 7 66 N/A N/A N/A 
PA0080 Feb-02 Sputum York, UK 4 4 16 19 13 10 23 72 N/A N/A N/A 
PA0082 Jan-02 Blood culture Wycombe, UK 4 5 1 19 13 7 23 74  N/A N/A N/A 
PA0084 Jan-02 Skin swab London, UK 17 21 12 5 1 17 1 76 N/A N/A N/A 
PA0085 Jan-02 Hospital floor London, UK 17 22 12 12 1 18 3 77 N/A N/A N/A 
PA0086 Dec-01 Catheter Stoke, UK 11 11 11 3 3 19 19 78 N/A N/A N/A 
PA0088 Dec-01 Trachea London, UK 35 23 27 6 6 4 5 80 N/A N/A N/A 
PA0093 Nov-01 Tissue Sample Folkestone, UK 11 5 1 3 14 17 7 83  N/A N/A N/A 
PA0101 Sep-01 Blood culture Windsor, UK 17 5 5 1 1 21 1 91 N/A N/A N/A 
PA0103 Sep-01 Blood culture Leeds, UK 22 5 11 13 1 15 4 93 N/A N/A N/A 
PA0104 Aug-01 Hospital floor Leicester, UK 24 5 3 5 16 6 28 94 N/A N/A N/A 
PA0107 Aug-01 Sputum Leicester, UK 6 5 1 11 17 7 2 96 N/A N/A N/A 
PA0109 Jul-01 Blood culture Cheshire, UK 41 12 4 3 3 4 14 98 N/A N/A N/A 
6950 N/A Sputum Southport, UK 15 5 5 3 4 4 3 102 N/A N/A N/A 
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 Allelic profile 
Isolate name Date of isolation 
Source of 
isolate Location acsA       
  
aroE guaA mutL nuoD ppsA trpE
ST eBURST group exoS exoU serotype 
7186             N/A Sputum Truro, UK 17 5 12 22 14 22 29 103 N/A N/A N/A 
7215             
             
             
             
                
             
             
             
             
             
             
             
             
             
             
             
            
             
                
            
             
                
N/A Sputum Bath, UK 4 4 16 3 1 6 30 104 N/A N/A N/A 
8113 N/A Sputum N/A 22 20 11 23 1 3 3 106 N/A N/A N/A 
8202 N/A Sputum London, UK 4 4 16 21 1 6 1 107 N/A N/A N/A 
8318 N/A Sputum Sutton, UK 39 5 20 5 1 6 31 108 N/A N/A N/A 
PSA103 N/A Corneal scrape Beijing, China 15 5 1 3 2 12 7 110 + - N/A
8623 N/A Sputum UK 15 5 1 3 2 12 7 110 N/A N/A N/A 
8734 N/A Sputum Stoke, UK 6 5 1 25 1 12 1 112 N/A N/A N/A 
7916 N/A Sputum Bristol, UK 17 22 5 3 4 14 3 120 N/A N/A N/A 
7193 N/A Sputum N/A 11 5 7 27 1 7 33 121 N/A N/A N/A 
5798 Jan-03 Sputum Sheffield, UK 17 5 5 1 10 12 2 123 N/A N/A N/A 
PA0111 Jul-01 Blood Culture London, UK 5 27 5 13 1 13 4 126 N/A N/A N/A 
8405 N/A Sputum Bangor, UK 43 30 31 26 4 24 32 127 N/A N/A N/A 
8103 N/A Sputum London, UK 1 20 32 3 4 25 3 133 N/A N/A N/A 
7306 N/A Sputum Cumbria, UK 6 20 11 7 1 12 19 134 N/A N/A N/A 
K1SIB1 Feb-90 Sputum BC, Canada 1 5 7 5 4 4 2 192 N/A N/A N/A 
8715 N/A Sputum Birmingham, UK 28 5 11 18 4 13 3 217 N/A N/A N/A 
WID283-
D06 2005 Sputum UK 16 5 30 11 4 31 41 233 N/A N/A N/A 
NIL:2026/05 2005 Urine Poland 16 5 30 11 4 31 41 233 N/A N/A N/A 
PSA112 N/A Corneal scrape Beijing, China 16 5 30 11 4 31 41 233 + - N/A
PS-19 N/A Sputum Birmingham, UK 28 5 1 5 4 32 10 236 N/A N/A N/A 
245 2005 Urine Poland 39 6 12 11 3 15 2 245 N/A N/A N/A 
PSA056 N/A Corneal scrape London, UK 39 6 12 11 3 15 2 245 + - PME
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 Allelic profile 
Isolate name Date of isolation Source of isolate Location acsA       
  
aroE guaA mutL nuoD ppsA trpE
ST eBURST group exoS exoU serotype 
PSA082 N/A Corneal scrape Beijing, China 5 62 67 3 1 16 50 246  N/A N/A N/A 
PSA084 N/A Corneal scrape Beijing, China 101 5 11 5 4 4 7 247  N/A N/A N/A 
PSA090             
                
             
             
             
                
                
                
                
                
                
                
N/A Corneal scrape Beijing, China 38 64 69 13 1 2 51 248 N/A N/A N/A 
PSA001 Aug-03 Corneal scrape Birmingham, UK 18 54 5 5 1 6 8 249  - + N/A 
PSA079 N/A Corneal scrape Birmingham, UK 18 54 5 5 1 6 8 249  - + O:11 
PSA015 Sep-04 Corneal scrape Birmingham, UK 28 5 36 3 1 13 7 250 + - N/A
PSA080 N/A Corneal scrape Beijing, China 28 61 66 6 1 33 55 263  N/A N/A N/A 
PSA088 N/A Corneal scrape Beijing, China 36 5 68 3 4 10 7 265 N/A N/A N/A 
PSA093 N/A Corneal scrape Beijing, China 16 5 11 72 44 7 52 266  N/A N/A N/A 
PSA094 N/A Corneal scrape Beijing, China 19 5 12 11 11 4 14 267  N/A N/A N/A 
PSA095 N/A Corneal scrape Beijing, China 23 5 70 7 1 12 7 268 N/A N/A N/A 
PSA097 N/A Corneal scrape Beijing, China 6 5 11 3 4 3 7 269  N/A N/A N/A 
PSA096 N/A Corneal scrape Beijing, China 22 3 17 5 2 10 7 270 N/A N/A N/A 
PSA099 N/A Corneal scrape Beijing, China 102 24 37 5 4 7 7 271  N/A N/A N/A 
PSA002 May-04 Corneal scrape Birmingham, UK 44 8 5 3 15 6 26 296  - + N/A 
PSA026 N/A Corneal scrape Newcastle, UK 44 8 5 3 15 6 26 296  - + O:1 
PSA003 Feb-04 Corneal scrape Birmingham, UK 91 4 5 5 5 20 4 297 - + N/A
PSA004 Jun-04 Corneal scrape Birmingham, UK 18 4 13 3 1 17 13 298 - + N/A
PSA007 Aug-04 Corneal scrape Birmingham, UK 17 5 36 3 3 7 3 299 + - N/A
PSA008 Aug-04 Corneal scrape Birmingham, UK 5 55 7 61 1 4 45 300 + - N/A
PSA009 Jun-03 Corneal scrape Birmingham, UK 38 4 57 62 1 1 26 301 - + N/A
PSA011 Aug-00 Vitreous humour Birmingham, UK 17 5 5 13 45 4 3 302 + - N/A
PSA013 Oct-04 Corneal scrape Birmingham, UK 16 5 12 11 3 4 18 303 + - N/A
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 Allelic profile 
Isolate name Date of isolation Source of isolate Location acsA       
  
aroE guaA mutL nuoD ppsA trpE
ST eBURST group exoS exoU serotype 
PSA017                 N/A Corneal scrape Liverpool, UK 92 8 11 11 4 43 7 305 + + O:4
PSA019                
               
            
                
                
                
                
                
                
                
                
                
                
                
                
                
                
                
             
             
             
N/A Corneal scrape London, UK 32 11 61 13 1 6 54 307 - + O:11
PSA027 N/A Corneal scrape Bristol, UK 5 3 57 6 1 33 47 312 - + O:1
05-97 2005 Soft tissue infection Hungary 47 8 7 6 8 11 40 313 N/A N/A O:1 
PSA030 N/A Corneal scrape Liverpool, UK 47 8 7 6 8 11 40 313 - + O:1
PSA035 N/A Corneal scrape London, UK 6 4 62 66 3 6 26 314 + - O:11
PSA052 N/A Corneal scrape London, UK 6 4 62 66 3 6 26 314 + - O:11
PSA036 N/A Corneal scrape Birmingham, UK 5 4 57 62 1 18 26 315 - + O:11
PSA034 N/A Corneal scrape London, UK 5 4 3 3 1 11 8 319 - + O:11
PSA040 N/A Corneal scrape London, UK 5 4 3 3 1 11 8 319 - + O:11
PSA057 N/A Corneal scrape Newcastle, UK 18 8 27 68 15 7 3 324  - - O:8 
PSA060 N/A Corneal scrape London, UK 96 4 16 12 1 7 3 326 - + O:10
PSA063 N/A Corneal scrape London, UK 33 56 65 5 1 10 49 328 - + O:1
PSA065 N/A Corneal scrape London, UK 6 20 36 67 1 6 3 330 - + O:10
PSA068 N/A Corneal scrape Newcastle, UK 33 5 1 13 4 4 7 333 + - O:1
PSA071 N/A Corneal scrape Bristol, UK 99 57 1 5 47 24 2 335 + - O:6
PSA074 N/A Corneal scrape London, UK 17 58 21 17 10 16 22 337 - + O:4
PSA014 Nov-01 Vitreous humour Birmingham, UK 5 14 25 3 1 16 46 341 - + N/A
PSA041 N/A Corneal scrape London, UK 81 8 5 67 1 40 13 344 - + O:1
PSA059 N/A Corneal scrape Manchester, UK 33 60 64 69 48 24 48 346 + - O:3
PS-3 N/A Sputum Birmingham, UK 40 5 17 5 4 15 7 347 N/A N/A N/A 
PS-58 N/A Sputum Birmingham, UK 89 30 64 78 48 24 32 349 N/A N/A N/A 
PS-130 N/A Sputum Birmingham, UK 106 66 11 3 29 4 9 351 N/A N/A N/A 
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 Allelic profile 
Isolate name Date of isolation 
Source of 
isolate Location acsA       
  
aroE guaA mutL nuoD ppsA trpE
ST eBURST group exoS exoU serotype 
PS-202             N/A Sputum Birmingham, UK 107 3 20 62 4 7 3 352 N/A N/A N/A 
NIL:2646/06            
               
                
                
                
                
                
             
                
                
                
                
                
                
                
2006 Urine Poland 2 4 5 3 1 6 11 357 N/A N/A N/A 
PSA087 N/A Corneal scrape Beijing, China 2 4 5 3 1 6 11 357 - + N/A
PSA101 N/A Corneal scrape Beijing, China 41 5 26 3 1 15 18 358 + + N/A
PSA114 N/A Corneal scrape Beijing, China 41 5 26 3 1 15 18 358 + + N/A
PSA104 N/A Corneal scrape Beijing, China 111 30 80 26 54 44 32 359 - - N/A
PSA113 N/A Corneal scrape Beijing, China 15 5 36 11 27 4 2 360 + - N/A
PSA121 N/A Corneal scrape Beijing, China 35 8 82 3 15 7 3 361 - + N/A
PS-47 N/A Sputum Birmingham, UK 1 5 20 16 3 4 7 369 N/A N/A N/A 
PSA092 N/A Corneal scrape Beijing, China 103 8 5 5 1 6 4 377 - + N/A
PSA106 N/A Corneal scrape Beijing, China 1 14 3 11 1 15 1 378 + - N/A
PSA108 N/A Corneal scrape Beijing, China 39 5 11 28 4 4 63 379 + - N/A
PSA115 N/A Corneal scrape Beijing, China 113 5 81 3 1 6 25 382 - + N/A
PSA116 N/A Corneal scrape Beijing, China 35 8 27 3 15 45 3 383 - - N/A
PSA118 N/A Corneal scrape Beijing, China 17 5 11 3 52 4 2 384 + - N/A
PSA119 N/A Corneal scrape Beijing, China 15 5 5 5 50 4 14 385 + - N/A
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 Table 6.2 Characteristics of the genes used in the P. aeruginosa MLST scheme (based on the study population) 
 
Gene Size of fragment sequenced (bp) 
No. of distinct 
alleles 
No. of polymorphic 
sites 
Proportion of 
polymorphic sites (%) 
Mean G+C 
content (%) 
 
dN/dS
acsA 390      59 53 13.6 66.8 0.0725
aroE 498      39 87 17.5 70.5 0.1320
guaA 373      47 32 8.6 65.7 0.0357
mutL 442      40 48 10.9 67.3 0.0440
nuoD 366      30 30 8.2 63.3 0.0090
ppsA 370      34 53 14.3 66.8 0.0435
trpE 443      42 41 9.3 66.2 0.0250
Mean       412 42 49 11.8 66.9 0.0517
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Chapter 6  P. aeruginosa MLST 
 
6.3.2 Analysis of P. aeruginosa isolates by ST 
From the 283 P. aeruginosa isolates analysed in the study population, 200 STs 
were generated. ST-235 was found to be the most common ST (n=30; 15%). This 
genotype was found in a variety of geographical locations (Russia, Brazil, 
Hungary, Poland, Serbia, China and UK) and from a wide range of infections 
(keratitis, soft tissue infection, sputum from CF patients, blood culture and urinary 
tract infections). Ten isolates were assigned ST-244, nine isolates were assigned 
ST-17, seven isolates were assigned ST-27 and five isolates were assigned ST-
253. Again, these genotypes were associated with different geographical locations 
and clinical diseases. ST-111, ST-175 and ST-316 were assigned to four isolates 
each. ST-187 and ST-233 had three isolates each. 14 of the STs had 2 isolates 
each and the remaining 176 isolates had a unique ST. The relatively high number 
of STs generated indicates that there is frequent alteration in the genetic structure 
of P. aeruginosa, either by point mutation or recombination.   
 
6.3.3 Phylogenetic analysis 
 
6.3.3.1 Phylogenetic trees 
Phylogenetic analysis was carried out on the 200 P. aeruginosa STs as described 
in section 2.13.6. Figure 6.1 is a Neighbour-Joining dendrogram based on allelic 
profiles of the 200 STs. eBURST groups 1-6 (Section 6.3.3.2) are highlighted. All 
30 clonal complexes identified by the BURST analysis are marked by a red dot. 
Each clonal complex consists of STs that have 6 or more alleles in common 
(SLVs). The STs did not sub-divide into distinct lineages as was the case in P. 
acnes. This data suggests that there is frequent point mutation or recombinational 
events leading to P. aeruginosa having a non-clonal population structure. 
 
Neighbour-Joining dendrogram of concatenated sequences divides the STs into 
numerous clusters (Figure 6.2). One particular cluster, consisting of three isolates 
represented by three different STs (ST-366, ST-368 and ST-372), is significantly 
different to the remaining isolates. These isolates were all cultures from sputum 
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samples from CF patients in Birmingham. Comparison of concatenated sequences 
of ST-366 and a randomly selected ST from the main cluster (ST-9) showed 4.6% 
sequence diversity, compared to 1.02% overall sequence diversity of all STs. 
More detailed analysis of individual loci is described in Section 6.3.4.2. The 
existence of this smaller cluster suggests that although P. aeruginosa has a non-
clonal structure, occasional epidemic clones or clonal complexes emerge. This 
cluster was not identified from the dendrogram of allelic profiles because the 
frequency of polymorphisms is not weighted and so one point mutation at a locus 
will change the allelic profile in the same way that multiple polymorphisms 
would. The existence of this epidemic clone is also demonstrated using split 
decomposition analysis (Section 6.3.4.2).  
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Figure 6.1 Unrooted Neighbour-Joining dendrogram based on allelic profiles of the 
200 P. aeruginosa STs (Jukes-Cantor-based algorithm, 1,000 bootstrap replications). 
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Figure 6.2 Unrooted Neighbour-Joining dendrogram of the 200 P. aeruginosa STs 
based on concatenated sequences of the seven housekeeping genes (with Jukes-
Cantor-based algorithm, 1,000 bootstrap replications). 
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6.3.3.2 eBURST analysis 
eBURST analysis was carried out on the P. aeruginosa MLST data, which divides 
genotypes into eBURST groups. Genotypes within an eBURST group have at 
least six or more loci in common (SLV) (Feil et al., 2004). 91 of the 200 STs 
generated from 283 isolates were divided into thirty eBURST groups (or clonal 
complexes) (Figure 6.3). The remaining 109 STs were singletons, i.e. they did not 
have any SLVs. eBURST group 1 was made up of 9 individual STs, eBURST 
group 2 had 8 STs and eBURST group 3 had 6 STs. Both eBURST groups 4 and 5 
had 5 STs each. eBURST group 6 had only 4 STs but made up from 33 isolates. 
This is due to the large number of ST-235 isolates (n=30). The remaining 
eBURST groups were made up of 2 or 3 STs each.  
 
Figure 6.3 show SLV connected by a pink line and Figure 6.4 has DLV shown in 
addition to the SLV. These clusters suggest the existence of epidemic clonal 
complexes within the study population, although none of the eBURST groups 
were associated with a particular geographical location or clinical disease. Figure 
6.5 looks more closely at strains from eye infections. STs associated with keratitis 
or endophthalmitis infections are circled in red and those associated with both eye 
infections and other clinical infections are shaded in red. The eBURST diagram 
shows that there were no clonal complexes made up of three or more STs that 
were associated exclusively with eye infections. There were eight clonal 
complexes made up of two different STs that were only found in eye infections. 
However, there were too few isolates within each of these clonal complexes to 
conclude if they were solely associated with eye infections.     
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Figure 6.3 eBURST diagram showing the clusters of related P. aeruginosa STs and individual unlinked STs. Thirty clonal complexes are 
identified. SLVs are shown as pink lines. 
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Figure 6.4 eBURST diagram showing the clusters of related P. aeruginosa STs and individual unlinked STs. Thirty clonal complexes are 
identified. SLVs are shown as pink lines and DLVs are shown in blue 
.  
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Figure 6.5 Association between sources of P. aeruginosa infection and eBURST groups. STs associated with eye infections are circled in red and 
those associated with eye infections and other clinical infections are in shaded circles.  
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6.3.4 Analysis of recombination 
 
6.3.4.1 Index of Association 
IA values provides an estimate of the extent of linkage equilibrium within a 
population (Haubold & Hudson, 2000). The IA value calculated using LIAN 3.5 
(Section 2.16.5) was 0.1835 (P<0.001) for all 283 isolates and 0.0636 (P<0.001) 
when a representative of each ST was included (n=200). An IA value not 
significantly greater than 0 after 1,000 computer randomisations indicates that the 
loci within the study population are in linkage equilibrium and therefore are freely 
recombining. The low IA value supports the theory that overall, the population 
structure of P. aeruginosa is non-clonal.  
 
6.3.4.2 Splits decomposition analysis 
As discussed in section 4.3.3.3, the split decomposition algorithm generates a 
network structure from the MLST data which allows the degree of recombination 
to be estimated. Split decomposition analysis of the P. aeruginosa MLST data 
was carried out using SplitsTree v4.1 (Huson & Bryant, 2006). Figure 6.6 shows 
the splits dendrogram based on allelic profiles of the 200 STs. The ‘splits’ indicate 
the partition of the taxa and the length of the edge is proportional to the weight of 
the associated split (Huson, 1998). There appears to be no distinct clusters of 
strains and the abundance of networks and splits demonstrates that recombination 
has had a huge contribution in shaping the genetic diversity within P. aeruginosa.     
 
Splits decomposition based on concatenated sequences (Figure 6.7) however, 
gives a slightly different picture. Although there are still numerous parallelogram 
structures formed between the majority of strains, three STs (ST-366, ST-368 and 
ST-372) did cluster away significantly from the other strains. This cluster of 
strains form eBURST group 11 (Section 6.3.3.2) and were also identified as a 
distinct cluster from the Neighbour-Joining dendrogram based on concatenated 
sequences (Figure 6.2). Comparisons were made between sequences of the allele 
from ST-366 and ST-9 (a randomly selected genotype from the main cluster). 
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This value was compared to the overall sequence divergence of each allele for all 
STs (Table 6.3). The sequence divergence of aroE is significantly higher between 
ST-9 and ST-366 (13.86% vs 1.71%) indicating that there is significant 
recombination at this locus. This is also the case for alleles ppsA and mutL (Table 
6.3). The sequence divergence of acsA between ST-9 and ST-366 is also slightly 
higher than the overall sequence divergence (2.34% vs 1.71%). The concatenated 
sequence divergence between ST-9 and ST-366 was 4.6%, compared to the 
overall concatenated sequence divergence of 1.02%. Therefore, this group of 
isolates (eBURST group 11) have evolved from the main cluster of P. aeruginosa 
strains through extensive recombination. These strains were all from sputum 
samples taken from different CF patients in Birmingham. This observation further 
confirms that P. aeruginosa has a non-clonal population structure with emergence 
of epidemic clones or clonal complexes.    
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Figure6.6 Splits decomposition analysis based on allelic profiles of the 200 P. 
aeruginosa STs. 
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Figure 6.7 Splits decomposition analysis based on concatenated sequences of the 
seven housekeeping genes of the 200 P. aeruginosa STs. 
 
 
 ST-366, ST-368, ST-372
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Table 6.3 Sequence divergence between P. aeruginosa MLST alleles. The overall 
percentage divergence of all 200 P. aeruginosa STs and the percentage divergence 
between ST-9 and ST-366 are shown. 
 
 
Housekeeping 
gene 
Overall sequence 
divergence (%) 
Sequence divergence between 
ST-9 and ST-366 (%) 
acsA 1.71 2.34 
aroE 2.30 13.86 
guaA 1.14 1.08 
mutL 1.02 3.47 
nuoD 1.28 1.94 
ppsA 1.59 8.23 
trpE 1.64 0.23 
Concatenated 1.02 4.60 
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6.3.5 Type III secretion system 
 
6.3.5.1 Determination of TTSS effector genotypes  
An important characteristic of P. aeruginosa, which allow it to cause a diverse 
range of clinical infections, is its ability to disrupt the functions of epithelial 
surfaces. This is partly achieved via a type III secretion system (TTSS). Four 
toxins (ExoS, ExoT, ExoU and ExoY) are known to be produced and secreted by 
P. aeruginosa, leading to the disruption of vital eukaryotic cellular signalling 
pathways (Lyczak et al., 2000). Studies have shown that P. aeruginosa isolates 
generally exhibit either cytotoxicity or invasion phenotypes, and these correspond 
to the secretion of ExoU and ExoS, respectively. Strains secreting ExoU remain 
extracellular promoting cells death via an acute cytotoxic process and those 
secreting ExoS become internalised and bring about apoptosis (Ha & Jin, 2001).  
 
In order to determine the TTSS effector genotype of P. aeruginosa strains from 
eye infections, PCR reactions to detect exoU and exoS were carried out on 105 P. 
aeruginosa eye isolates using methods described in Section 2.14 (Table 6.4). 
Although this data was already available for 42 of the P. aeruginosa isolates from 
a previous study (Winstanley et al., 2005), the PCR assay was repeated for these 
isolates, which generated the same results. Overall, more isolates possessed the 
exoS–/exoU+ genotype (n=53, 50.5%) than the exoS+/exoU– genotype (n=44, 
41.9%), i.e. more cytotoxic strains than invasive strains (although this is not 
statistically significant (p=0.27, Fisher’s exact test). Three isolates possessed both 
exoS and exoU genes (One was a corneal scrape specimen from Liverpool [ST-
305], and two were corneal scrape specimens from Beijing, both being ST-358). 
In five of the isolates, neither gene was detected (two ST-28 strains from London, 
one ST-324 from Newcastle, one ST-359 and one ST-383 both from Beijing). 
When a representative of each ST was used instead (to exclude bias due to 
presence of clones), the number of exoS+/exoU– genotype (n=39, 41.1%) was 
marginally more than exoS–/exoU+ genotype (n=37, 38.9%) (p=0.88).   
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Analysis of only the UK isolates showed that more isolates possessed the exoS–
/exoU+ genotype (n=45, 57%) than the exoS+/exoU– genotype (n=30, 38%) 
(p<0.05). In contrast, the Chinese isolates showed more exoS+/exoU– genotype 
(n=14, 53.8%) than exoS–/exoU+ genotype (n=8, 30.8%) although this was not 
statistically significant (p=0.16).  
 
The current study data confirms that the exoU and exoS genes are almost mutually 
exclusive (Berthelot et al., 2003; Feltman et al., 2001; Fleiszig et al., 1997; 
Lomholt et al., 2001). When a representative of each ST was included in the 
analysis, the proportion of strains possessing the exoU genotype was similar to the 
number possessing the exoS genotype. This is comparable to a previous study by 
Zhu et al. who also found no significant difference between the number of strains 
carrying the exoU gene (n=20, 43%) and those carrying the exoS (n=23, 50%) 
gene amongst 46 P. aeruginosa strains cultured from eye infections (Zhu et al., 
2006). Lombolt et al. showed that amongst 61 keratitis cases, exoU and exoS 
genotypes were evenly distributed (Lomholt et al., 2001). Interestingly, when all 
145 isolates were analysed, including isolates from a variety of clinical infections 
and environmental sources, the strains were found to possess predominantly exoS 
genotype (n=95, 66%). Similarly, a study of 115 clinical and environmental 
isolates which did not include any eye infection isolates, found that the majority 
(n=83, 72%) possessed the exoS gene and only 32 (28%) possessed the exoU gene 
(Feltman et al., 2001). Berthelot et al. also demonstrated a higher proportion of 
exoS genotype strains (n=63, 68%) than exoU genotype strains (n=27, 29%) 
amongst 92 bacteraemia isolates from six different French hospitals (Berthelot et 
al., 2003). They also reported a statistically significant correlation between the 
presence or absence of the exoU and exoS genes and TTSS protein secretion 
(Feltman et al., 2001). Therefore, PCR screening of exoU and exoS genes can give 
an indication of the probable secretion phenotype. 
 
P. aeruginosa strains resistant to contact lens-disinfecting solutions have been 
associated with the cytotoxic phenotype (Lakkis & Fleiszig, 2001). Zhu et al. also 
identified a significant correlation between multidrug resistance, the cytotoxic 
phenotype and serotype O:11 (Zhu et al., 2006). 23 (39%) of the 59 P. aeruginosa 
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eye isolates in the current study population were observed to harbour the exoU 
gene and belong to serotype O:11. Therefore, a significant proportion may be 
multidrug resistant and the management of these infections would differ from 
standard regimens.   
 
6.3.5.2 Correlation between MLST, TTSS genotyping and serotyping 
Where TTSS genotype data was available, isolates with the same ST were found 
to have the same TTSS genotype. Isolates belonging to the same eBURST group 
were found to have the same TTSS genotype (Table 6.1). Therefore, MLST 
analysis corresponded well with TTSS genotyping data. Lomholt et al. also found 
a strong correlation between exoU genotype and enzymes types based on MLEE 
data of 145 P. aeruginosa strains (Lomholt et al., 2001).  
 
Of the 283 P. aeruginosa isolates in the study population, 76 isolates had serotype 
data available, either from the P. aeruginosa MLST website or from previous 
studies (http://pubmlst.org/paeruginosa) (Curran et al., 2004; Winstanley et al., 
2005). Serotype data for 63 of the eye isolates were available from a previous 
study (Winstanley et al., 2005). 59 of the 63 isolates were assigned to seven 
different O-serotype groups: O:1, O:2, O:4, O:6, O:8, O:10 and O:11. The 
remaining four isolates gave agglutination with the polyvalent PME serum but 
failed to agglutinate with monovalent sera (Winstanley et al., 2005). Serotypes 
O:11 and O:1 were the most commonly found serotypes (42.4% and 25.4%, 
respectively) (Table 6.5). There was good correlation between MLST data and 
serotype data. Of the 59 isolates which were serotyped, isolates with same ST also 
had the same serotype, with one exception (Table 6.1). Isolate PSA021 and 
PSA024 were both ST-309 strains and belong to eBURST group 30. However, 
isolate PSA021 was serotype O:1 whereas isolate PSA024 was serotype O:11.  
 
There was also good correlation between eBURST groups and serotype data. The 
majority of strains belonging to the same eBURST group also had the same 
serotype. The only exception was eBURST group 7 where two isolates from this 
group were serotype O:10 and one isolate was serotype O:11. Strains with the 
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same serotype were not exclusively found in one eBURST group. Serotype O:1 
strains were found in eBURST groups 1, 2 and 30. Serotype O:6 strains were 
found in eBURST groups 3 and 27. Serotype O:11 strains were found in eBURST 
groups 6, 7, 13, 14, 26 and 30. This suggests that although MLST data generally 
correlates well with serotyping data, MLST analysis is more discriminative than 
serotyping for P. aeruginosa.    
 
Previously published serotype data available for 59 of the P. aeruginosa eye 
infection isolates within the current study population (Winstanley et al., 2005) 
showed that strains having the exoU genotype were associated with serotypes O:8, 
O:10 and O:11 (Table 6.5). ExoS genotype strains were associated with serotypes 
O:2, O:4 and O:6. Serotype O:1 strains were associate with both genotypes 
although more so with the exoS than the exoU genotype.  
 
Berthelot et al. observed a statistically significant correlation between O serotype 
and TTSS genotype (Berthelot et al., 2003). In their study of P. aeruginosa 
bacteraemic isolates, all strains belonging to serotypes O:1, O:10 or O:11 (n=24), 
except for one, harboured the exoU gene and all strains belonging to serotypes 
O:3, O:4, O:6, O:12, or O:16 (n=64), except one, harboured the exoS gene 
(Berthelot et al., 2003). In contrast, lung infections strains belonging to serotype 
O:1 more frequently harbour the exoS gene (Faure et al., 2003). Zhu et al. 
observed that eye infection strains carrying the exoS gene were more frequently 
associated with serotypes O:1, O:3, O:6 and O:16; and those carrying the exoU 
gene were associated with serotypes O:7, O:8 and O:11 (Zhu et al., 2006). It has 
been postulated that the relationship between serotype and TTSS may be brought 
about by genomic linkages (Zhu et al., 2006). The exoU gene is located adjacent 
to an insertion-like element that demonstrates homology with an insertion-like 
sequence that determines the serotype of P. aeruginosa (Raymond et al., 2002).  
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Table 6.4 TTSS genotype of 105 P. aeruginosa isolates from eye infections. Isolates 
from China are compared to those from the UK 
 
exoS exoU 
No. of UK 
isolates (%) 
No. of Chinese 
isolates (%) 
Total no. of 
isolates (%) 
+ + 1 (1.3%) 2 (7.7%) 3 (2.9%) 
- - 3 (3.8%) 2 (7.7%) 5 (4.8%) 
+ - 30 (38%) 14 (53.8%) 44 (41.9%) 
- + 45 (57%) 8 (30.8%) 53 (50.5%) 
 Total 79 26 105 
 
 
 
 
 
Table 6.5 TTSS genotype and serotype of 59 P. aeruginosa isolates from eye 
infections. Serotype data from Winstanley et al. (Winstanley et al., 2005). 
 
Serotype 
exoS exoU 
O:1 O:2 O:4 O:6 O:8 O:10 O:11 
+ + 0 0 1 0 0 0 0 
- - 0 0 0 0 1 0 0 
+ - 9 3 2 5 0 0 2 
- + 6 0 1 0 2 4 23 
 Total 
15 
(25.4%) 
3  
(5.1%) 
4 
(6.8%) 
5 
(8.5%) 
3 
(5.1%) 
4 
(6.8%) 
25 
(42.4%) 
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6.4  Future work 
Serotype and TTSS data available for a selection of P. aeruginosa eye infection 
isolates has generally correlated well with MLST data. However, this association 
would need to be verified by serotyping and determining the TTSS genotype of 
the remaining P. aeruginosa infections isolates. The presence of the exoU or exoS 
gene does not necessarily equate to protein expression and therefore the 
production of these exotoxins should be determined to confirm the virulence of 
these strains. As previously suggested by Zhu et al., P. aeruginosa strains 
possessing the cytotoxic phenotype may be associated with multidrug resistance 
(Zhu et al., 2006). It would therefore be valuable to determine whether this 
observation is also seen in our collection of P. aeruginosa strains, especially those 
from eye infections. If this correlation is observed, then it would be useful to 
determine the TTSS genotype of P. aeruginosa cultured from infections and 
instigate the appropriate management.  
 
6.5 Conclusions 
A selection of 283 P. aeruginosa isolates including 117 from eye infections were 
analysed by MLST. 200 individual STs were designated to the 283 isolates, with 
ST-235 being the most frequently observed ST (n=30). Phylogenetic analysis 
based on allelic profiles demonstrated that P. aeruginosa has a non-clonal 
population structure. In addition, phylogenetic analysis of the concatenated 
sequences of the seven housekeeping genes identified the existence of an 
epidemic clonal complex. Analysis of recombination using the splits 
decomposition program and the IA value supports the finding that the population 
structure of P. aeruginosa is non-clonal and that recombination has had an 
important role in determining its evolution.   
 
eBURST analysis of the MLST data identified 30 eBURST groups. However, 109 
of the 283 isolates did not belong to an eBURST group. There appears to be no 
association between individual clones or eBURST groups and the clinical source 
of infection or geographical distribution of these strains.  
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The presence or absence of exoU and exoS genes in 105 P. aeruginosa isolates 
from eye infections was determined by PCR amplification. Data confirmed that 
the exoU and exoS genes are generally mutually exclusive (three isolates 
harboured both genes and five isolates possessed neither genes). There was no 
statistically significant difference between the proportion of isolates possessing 
the exoU gene and those possessing the exoS gene. The distribution of TTSS 
genotypes of the eye infection strains in the current study appear to confirm 
previous studies of eye infection isolates but differ from isolates from other 
infection sites.  
 
MLST data corresponded well with TTSS genotype. Isolates with the same ST 
were found to have the same TTSS genotype and isolates belonging to the same 
eBURST group were also found to possess the same TTSS genotype. With one 
exception, MLST data and serotype data for 63 of the isolates were found to 
correlate i.e. isolates from the same eBURST group had the same serotype. The 
reverse was not true, i.e. isolates with the same serotype could be found in several 
different eBURST groups. This further validates the higher discriminatory power 
of MLST compared to phenotyping methods. 
 
In conclusion, MLST analysis of a selection of 283 P. aeruginosa shows that this 
organism has a non-clonal epidemic population structure. Clones or clonal 
complexes were not found to be associated with particular clinical manifestation 
or geographical distribution. Further study to determine any association between 
antibiotic resistance and MLST data would be useful for clinical management of 
P. aeruginosa infection.  
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CHAPTER 7 GENERAL DISCUSSION  
 
7.1 Main objectives 
The main objectives of the project were (1) to identify the common 
microorganisms that cause microbial keratitis and endophthalmitis in a large 
tertiary eye centre in the West Midlands, UK (2) to develop an MLST scheme for 
P. acnes, (3) to study the population biology of P. acnes and P. aeruginosa 
cultured from eye infections using MLST, determine whether specific clones were 
associated with eye infections and (4) to develop a PCR based rapid diagnostic 
test to detect P. acnes from ocular samples.  
 
7.2 Microbial keratitis study 
Microbial keratitis is infection of the cornea, the clear transparent structure at the 
front of the eye. It is an ophthalmic emergency and the visual prognosis of the 
patient depends on prompt identification of the causative organism and initiation 
of appropriate topical antibiotic therapy. The causative microorganism is partly 
dependent on the geographical location and climatic factors. Identification of the 
organism in most hospitals is dependent on culturing the organism from corneal 
scrape specimens using conventional techniques. Culture positive rates using 
these techniques vary widely from 50% to 86% (Alexandrakis et al., 2000; 
Bennett et al., 1998; Bourcier et al., 2003; Fong et al., 2007; Neumann & 
Sjostrand, 1993; Schaefer et al., 2001; Wong et al., 2003). The low culture 
positive rates lead to most cases being treated with broad spectrum antibiotics 
which the infecting organisms may not be sensitive to. Poor visual outcome and 
increased antimicrobial resistance are unfortunately the potential consequences.  
 
The current retrospective study looked at patient records for 303 cases of 
suspected microbial keratitis at the Birmingham and Midland Eye Centre over a 
29-month period. Contact lens wear was found to be the most common 
predisposing factor for the development of microbial keratitis, followed by ocular 
surgery, previous microbial keratitis and ocular trauma. The culture positive rate 
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was found to be under 40% and the mean average time taken to obtain a culture 
positive result was 5.3 days. This low culture positive rate could be a consequence 
of sampling sterile ulcers, small amounts of sample, poor sampling technique, use 
of topical anaesthetic agents before sampling, possible delay in transporting the 
sample to the laboratory and poor sensitivity of conventional culture methods. 
Prior use of antibiotics before obtaining the specimen was not found to 
significantly reduce the culture positive rate. Pseudomonas spp. were the most 
frequently cultured organisms and the proportion of Pseudomonas spp. infection 
was even higher in contact lens-related cases. Low culture positive rate and 
prolonged time to culture result, indicates a more rapid and sensitive molecular 
diagnostic test, such as PCR, is required for optimal management of this sight 
threatening eye infection.  
 
7.3 P. acnes MLST 
P. acnes  belongs to the human cutaneous propionibacteria and usually lives on 
the skin as a harmless commensal (Brook & Frazier, 1991). The potential for this 
organism to cause serious clinical infections is being increasingly reported. It is 
the most common organism found in chronic postoperative endophthalmitis 
(Aldave et al., 1999), a dreaded complication of cataract surgery and has also 
been reported to cause keratitis (Jones & Robinson, 1977; Perry et al., 1982; 
Wong et al., 2003; Zaidman, 1992). P. acnes was originally classified into two 
phenotypes, known as types I and II, based on serological agglutination tests and 
cell wall sugar analysis (Johnson & Cummins, 1972). Analysis of the P. acnes 
recA gene and tly gene sequences found that types I and II represent distinct 
phylogenetic lineages and that type I strains could be subdivided into groups IA 
and IB (Cohen et al., 2005; McDowell et al., 2005). Recently, a novel lineage of 
strains, known as type III, has been described (McDowell et al., 2008).  
 
Previously described genetic fingerprinting methods to type P. acnes, including 
RAPD (Kunishima et al., 2001; Perry et al., 2003) and PFGE (Cohen et al., 2005; 
Oprica & Nord, 2005; Ting et al., 1999), suffer from variability, poor 
reproducibility and lack of inter-laboratory transferability. Typing methods based 
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on the analysis of DNA sequences rather than genome organisation or restriction 
fragments is much more robust, reliable and transferable between laboratories. 
MLST, developed in 1998, is a nucleotide sequence-based method enabling 
comparative characterisation of bacterial isolates usually based on seven 
housekeeping genes (Maiden et al., 1998). MLST has the advantage of being a 
reproducible and scalable typing system that is portable between laboratories 
(Urwin & Maiden, 2003). An MLST scheme was set up for P. acnes to 
characterise the population structure of a diverse collection of clinical P. acnes 
isolates and to determine the level of recombination contributing to its diversity. 
MLST analysis was also done to ascertain whether certain genotypes were 
associated with particular clinical diseases or geographical locations. 
 
Seven P. acnes housekeeping genes: aroE, atpD, gmk, guaA, lepA, recA and sod 
A were selected to be examined in the MLST scheme. Although atpD, gmk and 
aroE were located relatively close together around the P. acnes chromosome, 
analysis of recombination at these genes demonstrated that a single 
recombinogenic event was unlikely to have involved two or even three of these 
genes simultaneously. The ratio of non-synonymous (dN) to synonymous (dS) 
changes calculated for each of the seven genes showed that there was no strong 
selective pressure operating on these genes and therefore validated their suitability 
for inclusion in the MLST scheme.  
 
A total of 125 P. acnes isolates, including two reference strains and isolates 
cultured from a variety of clinical infections were analysed. 38 different STs were 
assigned to these isolates, with nearly half of the isolates being represented by ST-
6. The frequent occurrence of ST-6 raises the question as to whether this genotype 
is just more common, even in healthy individuals or whether it is a more virulent 
strain with greater capacity to cause disease. Further work using MLST to type P. 
acnes isolates from healthy, carrier skin and analysis of virulence genes would be 
useful to answer this question.  
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Phylogenetic analyses of the MLST data, either based on concatenated sequences 
or allelic profiles, were carried out using a variety of methods. eBURST analysis 
grouped the 38 STs into seven clonal complexes based on isolates having identical 
alleles at six or more of the loci. 3 STs did not fall into any eBURST group. ST-6 
was identified as the founding genotype, having the largest number of SLVs. 
Phylogenetic dendrogram representation of the concatenated sequences of the 38 
STs correlated with eBURST analysis to some extent although there were 
differences in designation of isolates into groups. This is not unexpected as 
analysis based on allelic profiles does not take into consideration of the number of 
nucleotide substitutions occurring at a gene. Comparison of P. acnes isolates does 
not show an association between a particular ST or clonal complex with certain 
clinical infections or geographical locations. Some STs were found in numerous 
different countries, cultured from a variety of clinical sites. A variety of methods 
used to determine the level of recombination occurring within the study 
population suggest that frequent recombinogenic events occur within, but not 
between the P. acnes phylogenetic subgroups.   
 
7.4 Comparisons of P. acnes MLST with 16S rRNA gene and recA 
gene analyses  
Validation of the P. acnes MLST scheme was achieved by comparing 16S rRNA 
gene and the complete recA gene sequencing data, IFM analysis and RAPD 
analysis. 16S rRNA gene analysis of eleven of the 125 isolates included in the 
MLST scheme had previously been published (McDowell et al., 2005; McDowell 
et al., 2008). The selection of isolates included representatives of type IA, IB, II 
and III isolates. The eleven isolates were subdivided into three main lineages 
corresponding to types I, II and III strains, but could not distinguish between types 
IA and IB. The 16S rRNA gene analysis data was in concordance with the 
eBURST group clustering generated by MLST data and thus validated the MLST 
scheme. However, MLST provides much better discrimination as shown by 
isolates with the same 16S rRNA gene sequences belonging to different STs.  
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P. acnes has previously been shown to be composed of phylogenetically distinct 
clusters or lineages based on sequence analysis of the complete recA gene 
(McDowell et al., 2005; McDowell et al., 2008). It was therefore important to 
determine whether these phylogenetic types corresponded to MLST clusters. Of 
the 125 isolates used in the MLST scheme, the recA phylotype of 58 isolates was 
determined based on complete recA gene sequencing. The distinct groups or 
lineages based on recA sequence analysis (IA, IB, II & III) were mostly congruent 
with the clonal complexes resolved using MLST. eBURST analysis revealed that 
groups 1, 2 and 4 consisted of type IA strains and group 3 consisted of type IB 
strains. Type II strains were found to form two closely related clonal complexes 
(eBURST groups 5 and 6), while strains belonging to type III formed a single 
clonal complex (eBURST group 7).  
 
While phylotype data for P. acnes isolates based on complete recA sequences 
correlated well with MLST data, there were a few exceptions. Three isolates 
formed a highly distinct cluster (group 4) based on eBURST analysis, but one of 
these strains (PV66) was classified as a type IA organism based on recA and tly 
gene sequencing (McDowell et al., 2005). Multiple methods of analysing MLST 
data have demonstrated that these strains form a distinct cluster away from the 
other P. acnes strains. Therefore, this novel cluster does not belong to any of the 
four previously confirmed phenotypes (IA, IB, II and III). Two further isolates 
were found to have conflicting MLST and recA gene analysis data. Isolates Asn7 
and JMK9 clustered in eBURST group 1 with other type IA strains. However, 
based on complete recA sequence, they were characteristic of type IB organisms. 
This discrepancy may have come about from a recombinational event occurring at 
the recA gene between type IA and IB strains, resulting in a type IA strain 
acquiring the segment distinguishing it as a type IB strain. Therefore, analysis of 
multiple housekeeping genes is more reliable in determining phylogenetic 
relationships, as sequence data from each gene is buffered against potential 
recombinogenic events that might occur at other loci. 
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7.5 Comparison of P. acnes MLST with IFM analysis  
IFM using type-specific based MAbs generated by Andrew McDowell was 
carried out on 76 P. acnes isolates. Previous IFM analysis have found that MAbs 
QUBPa1 and QUBPa2 labelled P. acnes type IA and II, respectively, and 
QUBPa3 reacted with all P. acnes strains. No labelling with QUBPa1 or QUBPa2 
was observed for the type III isolates.  
 
A selection of P. acnes isolates from eBURST groups 1 and 2 showed that they 
were all type IA strains based on IFM analysis. All eBURST groups 5 and 6 
strains were identified as type II strains and all eBURST group 7 strains were 
identified as type III strains. IFM analysis of type IB (eBURST group 3) strains 
showed variable reaction to QUBPa1 and QUBPa2. Some strains showed absence 
of reaction with QUBPa1 and weak–to-no reaction with the MAb QUBPa2, whilst 
other strains were found to react with QUBPa1, but not with QUBPa2. This 
illustrates that, while useful, immunological typing with MAbs is unpredictable 
due to the emergence of antigenic variants that do not react.  
 
In the study population, a novel cluster (eBUSRT group 4) comprising three 
isolates was identified. All isolates within this group displayed dual labelling with 
MAbs that normally react with either types IA (QUBPa1) or II (QUBPa2), further 
highlighting their distinct nature.  
 
7.6 Comparison of P. acnes MLST with RAPD analysis 
RAPD typing using RAPD-208 primer was carried out on 92 P. acnes as well as 
one P. avidum, one P. propionicus and one P. granulosum isolate. Although P. 
granulosum gave markedly different profiles with less than 40% similarity to 
those of the other species, P. propionicus and P. avidum appear to be more closely 
related to P. acnes at 70% and 73% similarities, respectively. Type II isolates 
appear to have clustered together. However, this group also clustered together 
with a type III and a type IA strain. Similarly, type III strains have clustered 
together but along with a type IA and a type IB strain. Type IA and IB strains 
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were distributed throughout the dendrogram, as there are too few band differences 
for the two types to be distinguished by RAPD analysis. MLST is a far superior 
genotyping technique at differentiating closely related strains than RAPD typing.  
 
7.7 P. acnes molecular diagnostics 
Study of the population biology of P. acnes using MLST identified distinct clonal 
complexes but found no distinction between strains from different clinical 
diseases or geographical locations. Therefore, a PCR assay for the detection of P. 
acnes from ocular samples does not need to target a specific subgroup, so any of 
the seven housekeeping genes used in the MLST scheme were potential targets for 
PCR assays. Real-time PCR, developed by Higuchi et al. (Higuchi et al., 1992; 
Higuchi et al., 1993) has the advantage of being more rapid than standard PCR 
protocols and enables real-time quantification of copy numbers.  
 
The real-time PCR assay developed here for the detection of the P. acnes gmk 
gene was applied to the four cutaneous Propionibacterium spp. (P. acnes, P. 
avidum, P. granulosum and P. propionicum) as well as other common eye 
infection organisms ((P. aeruginosa, S. aureus, coagulase negative 
Staphylococcus and S. pneumoniae) and was found to be specific for P. acnes. 
The assay was repeated on serial dilutions of the P. acnes type strain NCTC 737 
(0.1pg/ml to 1ng/ml). Melt-curve analysis of the real-time PCR reactions showed 
that the limit of detection of the assay was 0.1pg/ml of DNA, although a reliable 
level of detection would be 1pg/ml. The total assay time, excluding DNA 
extraction, was completed within 2 hours 30 minutes. In order to avoid the routine 
use of the phenol/chloroform DNA extraction method in the diagnostic setting, 
three different DNA extraction protocols were compared. The Chelex DNA 
extraction method and the DNAmite kit appeared to yield better genomic DNA 
from P. acnes than the HiPure Viral Nucleic Acid extraction kit.  
 
The current P. acnes real-time PCR assay needs to be applied to sterile aqueous or 
vitreous samples spiked with known concentrations of P. acnes organisms to 
further test its sensitivity and to optimise the various DNA extraction methods.  
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The assay can then be applied to aqueous and vitreous samples from suspected 
endophthalmitis and keratitis cases in the clinical setting. 
 
7.8 P. aeruginosa MLST 
P. aeruginosa is an opportunistic pathogen capable of infecting a variety of hosts 
(Lavenir et al., 2007; Pukatzki et al., 2002; Rahme et al., 2000). It is capable of 
causing severe keratitis, especially in contact lens wearers, and endophthalmitis 
(Mondino et al., 1986; Rattanatam et al., 2001; Wilhelmus, 1996). It can also lead 
to numerous other serious infections such as septicaemia, pneumonia, endocarditis 
and otitis (Eifrig et al., 2003; Jackson et al., 2003; Kashkouli et al., 2007; 
Kielhofner et al., 1992).  
 
Previous typing studies have reported that P. aeruginosa has a non-clonal 
population structure (Denamur et al., 1993; Dinesh et al., 2003; Lomholt et al., 
2001; Martin et al., 1999; Morales et al., 2004; Picard et al., 1994; Pirnay et al., 
2002; Romling et al., 1994; Ruimy et al., 2001). Kiewitz et al. analysed six 
sequences of 19 environmental and clinical isolates and demonstrated that the 
frequency of recombination among different P. aeruginosa genotypes was high 
(Kiewitz & Tummler, 2000). Curran et al. developed a P. aeruginosa MLST 
scheme to characterise a large collection of clinical and environmental isolates 
(Curran et al., 2004). The 143 isolates investigated were assigned to 139 different 
STs. The IA value for the individual STs was 0.17, supporting the theory that P. 
aeruginosa has a non-clonal population structure. 
 
In this study, 117 P. aeruginosa isolates from eye infections in the UK and China 
were analysed by MLST. MLST data on a further 166 P. aeruginosa isolates from 
other clinical infections, available on the P. aeruginosa MLST website, were also 
included in the analyses. 200 individual STs were designated to all 283 isolates, 
with ST-235 being the most frequently observed ST (n=30, 15%). eBURST 
analysis of the MLST data identified 30 eBURST groups. However, 109 of the 
283 isolates did not belong to an eBURST group. No association was found 
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between STs or eBURST groups and the clinical source of infection or 
geographical distribution. Phylogenetic analysis of the concatenated sequences of 
the seven housekeeping genes identified the existence of an epidemic clonal 
complex. Analysis of recombination using the splits decomposition program and 
the IA value supports the finding that the population structure of P. aeruginosa is 
non-clonal and that recombination has had an important role in determining its 
evolution.   
 
7.9 P. aeruginosa exoU and exoS genotyping  
The P. aeruginosa TTSS enables production and secretion of virulence factors 
directly into the cytoplasm of host cells (Ajayi et al., 2003). The effector proteins  
(secreted toxins) comprise of ExoS, ExoT, ExoU and ExoY  (Finck-Barbancon et 
al., 1997; Frank, 1997; Frithz-Lindsten et al., 1997; Hauser et al., 1998; Yahr et 
al., 1996; Yahr et al., 1998). Although exoY and exoT are present in nearly all P. 
aeruginosa isolates, the majority possess either exoS or exoU, not both (Feltman 
et al., 2001; Finck-Barbancon et al., 1997; Hauser et al., 1998). Invasive P. 
aeruginosa strains tend to express ExoS (Fleiszig et al., 1997), whereas non-
invasive or cytotoxic strains express ExoU (Finck-Barbancon et al., 1997; Hauser 
et al., 1998). The TTSS has been identified in nearly all clinical and 
environmental isolates but isolates from distinct disease sites appear to differ in 
their effector genotype (Feltman et al., 2001).   
 
In order to determine the TTSS effector genotype of P. aeruginosa strains from 
eye infections, PCR reactions to detect exoU and exoS were carried out on 105 P. 
aeruginosa eye isolates. The findings confirm that the exoU and exoS genes are 
almost mutually exclusive (Berthelot et al., 2003; Feltman et al., 2001; Fleiszig et 
al., 1997; Lomholt et al., 2001). When a representative of each ST was included 
in the analysis, the number of exoU genotype strains was similar to the number 
the exoS genotype strains. This correlates with previous studies which found no 
significant difference between the number of strains carrying the exoU gene and 
those carrying the exoS gene amongst P. aeruginosa strains from eye infections 
(Lomholt et al., 2001; Zhu et al., 2006). In contrast, studies of clinical and 
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environmental isolates which did not include eye infection isolates found that the 
majority of strains possessed the exoS gene (Berthelot et al., 2003; Feltman et al., 
2001). MLST analysis corresponded well with TTSS genotyping data as isolates 
with the same ST were found to have the same TTSS genotype.  
 
Serotype data of the eye isolates were available from a previous study 
(Winstanley et al., 2005). 59 isolates were assigned to seven different O-serotype 
groups: O:1, O:2, O:4, O:6, O:8, O:10 and O:11 (Winstanley et al., 2005). O:11 
and O:1 were the most commonly found serotypes (42.4% and 25.4%, 
respectively). There was good correlation between MLST data and serotype data 
as isolates with same ST also had the same serotype, with one exception: two 
isolates with the same ST were found to have different serotypes. Strains with the 
same serotype were not exclusively found in one eBURST group. This suggests 
that although MLST data generally correlates well with serotyping data, MLST 
analysis is more discriminative than serotyping for P. aeruginosa.    
 
7.10 Conclusions 
In conclusion, MLST has been used to study the population biology of P. acnes 
and P. aeruginosa, two organisms with potential to cause sight threatening ocular 
infections. The novel P. acnes MLST scheme reported here has proved a valuable 
tool for high-level strain identification and epidemiological investigation of P. 
acnes. The method has confirmed the previously described phylogenetic groups of 
the organism and identified an additional novel cluster. There appears to be no 
association between these distinct groups and clinical manifestation of the 
infection, nor the geographical location of these strains. These findings have 
allowed the development of a real-time diagnostic PCR assay targeting the gmk 
gene. The assay has been proven to be specific for P. acnes and also highly 
sensitive. MLST analysis confirmed that P. aeruginosa has a non-clonal 
population structure. As in the case of P. acnes, specific clones or clonal 
complexes were not associated with eye infection isolates or geographical origin 
of the isolates.  
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